10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2022

OR

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from  to

Commission file number 000-56021

ACREAGE HOLDINGS, INC.

(Exact name of registrant as specified in its charter)

British Columbia, Canada			98-1463868
(State or other jurisdiction of incorporation or organization)			(I.R.S. Employer Identification No.)
366 Madison Ave, 14th floor	New York	New York	10017
(Address of Principal Executive Offices)			(Zip Code)

(646) 600-9181

Registrant’s telephone number, including area code

Securities registered pursuant to Section 12(b) of the Act: None.

Securities registered pursuant to section 12(g) of the Act: Class D Subordinate Voting Shares, no par value; Class E Subordinate Voting Shares, no par value.

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.

Yes o No x

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.

Yes o No x

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports); and (2) has been subject to such filing requirements for the past 90 days.    Yes  x    No  o 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).

Yes  x   No  o 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	o	Accelerated filer	☒
Non-accelerated filer	o	Smaller reporting company	o
		Emerging growth company	☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).     Yes ☐   No  x

The Company has three classes of issued and outstanding shares: the Class E subordinate voting shares (the “Fixed Shares”), the Class D subordinate voting shares (the “Floating Shares”) and the Class F multiple voting shares (the “Fixed Multiple Shares”). The Fixed Shares and Floating Shares each entitle the holders to notice of and to attend at any meeting of the shareholders of the Company, except a meeting of which only holders of another particular class or series of shares of the Company have the right to vote. Each Fixed Share is entitled to one vote per Fixed Share, each Floating Share is entitled to one vote per Floating Share and each Fixed Multiple Share is entitled to 4,300 votes per Fixed Multiple Share on all matters upon which the holders of shares are entitled to vote. As of November 2, 2022, there were 79,046,738 Fixed shares, 34,114,596 Floating Shares, and 117,600 Fixed Multiple Shares, in each case, issued and outstanding.

TABLE OF CONTENTS

Acreage Holdings, Inc.

Form 10-Q

For the Three and Nine Months Ended September 30, 2022

PART I	Financial Information
Item 1.	Condensed Consolidated Statements of Financial Position as of September 30, 2022 (unaudited) and December 31, 2021 (audited)	1
	Unaudited Condensed Consolidated Statements of Operations for the three and nine months ended September 30, 2022 and 2021	3
	Unaudited Condensed Consolidated Statements of Shareholders’ Equity for the three and nine months ended September 30, 2022 and 2021	4
	Unaudited Condensed Consolidated Statements of Cash Flows for the nine months ended September 30, 2022 and 2021	6
	Notes to the Unaudited Condensed Consolidated Financial Statements	8
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	33
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	45
Item 4.	Controls and Procedures	45
PART II	Other Information
Item 1.	Legal Proceedings	47
Item 1A.	Risk Factors	47
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	47
Item 3.	Defaults Upon Senior Securities	47
Item 4.	Mine Safety Disclosures	47
Item 5.	Other Information	47
Item 6.	Exhibits	48
	SIGNATURES

PART I

Item 1. Financial Statements and Supplementary Data.

ACREAGE HOLDINGS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION

(in thousands)	September 30, 2022		December 31, 2021
	(unaudited)		(audited)
ASSETS
Cash and cash equivalents	$	26,476	$	43,180
Restricted cash	95		1,098
Accounts receivable, net	9,466		8,202
Inventory	50,892		41,804
Notes receivable, current	2,500		7,104
Assets held-for-sale	—		8,952
Other current assets	3,843		2,639
Total current assets	93,272		112,979
Long-term investments	34,328		35,226
Notes receivable, non-current	27,343		27,563
Capital assets, net	135,362		126,797
Operating lease right-of-use assets	22,730		24,598
Intangible assets, net	135,807		119,695
Goodwill	30,492		43,310
Other non-current assets	3,563		1,383
Total non-current assets	389,625		378,572
TOTAL ASSETS	$	482,897	$	491,551
LIABILITIES AND SHAREHOLDERS’ EQUITY
Accounts payable and accrued liabilities	$	26,082	$	23,861
Taxes payable	29,240		24,572
Interest payable	1,167		1,432
Operating lease liability, current	2,298		2,145
Debt, current	7,218		1,583
Non-refundable deposits on sale	—		1,000
Liabilities related to assets held for sale	—		1,867
Other current liabilities	10,500		10,333
Total current liabilities	76,505		66,793
Debt, non-current	194,874		169,151
Operating lease liability, non-current	22,324		24,255
Deferred tax liability	29,875		27,082
Other liabilities	1,125		—
Total non-current liabilities	248,198		220,488
TOTAL LIABILITIES	324,703		287,281

See accompanying Notes to Unaudited Condensed Consolidated Financial Statements

F-1

ACREAGE HOLDINGS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION

Commitments and contingencies
Common stock, no par value - unlimited authorized, 112,147 and 106,903 issued and outstanding, respectively	—		—
Additional paid-in capital	761,684		756,536
Treasury stock, 842 common stock held in treasury	(21,054)		(21,054)
Accumulated deficit	(583,052)		(538,215)
Total Acreage Shareholders' equity	157,578		197,267
Non-controlling interests	616		7,003
TOTAL EQUITY	158,194		204,270
TOTAL LIABILITIES AND EQUITY	$	482,897	$	491,551

See accompanying Notes to Unaudited Condensed Consolidated Financial Statements

F-2

ACREAGE HOLDINGS, INC.

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

	Three Months Ended September 30,					Nine Months Ended September 30,
(in thousands, except per share amounts)	2022		2021			2022		2021
REVENUE
Retail revenue, net	$	48,314	$	30,795		$	136,426	$	85,038
Wholesale revenue, net	12,810		17,077			42,342		42,634
Other revenue, net	295		280			881		3,090
Total revenues, net	61,419		48,152			179,649		130,762
Cost of goods sold, retail	(26,097)		(16,279)			(70,331)		(43,412)
Cost of goods sold, wholesale	(14,096)		(8,069)			(27,968)		(19,049)
Total cost of goods sold	(40,193)		(24,348)			(98,299)		(62,461)
Gross profit	21,226		23,804			81,350		68,301
OPERATING EXPENSES
General and administrative	9,727		8,465			27,036		23,067
Compensation expense	15,271		10,699			42,045		32,236
Equity-based compensation expense	3,156		4,168			8,970		17,191
Marketing	735		583			2,396		992
Impairments, net	506		2,339			2,973		3,157
Loss on notes receivable	7,219		—			7,219		1,726
Write down (recovery) of assets held-for-sale	—		—			874		(8,616)
Legal settlements (recoveries)	—		—			(335)		322
Depreciation and amortization	1,047		4,044			6,019		9,670
Total operating expenses	37,661		30,298			97,197		79,745
Net operating loss	$	(16,435)	$	(6,494)		$	(15,847)	$	(11,444)
Income (loss) from investments, net	17		489			154		(777)
Interest income from loans receivable	474		1,067			1,256		4,125
Interest expense	(5,688)		(3,620)			(15,989)		(14,072)
Other income, net	4,743		80			5,019		7,825
Total other income (loss)	(454)		(1,984)			(9,560)		(2,899)
Loss before income taxes	$	(16,889)	$	(8,478)		$	(25,407)	$	(14,343)
Income tax expense	(8,109)		(5,579)			(24,105)		(11,661)
Net loss	$	(24,998)	$	(14,057)		$	(49,512)	$	(26,004)
Less: net loss attributable to non-controlling interests	(2,784)		(1,761)			(4,675)		(3,347)
Net loss attributable to Acreage Holdings, Inc.	$	(22,214)	$	(12,296)		$	(44,837)	$	(22,657)
Net loss per share attributable to Acreage Holdings, Inc. - basic and diluted:	$	(0.20)	$	(0.12)	(1)	$	(0.41)	$	(0.22)	(1)
Weighted average shares outstanding - basic and diluted	111,200		106,332		(1)	108,795		104,524		(1)

(1) Presentation of September 30, 2021 figures have been revised.

See accompanying Notes to Unaudited Condensed Consolidated Financial Statements

F-3

ACREAGE HOLDINGS, INC.

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY

			Attributable to shareholders of the parent
(in thousands)	LLC Membership Units	Pubco Shares (as converted)	Share Capital		Treasury Stock		Accumulated Deficit		Shareholders’ Equity		Non-controlling Interests		Total Equity
December 31, 2020	3,861	101,250	$	737,290	$	(21,054)	$	(475,205)	$	241,031	$	18,678	$	259,709
Purchase of non-controlling interest in subsidiary	—		(272)		—		—		(272)		(14)		(286)
NCI adjustments for changes in ownership	—	400	601		—		—		601		(601)		—
Capital distributions, net	—	—	—		—		—		—		(30)		(30)
Other equity transactions	—	97	300		—		—		300		—		300
Equity-based compensation expense and related issuances	—	1,693	6,042		—		—		6,042		—		6,042
Net loss	—	—	—		—		(7,809)		(7,809)		(833)		(8,642)
March 31, 2021	3,861	103,440	$	743,961	$	(21,054)	$	(483,014)	$	239,893	$	17,200	$	257,093
NCI adjustments for changes in ownership	—	666	(1,463)		—		—		(1,463)		1,463		—
Capital distributions, net	—	—	—		—		—		—		(2,547)		(2,547)
Other equity transactions	—	1	117		—		—		117		—		117
Equity-based compensation expense and related issuances	—	1,595	6,981		—		—		6,981		—		6,981
Net loss	—	—	—		—		(2,553)		(2,553)		(753)		(3,306)
June 30, 2021	3,861	105,702	$	749,596	$	(21,054)	$	(485,567)	$	242,975	$	15,363	$	258,338
NCI adjustments for changes in ownership	—	—	76		—		—		76		(76)		—
Equity-based compensation expense and related issuances	—	701	4,168		—		—		4,168		—		4,168
Net loss	—	—	—		—		(12,297)		(12,297)		(1,761)		(14,058)
September 30, 2021	3,861	106,403	$	753,840	$	(21,054)	$	(497,864)	$	234,922	$	13,526	$	248,448

See accompanying Notes to Unaudited Condensed Consolidated Financial Statements

F-4

ACREAGE HOLDINGS, INC.

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY

			Attributable to shareholders of the parent
(in thousands)	LLC Membership Units	Pubco Shares (as converted)	Share Capital		Treasury Stock		Accumulated Deficit		Shareholders’ Equity		Non-controlling Interests		Total Equity
December 31, 2021	3,861	106,903	$	756,536	$	(21,054)	$	(538,215)	$	197,267	$	7,003	$	204,270
NCI adjustments for changes in ownership	—	—	5		—		—		5		(5)		—
Equity-based compensation expense and related issuances	—	508	4,159		—		—		4,159		—		4,159
Net loss	—	—	—		—		(12,694)		(12,694)		(1,217)		(13,911)
March 31, 2022	3,861	107,411	$	760,700	$	(21,054)	$	(550,909)	$	188,737	$	5,781	$	194,518
NCI adjustments for changes in ownership	—	—	(4,524)		—		—		(4,524)		4,524		—
Capital distributions, net	—	—	—		—		—		—		(5,534)		(5,534)
Equity-based compensation expense and related issuances	—	1,778	1,655		—		—		1,655		—		1,655
Net loss	—	—	—		—		(9,929)		(9,929)		(674)		(10,603)
June 30, 2022	3,861	109,189	$	757,831	$	(21,054)	$	(560,838)	$	175,939	$	4,097	$	180,036
NCI adjustments for changes in ownership	—	—	697		—		—		697		(697)		—
Other equity transactions	—	378	—		—		—		—		—		—
Equity-based compensation expense and related issuances	—	2,580	3,156		—		—		3,156		—		3,156
Net loss	—	—	—		—		(22,214)		(22,214)		(2,784)		(24,998)
September 30, 2022	3,861	112,147	$	761,684	$	(21,054)	$	(583,052)	$	157,578	$	616	$	158,194

See accompanying Notes to Unaudited Condensed Consolidated Financial Statements

F-5

ACREAGE HOLDINGS, INC.

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

	Nine Months Ended September 30,
(in thousands)	2022		2021
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$	(49,512)	$	(26,004)
Adjustments for:
Depreciation and amortization	6,019		9,670
Depreciation and amortization included in COGS	4,840		1,714
Equity-based compensation expense	8,970		17,607
Gain on business divestiture	(3,490)		(11,681)
Loss on disposal of capital assets	49		1,690
Loss on impairment	2,973		9,947
Loss on notes receivable	7,219		3,726
Recovery on notes receivable	(1,107)		—
Bad debt expense	22		(1,060)		(1)
Non-cash interest expense	2,301		3,154
Non-cash operating lease expense	223		(572)
Loss on lease termination	297		—
Deferred tax (income) expense	(889)		(8,125)
Non-cash loss from investments, net	895		778
Other non-cash (income) expense, net	—		(2,500)
Write-down (recovery) of assets held-for-sale	874		(8,616)
Change, net of acquisitions in:
Accounts receivable, net	(2,787)		(11,128)		(1)
Inventory	(8,715)		(11,864)
Other assets	(1,240)		9,514		(1)
Interest receivable	(1,125)		(1,031)
Accounts payable and accrued liabilities	(279)		1,238
Taxes payable	4,668		12,935
Interest payable	(265)		(2,060)
Other liabilities	(414)		(5,644)
Net cash used in operating activities	$	(30,473)	$	(18,312)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of capital assets	$	(12,582)	$	(27,535)
Investments in notes receivable	—		(3,918)
Collection of notes receivable	7,106		13,225
Proceeds from business divestiture	—		24,407
Proceeds from sale of capital assets	—		5
Business acquisitions, net of cash acquired	—		541
Purchases of intangible assets	(900)		—
Distributions from investments	1,048		1,427
Proceeds from sale of promissory notes	—		26,000
Cash paid for short-term investment	(3,400)		—
Proceeds from disposal of short-term investments	3,400		—
Net cash provided by (used in) investing activities	$	(5,328)	$	34,152
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from financing (refer to Note 14 for related party financing)	$	25,000	$	6,301
Deferred financing costs paid	(511)		(975)

See accompanying Notes to Unaudited Condensed Consolidated Financial Statements

F-6

ACREAGE HOLDINGS, INC.

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

Repayment of debt	(1,084)		(46,321)
Capital distributions - non-controlling interests	(5,534)		—
Net cash provided by (used in) financing activities	$	17,871	$	(40,995)
Net decrease in cash, cash equivalents, restricted cash, and cash held for sale	$	(17,930)	$	(25,155)
Cash, cash equivalents, restricted cash, and cash held for sale - Beginning of period	44,501		54,639
Cash, cash equivalents, restricted cash, and cash held for sale - End of period	$	26,571	$	29,484
RECONCILIATION OF CASH FLOW INFORMATION:
Cash and cash equivalents	$	26,476	$	27,868
Restricted cash	95		1,098
Cash held for sale	$	—	$	518
Total cash, cash equivalents, restricted cash, and cash held for sale at end of period	$	26,571	$	29,484

(1) Presentation of September 30, 2021 figures have been revised, refer to Note 2 for further discussion.

	Nine Months Ended September 30,
(in thousands)	2022		2021
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
Interest paid - non-lease	$	12,730	$	11,444
Income taxes paid	21,742		6,346
OTHER NON-CASH INVESTING AND FINANCING ACTIVITIES:
Capital assets not yet paid for	$	6,242	$	4,063
Promissory note conversion (Note 6)	—		10,880
Insurance proceeds not yet received	—		6,790
Non-cash proceeds from business divestiture	7,850		34,475
Non-cash proceeds from finance lease	5,785		—

See accompanying Notes to Unaudited Condensed Consolidated Financial Statements

F-7

ACREAGE HOLDINGS, INC.

NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(in thousands, except per share data)

1.    NATURE OF OPERATIONS

Acreage Holdings, Inc. (the “Company”, “Pubco” or “Acreage”) is a vertically integrated, multi-state operator in the United States (“U.S.”) cannabis industry and has contractual relationships with cannabis cultivation facilities, dispensaries and other cannabis-related companies in the U.S. The Company’s operations include (i) cultivating and processing cannabis plants, (ii) manufacturing branded consumer products, (iii) distributing cannabis flower and manufactured products, and (iv) retailing dosable cannabis products to consumers. The Company’s products appeal to medical and adult recreational use customers through brand strategies intended to build trust and loyalty. The Company’s Class E subordinate voting shares (“Fixed Shares”) and Class D subordinate voting shares (“Floating Shares”) are listed on the Canadian Securities Exchange under the symbols “ACRG.A.U” and “ACRG.B.U”, respectively, quoted on the OTCQX under the symbols “ACRHF” and “ACRDF”, respectively, and traded on the Frankfurt Stock Exchange under the symbols “0VZ1” and “0VZ2”, respectively.

High Street Capital Partners, LLC, a Delaware limited liability company doing business as “Acreage Holdings” (“HSCP”), was formed on April 29, 2014. The Company became the indirect parent of HSCP on November 14, 2018 in connection with the reverse takeover (“RTO”) transaction described below.

The Company’s principal place of business is located at 366 Madison Ave, 14th floor, New York, New York in the U.S. The Company’s registered and records office address is Suite 2800, Park Place, 666 Burrard Street, Vancouver, British Columbia in Canada.

The RTO transaction

On September 21, 2018, the Company, HSCP, HSCP Merger Corp. (a wholly-owned subsidiary of the Company), Acreage Finco B.C. Ltd. (a special purpose corporation) (“Finco”), Acreage Holdings America, Inc. (“USCo”) and Acreage Holdings WC, Inc. (“USCo2”) entered into a business combination agreement (the “Business Combination Agreement”) whereby the parties thereto agreed to combine their respective businesses, which would result in the RTO of Pubco by the security holders of HSCP, which was deemed to be the accounting acquiror. On November 14, 2018, the parties to the Business Combination Agreement completed the RTO.

Canopy Growth Corporation transaction

On June 27, 2019, the Company and Canopy Growth Corporation (“Canopy Growth” or “CGC”) implemented the Prior Plan of Arrangement (as defined in Note 13) contemplated by the Original Arrangement Agreement (as defined in Note 13). Pursuant to the Prior Plan of Arrangement, Canopy Growth was granted an option to acquire all of the issued and outstanding shares of the Company in exchange for the payment of 0.5818 of a common share in the capital of Canopy Growth for each Class A subordinate voting share (each, a “SVS”) held (with the Class B proportionate voting shares (the “PVS”) and Class C multiple voting shares (the “MVS”) being automatically converted to SVS immediately prior to consummation of the Acquisition (as defined in Note 13), which original exchange ratio was subject to adjustment in accordance with the Original Arrangement Agreement. Canopy Growth was required to exercise the option upon a change in federal laws in the United States to permit the general cultivation, distribution and possession of marijuana (as defined in the relevant legislation) or to remove the regulation of such activities from the federal laws of the United States (the “Triggering Event”) and, subject to the satisfaction or waiver of certain closing conditions set out in the Original Arrangement Agreement, Canopy Growth was required to acquire all of the issued and outstanding SVS (following the mandatory conversion of the PVS and MVS into SVS).

On June 24, 2020, Canopy Growth and the Company entered into an agreement to, among other things, amend the terms of the Original Arrangement Agreement and the terms of the Prior Plan of Arrangement (the “Amended Arrangement”). On September 16, 2020, the Company’s shareholders voted in favor of a special resolution authorizing and approving the terms of, among other things, the Amended Arrangement. Subsequently, on September 18, 2020, the Company obtained a final order from the Supreme Court of British Columbia approving the Amended Arrangement, and on September 23, 2020 the Company and Canopy Growth entered into the Amending Agreement (as defined in Note 13) and implemented the Amended Arrangement. Pursuant to the Amended Arrangement, the Company’s articles were amended to create the Fixed Shares, the Floating Shares and the Class F multiple voting shares (the “Fixed Multiple Shares”), and each outstanding SVS was exchanged for 0.7 of a Fixed Share and 0.3 of a Floating Share, each outstanding PVS was exchanged for 28 Fixed Shares and 12 Floating Shares; and each outstanding MVS was exchanged for 0.7 of a Fixed Multiple Share and 0.3 of a Floating Share. Refer to Note 13 for further discussion.

F-8

ACREAGE HOLDINGS, INC.

NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(in thousands, except per share data)

Pursuant to the implementation of the Amended Arrangement, on September 23, 2020, a subsidiary of Canopy Growth advanced gross proceeds of $50,000 to Universal Hemp, LLC, an affiliate of the Company. The debenture bears interest at a rate of 6.1% per annum. Refer to Note 10 for further discussion.

Subsequent to the balance sheet date, the Company entered into a new arrangement agreement with Canopy Growth regarding the acquisition of the Company’s Floating Shares. Refer to Note 17 for further discussion.

COVID-19

In December 2019, a novel strain of coronavirus (“COVID-19”) emerged in Wuhan, China. Since then, it has spread to other countries and infections have been reported around the world. On March 11, 2020, the World Health Organization declared the outbreak of COVID-19 a global pandemic.

In response to the outbreak, governmental authorities in the United States, Canada and internationally have introduced various recommendations and measures to try to limit the pandemic, including travel restrictions, border closures, non-essential business closures, quarantines, self-isolations, shelters-in-place and social distancing. The COVID-19 outbreak and the response of governmental authorities to try to limit it are having a significant impact on the private sector and individuals, including unprecedented business, employment and economic disruptions. Management has been closely monitoring the impact of COVID-19, with a focus on the health and safety of the Company’s employees, business continuity and supporting the communities where the Company operates. The Company implemented various measures at the height of the pandemic to reduce the spread of the virus, such as implementing social distancing measures at its facilities. Most of these measures are no longer considered to be necessary or required; however, the Company reserves the right to implement similar precautionary measures in the future as circumstances change.

Despite some impact to our day-to-day operations at select locations from time-to-time, COVID-19 has had a minimal impact overall on the Company’s performance.

2.    SIGNIFICANT ACCOUNTING POLICIES

Basis of presentation and going concern

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. In the opinion of management, all adjustments consisting only of normal recurring adjustments necessary for a fair presentation have been reflected in these unaudited condensed consolidated financial statements. Operating results for the interim periods presented are not necessarily indicative of the results that may be expected for the fiscal year ending December 31, 2022, or any other period.

As reflected in the unaudited condensed consolidated financial statements, the Company had an accumulated deficit as of September 30, 2022, as well as a net loss and negative cash flow from operating activities for the nine months ended September 30, 2022. These factors raise substantial doubt about the Company’s ability to continue as a going concern for at least one year from the issuance of these financial statements.

However, management believes that substantial doubt about the Company’s ability to meet its obligations for the next twelve months from the date these financial statements were issued has been alleviated due to, but not limited to, (i) access to future capital commitments, (ii) continued sales growth from the Company’s consolidated operations, (iii) latitude as to the timing and amount of certain operating expenses as well as capital expenditures, (iv) restructuring plans that have already been put in place to improve the Company’s profitability, (v) the AFC-VRT credit facilities (refer to Notes 10 and 17 for further discussion), and (vi) access to the U.S. and Canadian public equity markets.

If the Company is unable to raise additional capital whenever necessary, it may be forced to decelerate or curtail its footprint build-out or other operational activities until such time as additional capital becomes available. Such limitation of the Company’s activities would allow it to slow its rate of spending and extend its use of cash until additional capital is raised. However, management cannot provide any assurances that the Company will be successful in accomplishing any of its plans. Management also cannot provide any assurance as to unforeseen circumstances that could occur at any time within the next twelve months or thereafter which could increase the Company’s need to raise additional capital on an immediate basis.

F-9

ACREAGE HOLDINGS, INC.

NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(in thousands, except per share data)

These interim unaudited condensed consolidated financial statements and notes thereto should be read in conjunction with the audited consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021, dated March 11, 2022, as filed with the Securities and Exchange Commission (the “2021 Form 10-K”).

Use of estimates

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”). Preparation of financial statements in conformity with GAAP requires management to make estimates, judgments and assumptions that affect the reported amounts of assets and liabilities as of the dates presented and the reported amounts of revenues and expenses during the periods presented. Actual results could differ from those estimates. Significant estimates inherent in the preparation of the accompanying unaudited condensed consolidated financial statements include the fair value of assets acquired and liabilities assumed in business combinations, assumptions relating to equity-based compensation expense, estimated useful lives for property, plant and equipment and intangible assets, the valuation allowance against deferred tax assets and the assessment of potential charges on goodwill, intangible assets and investments in equity and notes receivable.

Emerging growth company

The Company is an “emerging growth company” as defined in the Jumpstart Our Business Startups Act (the “JOBS Act”). Under the JOBS Act, emerging growth companies can delay adopting new or revised accounting standards until such time as those standards apply to private companies.

Functional and presentation currency

The unaudited condensed consolidated financial statements and the accompanying notes are expressed in U.S. dollars. Financial metrics are presented in thousands. Other metrics, such as shares outstanding, are presented in thousands unless otherwise noted.

Basis of consolidation

The Company’s unaudited condensed consolidated financial statements include the accounts of Acreage, its subsidiaries and variable interest entities (“VIEs”) where the Company is considered the primary beneficiary, if any, after elimination of intercompany accounts and transactions. Investments in business entities in which Acreage lacks control but is able to exercise significant influence over operating and financial policies are accounted for using the equity method. The Company’s proportionate share of net income or loss of the entity is recorded in Income (loss) from investments, net in the Unaudited Condensed Consolidated Statements of Operations.

VIEs

In determining whether the Company is the primary beneficiary of a VIE, the Company assesses whether it has the power to direct matters that most significantly impact the activities of the VIE and have the obligation to absorb losses or the right to receive benefits from the VIE that could potentially be significant to the VIE. There were no material consolidated VIEs as of September 30, 2022 or December 31, 2021.

Non-controlling interests (“NCI”)

Non-controlling interests represent ownership interests in consolidated subsidiaries by parties that are not shareholders of Pubco. They are shown as a component of Total equity in the Unaudited Condensed Consolidated Statements of Financial Position, and the share of loss attributable to non-controlling interests is shown as a component of Net loss in the Unaudited Condensed Consolidated Statements of Operations. Changes in the parent company’s ownership that do not result in a loss of control are accounted for as equity transactions.

Restricted cash

Restricted cash represents funds contractually held for specific purposes and, as such, not available for general corporate purposes.

F-10

ACREAGE HOLDINGS, INC.

NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(in thousands, except per share data)

Cash and restricted cash, as presented on the Unaudited Condensed Consolidated Statements of Cash Flows, consists of $26,476 and $95 as of September 30, 2022, respectively, and $27,868 and $1,098 as of September 30, 2021, respectively.

Accounts receivable valuations and reclassifications

Accounts receivable are stated at their net realizable value. The allowance against gross trade receivables reflects the best estimate of probable losses inherent in the receivables portfolio determined on the basis of historical experience, specific allowances for known troubled accounts and other currently available information. As of September 30, 2022 and December 31, 2021, the Company’s allowance for doubtful accounts was $63 and $445, respectively.

Income taxes

The Company has unrecognized tax benefits (“UTBs”) of $6,161 and $7,695 as of September 30, 2022 and December 31, 2021, respectively, which are included in Other current liabilities in the Consolidated Statements of Financial Position. UTBs arise as a result of differences existing between a tax position taken or expected to be taken on a tax return and the benefit recognized and measured.

Net loss per share

Net loss per share represents the net loss attributable to shareholders divided by the weighted average number of shares outstanding during the period on an as converted basis. Basic and diluted loss per share are the same as of September 30, 2022, 2021 and 2020, as the issuance of shares upon conversion, exercise or vesting of outstanding units would be anti-dilutive in each period. There were 47,999 and 42,621 anti-dilutive shares outstanding as of September 30, 2022 and 2021, respectively.

Change in presentation

Note that certain items presented on the nine months ended September 30, 2021, Unaudited Condensed Consolidated Statement of Cash Flows, includes a change in presentation to conform to the current year presentation. There was no impact to our Consolidated Financial Statements as a result of this reclassification.

Accounting Pronouncements Recently Adopted

As of January 1, 2022, the Company adopted ASU 2019-12 - Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes (ASU 2019-12). ASU 2019-12 attempts to simplify aspects of accounting for franchise taxes and enacted changes in tax laws or rates and clarifies the accounting for transactions that result in a step-up in the tax basis of goodwill. The adoption of ASU 2019-12 did not have a material effect on the Company’s unaudited condensed consolidated financial statements.

As of January 1, 2022, the Company adopted ASU 2020-01 - Investments-Equity Securities (Topic 321), Investments-Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815). The new standard clarifies the interaction of accounting for the transition into and out of the equity method. The new standard also clarifies the accounting for measuring certain purchased options and forward contracts to acquire investments. The adoption of ASU 2020-01 did not have a material effect on the Company’s unaudited condensed consolidated financial statements.

As of January 1, 2022, the Company adopted ASU 2021-04 - Earnings Per Share (Topic 260), Debt - Modifications and Extinguishments (Topic 470-50), Compensation - Stock Compensation (Topic 718), and Derivatives and Hedging - Contracts in Entity's Own Equity (Subtopic 815-40), which clarifies existing guidance for freestanding written call options which are equity classified and remain so after they are modified or exchanged in order to reduce diversity in practice. The standard applies prospectively to modifications or exchanges that occur after it is adopted. The adoption of ASU 2021-04 did not have a material effect on the Company’s unaudited condensed consolidated financial statements.

Accounting Pronouncements Not Yet Adopted

In June 2016, the FASB issued ASU 2016-13 - Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (“ASU 2016-13”), which was subsequently revised by ASU 2018-19 and ASU 2020-02. The ASU introduces a new model for assessing impairment on most financial assets. Entities will be required to use a forward-looking expected loss model, which will replace the current incurred loss model, which will result in earlier recognition of allowance for losses. The ASU will be effective for the Company’s first interim period of fiscal 2023. The Company continues to evaluate the impact of this ASU on its unaudited condensed consolidated financial statements.

F-11

ACREAGE HOLDINGS, INC.

NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(in thousands, except per share data)

In October 2021, the FASB issued ASU 2021-08 - Business Combinations (Topic 805), Accounting for Contract Assets and Contract Liabilities from Contracts with Customers. The new standard improves the accounting for acquired revenue contracts with customers in a business combination by addressing diversity in practice and inconsistency. The new standard requires an entity to recognize and measure contract assets and contract liabilities acquired in a business combination in accordance with ASC 606 - Revenue from Contracts with Customers. The ASU will be effective for the Company’s first interim period of fiscal 2024. The standard should be applied prospectively to business combinations occurring on or after the effective date of the amendments. The Company does not anticipate a material impact on the Company’s unaudited condensed consolidated financial statements upon adoption.

3.    ACQUISITIONS, DIVESTITURES AND ASSETS HELD FOR SALE

Acquisitions

During the nine-month period ended September 30, 2022, the Company did not complete any business acquisitions. During the year ended December 31, 2021, the Company completed the following business acquisitions, and has allocated the purchase price as follows:

Purchase Price Allocation	Greenleaf		CWG		Total
Assets acquired:
Cash and cash equivalents	$	1,209	$	828	$	2,037
Inventory	2,692		1,200		3,892
Other current assets	1,520		347		1,867
Capital assets, net	22,923		3,312		26,235
Operating lease right-of-use asset	2,819		1,584		4,403
Goodwill	1,819		1,482		3,301
Intangible assets, net - cannabis licenses	16,800		3,200		20,000
Intangible assets, net - customer relationships	—		1,000		1,000
Other non-current assets	189		40		229
Liabilities assumed:
Accounts payable and accrued liabilities	(1,829)		(464)		(2,293)
Taxes payable	(33)		(68)		(101)
Operating lease liability, current	(315)		(193)		(508)
Other current liabilities	(294)		3		(291)
Operating lease liability, non-current	(2,504)		(1,391)		(3,895)
Fair value of net assets acquired	$	44,996	$	10,880	$	55,876
Consideration paid:
Settlement of pre-existing relationship	44,996		10,880		$	55,876
Total consideration	$	44,996	$	10,880	$	55,876

Greenleaf

On October 1, 2021, a subsidiary of the Company acquired of 100% of Greenleaf Apothecaries, Greenleaf Gardens, and Greenleaf Therapeutics, collectively known as “Greenleaf.” Greenleaf consists of cannabis cultivation, processing, and dispensary operations in the state of Ohio. The completion of this acquisition established Acreage’s footprint in the Ohio cannabis market.

F-12

ACREAGE HOLDINGS, INC.

NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(in thousands, except per share data)

On July 2, 2018, the Company entered into purchase agreements for Greenleaf for the total purchase price of approximately $8,245 in cash, $6,096 in seller notes payable and 1.2 million shares of HSCP with an average fair value of $7.73 per share, which are convertible into shares of the Company. In addition, the Company extended a $31,200 line of credit and issued $12,500 in promissory notes to the Greenleaf entities. The consideration paid was made in exchange for: (a) the rights to acquire the Greenleaf entities upon state regulatory approval and; (b) master services agreements (“MSAs”) to operate the entities until such approval was granted and ownership interests were transferred. The purchase consideration paid represents the fair value of the intangible asset related to the MSA that was recorded on the Company’s Statement of Financial Position at the time of the transaction. The intangible asset was amortized over the life of the MSAs.

Upon closing, the Company repaid the remaining $3,300 worth of sellers notes payable and accrued interest and assumed $42,043 in notes and interest receivable owed to the Company by Greenleaf that was eliminated upon consolidation. Total consideration for the asset transfer transaction was $44,996, representing the sum of the $2,953 carrying value of intangible assets from the 2018 transaction and the liabilities assumed. As the Company owns 100% of Greenleaf, the subsidiary is accounted for on a consolidated basis as of the closing date.

The purchase price allocation is based upon final valuations within the measurement period (generally one year from the acquisition date)

CWG

On April 30, 2021, a subsidiary of the Company acquired 100% of CWG Botanicals, Inc. (“CWG”), an adult-use cannabis cultivation and processing operations in the state of California.

The consideration paid for CWG consisted of the settlement of a pre-existing relationship, which included a line of credit of $9,321 and the related interest receivable of $1,559, which were both previously recorded in Notes receivable, non-current on the Statements of Financial Position.

The purchase price allocation is based upon final valuations within the measurement period (generally one year from the acquisition date).

NCCRE

On March 19, 2021, a subsidiary of the Company, HSC Solutions, LLC entered into an assignment of membership agreement to acquire the remaining non-controlling interests of its subsidiary, NCC Real Estate, LLC (“NCCRE”), based primarily on the fair value of property held by NCCRE estimated in the amount of $850. The consideration paid to the non-controlling interest sellers of $286 was recorded in Additional paid-in capital and Non-controlling interests on the Statements of Financial Position. Additionally, the Company subsequently repaid the outstanding principal balance of the NCCRE secured loan.

Divestitures

In February 2021, a subsidiary of the Company entered into a definitive agreement and management services agreement to sell an indoor cultivation facility in Medford, Oregon ("Medford"), and a retail dispensary in Powell, Oregon ("Powell"), for total consideration of $3,000. In March 2022, the total consideration was reduced to $2,000. In April 2022, the Company sold all equity interests in Medford for an aggregate sale price of $2,000 and recognized a gain on sale of $290 for the nine months ended September 30, 2022 which was recorded in Other income, net in the Unaudited Condensed Consolidated Statements of Operations. The aggregate sales price consisted of $750 paid to the Company in February 2021 and $1,250 of promissory notes (refer to Note 6 for further discussion). In conjunction with the sale, the Company closed its dispensary in Powell. Further, the Company derecognized deferred tax liabilities of $375 related to Medford.

In September 2021, a subsidiary of the Company entered into a definitive agreement and management services agreements to sell, upon regulatory approval, four retail dispensaries in Oregon for total consideration of $6,500. In July 2022, the Company executed and closed an amendment to its previously announced asset purchase and services agreement for the sale of its four Oregon retail dispensaries (the “Amended Agreement”). Under the terms of the Amended Agreement, the sale price was reduced to $6,200 and the Company recognized a gain on sale of $3,189 for the nine months ended September 30, 2022 which was recorded in Other income, net in the Unaudited Condensed Consolidated Statements of Operations. The aggregate sales price consisted of a $250 payment previously made at the signing of the Original Agreement, plus an additional $100 in cash at closing. The remaining amount of $5,850 has been satisfied by a 36-month secured promissory note bearing interest at a rate of 12% per annum (the “Note”). Under the terms of the Note, quarterly interest payments commence on January 1, 2023, principal payments of $1,000 are due on January 1, 2024 and January 1, 2025, and the remaining principal is due on January 1, 2026.

F-13

ACREAGE HOLDINGS, INC.

NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(in thousands, except per share data)

During the nine months ended September 30, 2021, a subsidiary of the Company sold all equity interests in Acreage Florida, Inc. (“Acreage Florida”), for an aggregate sale price of $60,000. Acreage Florida is licensed to operate medical cannabis dispensaries, a processing facility and a cultivation facility in the state of Florida. The aggregate sales price consisted of approximately $21,500 in cash, $7,000 of the buyer’s common stock, subject to a rolling lock up restriction period ending one year after the disposition date, with the lock up expiring in monthly 1/6th increments beginning October 27, 2021, and secured promissory notes totaling approximately $31,500. This resulted in a gain on sale of $11,682 recorded in Other income, net on the Consolidated Statements of Operations for the nine months ended September 30, 2021. The Company subsequently sold the promissory notes and recognized a net loss of $2,000 as discussed in Note 6. Further, the Company de-recognized deferred tax liabilities related to indefinite-lived intangible lived assets held by Acreage Florida of $6,044 as a result of the disposition in Other income, net on the Unaudited Condensed Consolidated Statements of Operations for the nine months ended September 30, 2021.

Assets Held for Sale

As of September 30, 2022, the Company did not have any business or assets that met the held-for-sale criteria. As of December 31, 2021 the Company determined certain businesses and assets met the held-for-sale criteria. As such, the related assets and liabilities within these disposal groups were transferred into Assets held-for-sale and Liabilities related to assets held for sale on the Unaudited Condensed Consolidated Statements of Financial Position.

During the nine months ended September 30, 2022, the Company tested each disposal group for impairment and recognized charges of $874 within Write down (recovery) of assets held-for-sale on the Unaudited Condensed Consolidated Statements of Operations related to Medford and Powell. During the nine months ended September 30, 2021, the Company recognized a recovery of assets held-for-sale of $8,616 related to the Acreage Florida disposal group within Write down (recovery) of assets held-for-sale on the Unaudited Condensed Consolidated Statements of Operations.

The table below presents the assets and liabilities classified as held for sale on the Unaudited Condensed Consolidated Statements of Financial Position for the year ended December 31, 2021 and is subject to change based on developments during the sales process.

	December 31, 2021
	Michigan(1)		Oregon		Total
Cash	$	—	$	223	$	223
Inventory	—		445		445
Notes receivable, current	—		31		31
Other current assets	—		9		9
Total current assets classified as held-for-sale	—		708		708
Capital assets, net	1,907		2,342		4,249
Operating lease right-of-use assets	—		1,695		1,695
Goodwill	—		2,191		2,191
Non-current assets	—		109		109
Total assets classified as held for sale	$	1,907	$	7,045	$	8,952
Accounts payable and accrued liabilities	$	—	$	(639)	$	(639)
Operating lease liability, current	—		(441)		(441)
Total current liabilities classified as held-for-sale	—		(1,080)		(1,080)
Operating lease liability, non-current	—		(787)		(787)
Total liabilities classified as held-for-sale	$	—	$	(1,867)	$	(1,867)

(1) During the nine months ended September 30, 2022, the Company was unsuccessful in finding a satisfactory buyer for certain of its Michigan locations. As a result, the assets at these specific locations no longer meet the criteria for being classified as held-for-sale (refer to Note 7 for further discussion).

F-14

ACREAGE HOLDINGS, INC.

NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(in thousands, except per share data)

4.    INTANGIBLE ASSETS AND GOODWILL

Intangible assets

The following table details the intangible asset balances by major asset classes:

Intangibles	September 30, 2022		December 31, 2021
Finite-lived intangible assets:
Management contracts	$	1,808	$	1,511
Customer relationships	1,000		1,000
Total finite-lived intangible assets	2,808		2,511
Accumulated amortization on finite-lived intangible assets:
Management contracts	(931)		(493)
Customer relationships	(850)		—
Total accumulated amortization on finite-lived intangible assets	(1,781)		(493)
Finite-lived intangible assets, net	1,027		2,018
Indefinite-lived intangible assets
Cannabis licenses	134,780		117,677
Total intangibles, net	$	135,807	$	119,695

The intangible assets balance as of December 31, 2021 excludes intangible assets reclassified to assets held-for-sale (refer to Note 3 for further discussion). The average useful life of finite-lived intangible assets as of September 30, 2022 ranges from 0.3 to 1.5 years, with 0.3 and 1.5 years being the average useful life for customer relationships and management contracts, respectively.

During the three and nine months ended September 30, 2022, the Company amended the purchase price allocation related to its acquisition of Greenleaf based upon final valuations within the measurement period (refer to Note 3 for further discussion). As a result, $16,800 was re-allocated from Goodwill to Intangible assets, net on the Unaudited Condensed Consolidated Statements of Financial Position.

Impairment of intangible assets

The Company assessed whether any events or changes in circumstances ("triggering events") indicated finite-lived intangible assets to be held-and-used would not be recovered. During the three and nine months ended September 30, 2022, the Company did not identify any triggering events. During the nine months ended September 30, 2021, the Company identified a triggering event for its management contract owned by Prime Alternative Treatment Center Consulting, LLC ("PATCC"). The Company evaluated the recoverability of the asset by comparing the carrying value of the asset to the future net undiscounted cash flows expected to be generated by the asset. The carrying value was determined to not be recoverable and the Company proceeded to test the asset for impairment. The Company recognized an impairment charge of $818 due to changes in expected cash flows pursuant to a revised consulting services agreement. These charges are recognized in Impairments, net on the Unaudited Condensed Consolidated Statements of Operations. The impairment resulted in the recognition of a tax provision benefit and an associated reversal of deferred tax liabilities of $207 during the nine months ended September 30, 2021.

During the three and nine months ended September 30, 2021, the Company de-recognized deferred tax liabilities related to indefinite-lived intangible assets held by Acreage Florida of $6,044 in Other income (loss), net on the Unaudited Condensed Consolidated Statements of Operations. Refer to Note 3 for further discussion.

Amortization expense associated with the Company’s intangible assets was $296 and $1,288 for the three and nine months ended September 30, 2022, respectively, and $3,117 and $7,588 for the three and nine months ended September 30, 2021, respectively.

F-15

ACREAGE HOLDINGS, INC.

NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(in thousands, except per share data)

Expected annual amortization expense for existing intangible assets subject to amortization as of September 30, 2022 is as follows for each of the next five fiscal years:

Amortization of Intangibles	2022		2023		2024		2025		2026
Amortization expense	$	297	$	584	$	146	$	—	$	—

Goodwill

The following table details the changes in the carrying amount of goodwill:

Goodwill	Total
December 31, 2021	$	43,310
Adjustment to purchase price allocation	(16,500)
Other Adjustments(1)	3,682
September 30, 2022	$	30,492

(1) Represents adjustments related to the remeasurement of certain deferred tax assets and related adjustments within the measurement period.

During the three and nine months ended September 30, 2022, the Company amended the purchase price allocation related to its acquisition of Greenleaf based upon final valuations within the measurement period (refer to Note 3 for further discussion). As a result, $16,800 was re-allocated from Goodwill to Intangible assets, net on the Unaudited Condensed Consolidated Statements of Financial Position.

5.    INVESTMENTS

The carrying values of the Company’s investments in the Unaudited Condensed Consolidated Statements of Financial Position as of September 30, 2022 and December 31, 2021 are as follows:

Investments	September 30, 2022		December 31, 2021
Investments held at FV-NI	$	34,328	$	35,226
Total long-term investments	$	34,328	$	35,226

Income (loss) from investments, net in the Unaudited Condensed Consolidated Statements of Operations during the three and nine months ended September 30, 2022 and 2021 is as follows:

Investment income (loss)	Three Months Ended September 30,				Nine Months Ended September 30,
	2022		2021		2022		2021
Short-term investments	$	1	$	—	$	4	$	—
Investments held at FV-NI	16		489		150		(777)
Income (loss) from investments, net	$	17	$	489	$	154	$	(777)

F-16

ACREAGE HOLDINGS, INC.

NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(in thousands, except per share data)

Investments held at FV-NI

The Company has investments in equity of several companies that do not result in significant influence or control. These investments are carried at fair value, with gains and losses recognized in the Unaudited Condensed Consolidated Statements of Operations.

As further described under the “6.10% Secured debenture due September 2030” in Note 10, on September 23, 2020, a subsidiary of the Company, Universal Hemp, LLC ("Universal Hemp") was advanced gross proceeds of $50,000 (less transaction costs) pursuant to the terms of a secured debenture. The Company subsequently engaged an investment advisor, which under the investment advisor's sole discretion, on September 28, 2020 invested $34,019 of these proceeds on behalf of Universal Hemp. As a result, Universal Hemp acquired 34,019 class B units, at $1 par value per unit, which represented 100% financial interest in an Investment Partnership, a Canada-based limited partnership. An affiliate of the Institutional Investor holds Class A units of the Investment Partnership. The general partner of the Investment Partnership is also an affiliate of the Institutional Investor. The Class B units are held by the Investment Advisor as an agent for Universal Hemp.

6.     NOTES RECEIVABLE

Notes receivable as of September 30, 2022 and December 31, 2021 consisted of the following:

	September 30, 2022		December 31, 2021
Promissory notes receivable	$	34,257	$	27,260
Line of credit receivable	6,831		12,609
Interest receivable	3,524		2,834
Allowance for notes and interest receivables	(14,769)		(8,036)
Total notes receivable	$	29,843	$	34,667
Less: Notes receivable, current	2,500		7,104
Notes receivable, non-current	$	27,343	$	27,563

Interest income on notes receivable during the three and nine months ended September 30, 2022 was $474 and $1,256, respectively, and $1,067 and $4,125 for the three and nine months ended September 30, 2021, respectively.

The Company determined that the collectability of certain notes receivables is doubtful based on information available. As of September 30, 2022 and December 31, 2021, the Company’s allowance for notes receivable of $14,769 and $8,036, respectively, included $12,292 and $6,046 of principal outstanding and $2,477 and $1,990 of accrued interest, respectively, and represents the full value of such loan balances.

Activity during the nine months ended September 30, 2022

In February 2022, the Company received a $5,279 cash payment in full on a line of credit due from Patient Centric Martha’s Vineyard, and subsequently closed the line of credit.

In April 2022, the Company executed and closed its previously announced asset purchase agreement for the sale of Medford and Powell in Oregon. Part of the total consideration was satisfied by a 12-month $1,250 secured promissory note bearing interest at a rate of 12.5% per annum, refer to Note 3 for further discussion. In August 2022, the secured promissory note was replaced with a $500 secured promissory note bearing interest at a rate of 12.5% per annum and a $750 non-interest bearing secured promissory note, with both secured promissory notes due on May 1, 2023.

In July 2022, the Company executed and closed an amendment to its previously announced asset purchase and services agreement for the sale of its four Oregon retail dispensaries (the “Amended Agreement”). Part of the total consideration was satisfied by a 36-month $5,850 secured promissory note bearing interest at a rate of 12% per annum, refer to Note 3 for further discussion.

Activity during the nine months ended September 30, 2021

In March 2021, the Company entered into a revised consulting services and line of credit agreement with PATCC, whereby previously unrecognized management fees were settled for $2,500, which was recognized in Other revenue, net on Unaudited

F-17

ACREAGE HOLDINGS, INC.

NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(in thousands, except per share data)

Condensed Consolidated Statements of Operations during the three and nine months ended September 30, 2021. Pursuant to the revised line of credit agreement, the line of credit is non-interest bearing and will be repaid on a payment schedule with seven payments in the aggregate amount of $7,150 through June 2023.

In April 2021, the Company received three secured promissory notes in the aggregate amount of $31,500 related to the sale of Acreage Florida. Of the $31,500 in promissory notes, a promissory note for $3,500 was collected during the year ended December 31, 2021. In June 2021, the remaining two promissory notes totaling $28,000 were sold in a related party transaction to Viridescent Realty Trust, Inc. (“Viridescent”) for cash proceeds of $26,000. This sale resulted in a loss of $2,000 recorded in Other income, net on the Unaudited Condensed Consolidated Statements of Operations. Refer to Notes 3 and 14 for further discussion.

In April 2021, a subsidiary of the Company acquired 100% of CWG, and the amounts outstanding under the line of credit were converted into equity in CWG. Refer to Note 3 for further discussion.

7.    CAPITAL ASSETS, net

Net property, plant and equipment consisted of:

	September 30, 2022		December 31, 2021
Land	$	3,828	$	3,777
Building	57,935		43,921
Right-of-use asset, finance leases	10,731		5,077
Furniture, fixtures and equipment	31,587		31,325
Leasehold improvements	37,399		51,646
Construction in progress	17,409		7,644
Capital assets, gross	$	158,889	$	143,390
Less: accumulated depreciation	(23,527)		(16,593)
Capital assets, net	$	135,362	$	126,797

Depreciation of capital assets for the three and nine months ended September 30, 2022 is comprised of $751 and $4,731 of depreciation expense, and $1,963 and $5,679 that was capitalized to inventory, respectively, and $928 and $2,083 of depreciation expense and $876 and $2,567 that was capitalized to inventory for the three and nine months ended September 30, 2021, respectively.

During the nine months ended September 30, 2022, the Company determined that it was unable to find a satisfactory buyer for the held-for-sale assets related to its Michigan operations and, as such, these assets were reclassified as held-and-used. This conclusion was considered a triggering event for capital asset impairment testing. Upon assessment, these specific capital assets were not considered to have future economic value. As such, the fair value of the assets was considered to be nil and the Company recognized an impairment charge of $1,907 within Impairments, net on the Statements of Operations during the nine months ended September 30, 2022. Refer to Note 3 for further discussion on changes in held-for-sale entities.

In August 2021, the Company’s Sewell facility in New Jersey was negatively impacted by a tornado formation from Hurricane Ida. The unusually severe weather conditions caused widespread damage and resulted in a $9,130 loss to capital assets, which has been offset by insurance proceeds of $7,000. The net loss of $2,130 was recognized in Impairments, net on the Statements of Operations for the three months ended September 30, 2021.

F-18

ACREAGE HOLDINGS, INC.

NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(in thousands, except per share data)

8.    LEASES

The Company leases land, buildings, equipment and other capital assets which it plans to use for corporate purposes in addition to the production and sale of cannabis products. Leases with an initial term of 12 months or less are not recorded on the Unaudited Condensed Consolidated Statements of Financial Position and are expensed in the Unaudited Condensed Consolidated Statements of Operations on the straight-line basis over the lease term. The Company does not have any material variable lease payments and accounts for non-lease components separately from leases.

Balance Sheet Information	Classification	September 30, 2022		December 31, 2021
Right-of-use assets
Operating	Operating lease right-of-use assets	$	22,730	$	24,598
Finance	Capital assets, net	9,986		4,522
Total right-of-use assets		$	32,716	$	29,120
Lease liabilities
Current
Operating	Operating lease liability, current	$	2,298	$	2,145
Financing	Debt, current	5,635		—
Non-current
Operating	Operating lease liability, non-current	22,324		24,255
Financing	Debt, non-current	5,290		5,245
Total lease liabilities		$	35,547	$	31,645

		Three Months Ended September 30,				Nine Months Ended September 30,
Statement of Operations Information	Classification	2022		2021		2022		2021
Short-term lease expense	General and administrative	$	(28)	$	(40)	$	190	$	17
Operating lease expense	General and administrative	1,221		1,038		3,613		3,175
Finance lease expense:
Amortization of right of use asset	Depreciation and amortization	63		63		190		190
Interest expense on lease liabilities	Interest expense	314		190		855		561
Sublease income	Other income (loss), net	—		—		—		(3)
Net operating and finance lease cost		$	1,598	$	1,291	$	4,658	$	3,923

		Nine Months Ended September 30,
Statement of Cash Flows Information	Classification	2022		2021
Cash paid for operating leases	Net cash used in operating activities	$	3,390	$	3,747
Cash paid for finance leases - interest	Net cash used in operating activities	$	843	$	508

F-19

ACREAGE HOLDINGS, INC.

NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(in thousands, except per share data)

The following represents the Company’s future minimum payments required under existing leases with initial terms of one year or more as of September 30, 2022:

Maturity of lease liabilities	Operating Leases		Finance Leases
2022	$	1,147	$	5,858
2023	4,349		722
2024	4,310		743
2025	4,347		766
2026	4,428		789
Thereafter	20,285		12,487
Total lease payments	$	38,866	$	21,365
Less: interest	14,244		10,440
Present value of lease liabilities	$	24,622	$	10,925
Weighted average remaining lease term (years)	8		2
Weighted average discount rate	10%		12%

As of September 30, 2022, there have been no leases entered into that have not yet commenced.

9.    INVENTORY

The Company’s inventory balance consists of the following:

	September 30, 2022		December 31, 2021
Retail inventory	$	4,116	$	3,331
Wholesale inventory	37,143		28,643
Cultivation inventory	6,492		6,367
Supplies & other	3,141		3,463
Total	$	50,892	$	41,804

Inventory is valued at the lower of cost and net realizable value (“NRV”), defined as estimated selling price in the ordinary course of business, less estimated costs of disposal. During the nine months ended September 30, 2022, the Company analyzed its inventory balances, and recorded wholesale inventory adjustments as a result of (i) having excess inventory and (ii) reducing the carrying value to ensure inventory balances are properly recorded at the lower of cost and NRV. The Company recognized $6,286 of wholesale inventory adjustments within Cost of goods sold, wholesale on the Statements of Operations during the three and nine months ended September 30, 2022.

10.    DEBT

The Company’s debt balances consist of the following:

Debt balances	September 30, 2022		December 31, 2021
Financing liability (failed sale-leaseback)	$	15,253	$	15,253
Finance lease liabilities	10,925		5,245
7.50% Loan due April 2026	31,156		30,763
6.10% Secured debenture due September 2030	46,388		46,050
Note due December 2024	3,958		4,750
9.75% Credit facilities due January 2026	94,412		68,673
Total debt	$	202,092	$	170,734
Less: current portion of debt	7,218		1,583
Total long-term debt	$	194,874	$	169,151

F-20

ACREAGE HOLDINGS, INC.

NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(in thousands, except per share data)

Scheduled maturities of debt, excluding amortization of discount and issuance costs, are as follows:

2022	$	6,426
2023	1,583
2024	1,584
2025	—
2026	133,011
Thereafter	70,532
Total payments (excluding amortization of discount and issuance costs)	$	213,136

During the three and nine months ended September 30, 2022, the Company incurred interest expense of $5,688 and $15,989, respectively, and $3,620 and $14,072 during the three and nine months ended September 30, 2021, respectively, on the Unaudited Condensed Consolidated Statements of Operations. Interest expense for the three and nine months ended September 30, 2022 included debt discount amortization of $381 and $1,132, respectively, and amortization of debt issuance costs of $297 and $849, respectively. Interest expense for the three and nine months ended September 30, 2021 included debt discount amortization of $298 and $821, respectively, and amortization of debt issuance costs of $493 and $2,914, respectively. As of September 30, 2022 and December 31, 2021, the Company had unamortized discount $5,062 and $6,194, respectively, and debt issuance costs of $5,982 and $6,320, respectively, which is netted against the gross carrying value of long-term debt in Debt, non-current on Unaudited Condensed Unaudited Condensed Consolidated Statements of Financial Position. Additionally, as of September 30, 2022 and December 31, 2021, the Company had accrued interest of $1,167 and $1,432, respectively, within Interest payable on the Unaudited Condensed Consolidated Statements of Financial Position.

Financing liability (failed sales leaseback)

In connection with the Company’s failed sale-leaseback transaction in November 2020, a financing liability was recognized equal to the cash proceeds received. The Company will recognize the cash payments made on the lease as interest expense, and the principal will be de-recognized upon expiration of the lease.

6.10% Secured debenture due September 2030

On September 23, 2020, pursuant to the implementation of the Amended Arrangement (Refer to Note 13 for further discussion), a subsidiary of Canopy Growth advanced gross proceeds of $50,000 (less transaction costs of approximately $4,025) to Universal Hemp, an affiliate of the Company, pursuant to the terms of a secured debenture (“6.1% Loan”). In accordance with the terms of the debenture, the funds cannot be used, directly or indirectly, in connection with or for any cannabis or cannabis-related operations in the United States, unless and until such operations comply with all applicable laws of the United States. An additional $50,000 may be advanced pursuant to the debenture subject to the satisfaction of certain conditions by Universal Hemp. The debenture bears interest at a rate of 6.1% per annum, matures 10 years from the date hereof or such earlier date in accordance with the terms of the debenture and all interest payments made pursuant to the debenture are payable in cash by Universal Hemp. The debenture is secured by substantially all of the assets of Universal Hemp and its subsidiaries and, further, is not convertible and is not guaranteed by Acreage.

With a portion of the proceeds for the 6.1% Loan received by Universal Hemp, Acreage engaged an Investment Advisor which, under the Investment Advisor’s sole discretion, invested on behalf of Universal Hemp $34,019 on September 28, 2020. As a result, Universal Hemp acquired 34,019 class B units, at $1.00 par value per unit, which represented 100% financial interest in the Investment Partnership, a Canada-based limited partnership. An affiliate of the Institutional Investor holds class A units of the Investment Partnership. The general partner of the Investment Partnership is also an affiliate of the Institutional Investor. The class B units are held by the Investment Advisor as an agent for Universal Hemp. Upon execution of the limited partnership agreement, $1,019 was distributed to the class A unit holders of the Investment Partnership.

F-21

ACREAGE HOLDINGS, INC.

NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(in thousands, except per share data)

7.50% Loan due April 2026

On September 28, 2020, the Company received gross proceeds of $33,000 (less transaction costs of approximately $959) from an affiliate of the Institutional Investor (the “Lender”) and used a portion of the proceeds of this loan to retire its short-term $11,000 convertible note (as described above) and its short-term note aggregating approximately $18,000 in October 2020, with the remainder being used for working capital purposes. The loan is unsecured, matures in 3 years and bears interest at a 7.5% annual interest rate. The Lender is controlled by the Institutional Investor. The Investment Partnership is the investor in the Lender. On December 16, 2021, the Company paid an amendment fee of $413 to extend the maturity date from September 28, 2023 to April 2, 2026. The amendment was treated as a debt extinguishment.

Note due December 2024

In November 2020, the Company issued a promissory note with a third party, which is non-interest bearing and payable based on a payment schedule with ten payments in the aggregate amount of $7,750 through December 31, 2024, as a result of a settlement described under the “CanWell Dispute” in Note 13.

9.75% Credit facilities due January 2026

On December 16, 2021, the Company entered into a $150,000 senior secured credit facility with a syndicate of lenders consisting of a $75,000 initial draw, a $25,000 delayed draw that must be advanced within 12 months and a $50,000 committed accordion facility that is available after December 1, 2022, provided certain financial covenants are met, and with a maturity of January 1, 2026. Upon closing, gross proceeds of $75,000 were drawn (before origination discounts and issuance costs of approximately $4,000 and $1,500, respectively, which were capitalized). In April 2022, the Company drew down on the remaining $25,000 under this facility. Refer to Note 14 for further discussion of the syndicated related party lender.

The loan is secured by pledged equity interests and substantially all of the assets of the Company. Advances under the facility bear interest at 9.75% per annum (plus an additional 1.0% per annum until certain collateral assignment agreements are delivered) and undrawn amounts (excluding the committed accordion facility until it is available) bear interest at 3.0% per annum.

The loan is subject to various financial covenants, including a fixed charge coverage ratio and two leverage ratios. The Company obtained a waiver of these covenants for the three month periods ended March 31, 2022 and June 30, 2022. This waiver included a $500 waiver fee that was paid to the lenders. Subsequent to the balance sheet date, the 9.75% Credit facilities due January 2026 were amended (refer to Note 17 for further discussion).

Commencing with the receipt of the of the loan, mandatory prepayments are required from net proceeds of certain sale or disposition activities provided these proceeds are not invested in additional capital assets within 12 months of the disposition date, as defined by the Credit Agreement.

11.    SHAREHOLDERS’ EQUITY AND NON-CONTROLLING INTERESTS

The table below details the change in Pubco shares outstanding by class for the three and nine months ended September 30, 2022:

Shareholders’ Equity	Fixed Shares	Floating Shares	Fixed Shares Held in Treasury	Floating Shares Held in Treasury	Fixed Multiple Shares	Total Shares Outstanding
December 31, 2021	74,665	32,962	(589)	(253)	118	106,903
Issuances	3,897	969	—	—	—	4,866
NCI conversions	265	113	—	—	—	378
September 30, 2022	78,827	34,044	(589)	(253)	118	112,147

F-22

ACREAGE HOLDINGS, INC.

NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(in thousands, except per share data)

Warrants

A summary of the warrants activity outstanding is as follows:

Warrants	Fixed Shares	Floating Shares
December 31, 2021	5,817	2,524
Expired	—	—
September 30, 2022	5,817	2,524

The exercise price of each Fixed Share warrant ranged from $3.15 to $4.00, respectively, and the exercise price of each Floating Share warrant ranged from $3.01 to $4.00, respectively. The warrants are exercisable for a period of 4 years. The weighted-average remaining contractual life of the warrants outstanding is approximately 2.4 years. There was no aggregate intrinsic value for warrants outstanding as of September 30, 2022.

Non-controlling interests - convertible units

The Company has NCIs in consolidated subsidiaries USCo2 and HSCP. The non-voting shares of USCo2 and HSCP units make up substantially all of the NCI balance as of September 30, 2022 and are convertible for either 0.7 of a Fixed Share and 0.3 of a Floating Share of Pubco or cash, as determined by the Company. Summarized financial information of HSCP is presented below. USCo2 does not have discrete financial information separate from HSCP.

HSCP net asset reconciliation	September 30, 2022			December 31, 2021
Current assets	$	93,253		$	113,011
Non-current assets	385,138			375,807
Current liabilities	(18,429)			(29,256)
Non-current liabilities	(220,299)			(195,791)
Other NCI balances	(723)			(718)
Accumulated equity-settled expenses	(239,592)			(226,596)
Net assets	$	(652)		$	36,457
HSCP/USCo2 ownership % of HSCP	16.36		%	17.24		%
Net assets allocated to USCo2/HSCP	$	(107)		$	6,285
Net assets attributable to other NCIs	723			718
Total NCI	$	616		$	7,003

	Three Months Ended September 30,						Nine Months Ended September 30,
HSCP Summarized Statement of Operations	2022			2021			2022			2021
Net loss allocable to HSCP/USCo2	$	(16,549)		$	(10,052)		$	(27,589)		$	(18,882)
HSCP/USCo2 weighted average ownership % of HSCP	16.84		%	17.57		%	16.96		%	17.80		%
Net loss allocated to HSCP/USCo2	$	(2,787)		$	(1,766)		$	(4,679)		$	(3,361)
Net loss allocated to other NCIs	3			5			4			14
Net loss attributable to NCIs	$	(2,784)		$	(1,761)		$	(4,675)		$	(3,347)

As of September 30, 2022, USCo2’s non-voting shares owned approximately 0.22% of HSCP units. USCo2’s capital structure is comprised of voting shares, all of which are held by the Company, and of non-voting shares held by certain former HSCP members. Certain executive employees and profits interests holders own approximately 16.14% of HSCP units. The remaining 83.64% interest in HSCP is held by USCo and represents the members’ equity attributable to shareholders of the parent.

During the nine months ended September 30, 2022 and 2021, the Company had several transactions with HSCP and USCo2 that changed its ownership interest in the subsidiaries but did not result in loss of control. These transactions included business acquisitions and the redemption of HSCP and USCo2 convertible units for Pubco shares (as shown in the table below), and

F-23

ACREAGE HOLDINGS, INC.

NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(in thousands, except per share data)

resulted in a $55 allocation from shareholders' equity to NCI and $862 allocation from NCI to shareholders' equity for the nine months ended September 30, 2022 and 2021, respectively.

A reconciliation of the beginning and ending amounts of convertible units is as follows:

Convertible Units	September 30, 2022	December 31, 2021
Beginning balance	23,076	24,142
NCI units converted to Pubco	(378)	(1,066)
Ending balance	22,698	23,076

12.    EQUITY-BASED COMPENSATION EXPENSE

Amended Arrangement with Canopy Growth

On September 23, 2020, the Company announced the implementation of the Amended Arrangement (as defined in Note 13). Pursuant to the Amended Arrangement, the Company’s articles have been amended to create new Fixed Shares, Floating Shares and Fixed Multiple Shares. Consequently, the Company’s equity-based compensation was modified into new equity awards of the Company. Refer to Note 13 for further discussion.

Equity-based compensation - Plan (Acreage Holdings, Inc. Omnibus Incentive Plan)

In connection with the RTO transaction, the Company’s Board of Directors adopted an Omnibus Incentive Plan, as amended September 23, 2020 (the “Plan”), which permits the issuance of stock options, stock appreciation rights, stock awards, share units, performance shares, performance units and other stock-based awards up to an amount equal to 15% of the issued and outstanding Subordinate Voting Shares of the Company.

Pursuant to the Amended Arrangement, the Company retained the Plan described above, the upper limit of issuances being up to an amount equal to 15% of the issued and outstanding Fixed Shares and Floating Shares of the Company. As of September 30, 2022, the Company had 3,199 shares authorized and available for grant under the Plan.

Restricted Share Units (“RSUs”)

	Fixed Shares			Floating Shares
Restricted Share Units (Fair value information expressed in whole dollars)	RSUs	Weighted Average Grant Date Fair Value		RSUs	Weighted Average Grant Date Fair Value
Unvested, January 1, 2022	3,188	$	7.30	1,262	$	7.39
Granted	7,717	$	0.67	95	$	1.19
Forfeited	(533)	$	2.07	(83)	$	2.54
Vested	(3,811)	$	4.08	(764)	$	7.90
Unvested, September 30, 2022	6,561	$	1.80	510	$	6.27
Vested and unreleased(1)	225	$	5.80	24	$	15.15
Outstanding, September 30, 2022	6,786	$	1.93	534	$	6.67

(1) RSUs that are vested and unreleased represent RSUs that are pending delivery.

RSUs of the Company generally vest over a period of three years and RSUs granted to certain executives vest based on achievement of specific performance conditions. In certain situations for specified individuals, RSUs vest on an accelerated basis on separation. The fair value for RSUs is based on the Company’s share price on the date of the grant. The Company recorded $2,256 and $7,645 as Equity-based compensation expense on Unaudited Condensed Consolidated Statements of Operations during the three and nine months ended September 30, 2022, respectively, and $3,092 and $14,044 during the three and nine months ended September 30, 2021, respectively. The fair value of RSUs vested during the three and nine months ended September 30, 2022 was $1,427 and $4,760, respectively, and $718 and $15,045 during the three and nine months ended September 30, 2021, respectively.

F-24

ACREAGE HOLDINGS, INC.

NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(in thousands, except per share data)

The total weighted average remaining contractual life and aggregate intrinsic value of unvested RSUs as of September 30, 2022 was approximately 2 years and $3,856, respectively. Unrecognized compensation expense related to these awards at September 30, 2022 was $13,005 and is expected to be recognized over a weighted average period of approximately 1 year.

Stock options

	Fixed Shares			Floating Shares
Stock Options (Exercise price expressed in whole dollars)	Options	Weighted Average Exercise Price		Options	Weighted Average Exercise Price
Options outstanding, January 1, 2022	1,529	$	11.07	2,414	$	3.06
Granted	5,849	$	0.59	—	$	—
Forfeited	(41)	$	5.66	(91)	$	2.57
Expired	—	$	—	(20)	$	2.55
Options outstanding, September 30, 2022	7,337	$	2.75	2,303	$	3.09
Options exercisable, September 30, 2022	1,229	$	12.85	1,925	$	3.14

Stock options of the Company generally vest over a period of three years and options granted to certain executives vest based on achievement of specific performance conditions. Stock options of the Company have an expiration period of 5 or 10 years from the date of grant. The weighted average contractual life remaining for Fixed Share options outstanding and exercisable as of September 30, 2022 was approximately 5 and 6 years, respectively. The weighted average contractual life remaining for Floating Share options outstanding and exercisable as of September 30, 2022 was approximately 4 and 4 years, respectively. The Company recorded $300 and $725 as Equity-based compensation expense on Unaudited Condensed Consolidated Statements of Operations during the three and nine months ended September 30, 2022 and $1,076 and $3,147 during the three and nine months ended September 30, 2021, respectively, in connection with these awards.

As of September 30, 2022, unamortized expense related to stock options totaled $2,182 and is expected to be recognized over a weighted-average period of approximately 2 years. As of September 30, 2022, the aggregate intrinsic value for unvested options and for vested and exercisable options was nil, respectively.

Equity-based compensation - other

In May 2022, the Company granted 301 Fixed Shares and 127 Floating Shares and recorded $600 as Equity-based compensation expense on Unaudited Condensed Consolidated Statements of Operations during the for the three and nine months ended September 30, 2022 in settlement of post-employment expenses.

13.    COMMITMENTS AND CONTINGENCIES

Commitments

The Company provides revolving lines of credit to several of its portfolio companies. As of September 30, 2022, the maximum obligation under these arrangements was $15,150 (refer to Note 6 for further discussion).

Prior Plan of Arrangement with Canopy Growth

On June 19, 2019, the shareholders of the Company and of Canopy Growth separately approved the proposed plan of arrangement (the “Prior Plan of Arrangement”) involving the two companies, and on June 21, 2019, the Supreme Court of British Columbia granted a final order approving the Prior Plan of Arrangement. Effective June 27, 2019, the articles of the Company were amended pursuant to the Prior Plan of Arrangement to provide that, upon the occurrence (or waiver by Canopy Growth) of the Triggering Event, subject to the satisfaction of the conditions set out in the arrangement agreement entered into between Acreage and Canopy Growth on April 18, 2019, as amended on May 15, 2019 (the “Original Arrangement Agreement”), Canopy Growth will acquire (the “Acquisition”) all of the issued and outstanding shares in the capital of the Company (each, an “Acreage Share”).

Second Amendment to the Arrangement Agreement with Canopy Growth

F-25

ACREAGE HOLDINGS, INC.

NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(in thousands, except per share data)

On September 23, 2020, Acreage and Canopy Growth entered into an amending agreement (the “Amending Agreement” or “Amended Arrangement”) (and together with the Original Arrangement Agreement and any further amendments thereto, the “Amended Plan of Arrangement”) and the Amended Arrangement became effective at 12:01 a.m. (Vancouver time) (the “Amendment Time”) on September 23, 2020 (the “Amendment Date”). Pursuant to the Amended Plan of Arrangement, Canopy Growth made a cash payment of $37,500 which was delivered to Acreage’s shareholders and certain holders of securities convertible or exchangeable into shares of Acreage. Acreage also completed a capital reorganization (the “Capital Reorganization”) effective as of the Amendment Time whereby: (i) each existing SVS was exchanged for 0.7 of a Fixed Share and 0.3 of a Floating Share; (ii) each issued and outstanding PVS was exchanged for 28 Fixed Shares and 12 Floating Shares; and (iii) each issued and outstanding MVS was exchanged for 0.7 of a Fixed Multiple Share and 0.3 of a Floating Share.

At the Amendment Time, each option, restricted share unit, compensation option, and warrant to acquire existing SVS (each a “Security”) that was outstanding immediately prior to the Amendment Time, was exchanged for a replacement Security to acquire Fixed Shares (a “Fixed Share Replacement Security”) and a replacement Security to acquire Floating Shares (a “Floating Share Replacement Security”) to account for the Capital Reorganization.

Pursuant to the Amended Plan of Arrangement, upon the occurrence or waiver (at the discretion of Canopy Growth) of the Triggering Event (the “Triggering Event Date”), Canopy Growth will, subject to the satisfaction or waiver of certain closing conditions set out in the Arrangement Agreement: (i) acquire all of the issued and outstanding Fixed Shares (following the mandatory conversion of the Fixed Multiple Shares into Fixed Shares) on the basis of 0.3048 of a common share of Canopy Growth (each whole common share, a “Canopy Growth Share”) for each Fixed Share held (the “Fixed Exchange Ratio”) at the time of the acquisition of the Fixed Shares (the “Acquisition Time”), subject to adjustment in accordance with the terms of the Amended Plan of Arrangement (the “Canopy Call Option”); and (ii) have the right (but not the obligation) (the “Floating Call Option”), exercisable for a period of 30 days following the Triggering Event Date to acquire all of the issued and outstanding Floating Shares at a price to be determined based upon the 30 day volume-weighted average trading price of the Floating Shares, subject to a minimum price of $6.41, as may be adjusted in accordance with the terms of the Amended Plan of Arrangement, to be payable, at the option of Canopy Growth, in cash, Canopy Growth Shares or a combination thereof. If any portion is paid in Canopy Growth Shares, the number of Canopy Growth Shares to be exchanged for each Floating Share shall be determined on the basis of a 30 day volume-weighted average calculation using the Floating Shares (the “Floating Ratio”). The closing of the acquisition of the Floating Shares pursuant to the Floating Call Option, if exercised, will take place concurrently with the closing of the acquisition of the Fixed Shares pursuant to the Canopy Call Option, if exercised. The Canopy Call Option and the Floating Call Option will expire 10 years from the Amendment Time.

At the Acquisition Time, on the terms and subject to the conditions of the Amended Plan of Arrangement, each Fixed Share Replacement Security will be exchanged for a replacement Security from Canopy Growth equal to: (i) the number of Fixed Shares that were issuable upon exercise of such Fixed Share Replacement Security immediately prior to the Acquisition Time, multiplied by (ii) the Fixed Exchange Ratio in effect immediately prior to the Acquisition Time (provided that if the foregoing would result in the issuance of a fraction of a Canopy Growth Share, then the number of Canopy Growth Shares to be issued will be rounded down to the nearest whole number).

In the event that the Floating Call Option is exercised and Canopy Growth acquires the Floating Shares at the Acquisition Time, on the terms and subject to the conditions of the Amended Plan of Arrangement, each Floating Share Replacement Security will be exchanged for a replacement Security from Canopy Growth equal to: (i) the number of Floating Shares that were issuable upon exercise of such Floating Share Replacement Security immediately prior to the Acquisition Time, multiplied by (ii) the Floating Ratio (if the foregoing would result in the issuance of a fraction of a Canopy Growth Share, then the number of Canopy Growth Shares to be issued will be rounded down to the nearest whole number). In the event that the Floating Call Option is exercised and Canopy Growth acquires the Floating Shares at the Acquisition Time, Acreage will be a wholly-owned subsidiary of Canopy Growth.

The Amended Plan of Arrangement provides for, among other things, Amendments to the definition of Purchaser Approved Share Threshold (as defined therein) to change the number of shares of Acreage available to be issued by Acreage without an adjustment in the Fixed Exchange Ratio such that Acreage may issue a maximum of 32,700 shares. Furthermore, Acreage generally may not issue any equity securities without Canopy Growth’s prior consent. Additionally, the Amended Plan of Arrangement allows for various Canopy Growth rights that extend beyond the Acquisition Date, including, among others: (i) rights to nominate a majority of Acreage’s Board of Directors following the Acquisition Time; (ii) restrictive covenants in respect of the business conduct in favor of Canopy Growth; (iii) termination of non-competition and exclusivity rights granted to Acreage by Canopy Growth in the event that Acreage does not meet certain specified financial targets; (iv) implementation of further restrictions on Acreage’s ability to operate its business in the event that Acreage does not meet certain specified

F-26

ACREAGE HOLDINGS, INC.

NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(in thousands, except per share data)

financial targets; and (v) termination of the Amended Plan of Arrangement in the event that Acreage does not meet certain specified financial targets in the trailing 12 month period. Each of the financial targets referred to above is specified in the Amending Agreement and related to the performance of Acreage relative to a business plan for Acreage for each fiscal year ended December 31, 2020 through December 31, 2029 set forth in the Proposal Agreement (the “Initial Business Plan”).

Further, the Amended Plan of Arrangement imposes restrictions on Acreage entering into any contracts in respect of Company Debt if: (i) such contract would be materially inconsistent with market standards for companies operating in the United States cannabis industry; (ii) such contract prohibits a prepayment of the principal amount of such Company Debt; and (iii) such contract would provide for interest payments to be paid through the issuance of securities as opposed to cash, among other restrictions. The Amended Plan of Arrangement also provides for the following: (i) certain financial reporting obligations to Canopy Growth; (ii) certain specified criteria related to any new directors or officers of Acreage, and (iii) a limit to Acreage’s operations to the Identified States (as defined therein).

Subsequent to the balance sheet date, the Company entered into a new arrangement agreement with Canopy Growth regarding the acquisition of the Company’s Floating Shares. Refer to Note 17 for further discussion.

Tax Receivable Agreement and Tax Receivable Bonus Plans

The Company is a party to i) a tax receivable agreement dated November 14, 2018 and subsequently amended (the “Tax Receivable Agreement”) between the Company and certain current and former unit holders of HSCP and ii) tax receivable bonus plans dated November 14, 2018 and subsequently amended (the “Tax Receivable Bonus Plans”) between the Company and certain directors, officers and consultants of the Company (together the “Tax Receivable Recipients”). Under the Tax Receivable Agreement and the Tax Receivable Bonus Plans, the Company is required to make cash payments to the Tax Receivable Recipients equal to 85% of the tax benefits, if any, that the Company actually realizes, or in certain circumstances is deemed to realize, as a result of (i) the increases in its share of the tax basis of assets of HSCP resulting from any redemptions or exchanges of Units from the HSCP Members, and (ii) certain other tax benefits related to the Company making payments under the Tax Receivable Agreement and the Tax Receivable Bonus Plan. Although the actual timing and amount of any payments that the Company makes to the Tax Receivable Recipients can not be estimated, it expects those payments will be significant. Any payments made by the Company to the Tax Receivable Recipients may generally reduce the amount of overall cash flow that might have otherwise been available to it. Payments under the Tax Receivable Agreement are not conditioned on any Tax Receivable Recipient’s continued ownership of Units or our shares after the completion of the RTO. Payments under the Tax Receivable Bonus Plan may, at times, be conditioned on the Tax Receivable Recipient’s continued employment by the Company.

In connection with the Amended Arrangement, the Company amended the terms of the Tax Receivable Agreement and the Tax Receivable Bonus Plans. Additionally, subsequent to the balance sheet date, the Company agreed to further amendments to The Tax Receivable Agreement and the Tax Receivable Bonus Plan. Refer to Note 17 for further discussion.

Debenture

In connection with the implementation of the Amended Arrangement, pursuant to a secured debenture dated September 23, 2020 (the “Debenture”) issued by Universal Hemp, LLC, an affiliate of Acreage that operates solely in the hemp industry in full compliance with all applicable laws (the “Borrower”), to 11065220 Canada Inc., an affiliate of Canopy Growth (the “Lender”), the Lender agreed to provide a loan of up to $100,000 (the “Loan”), $50,000 of which was advanced on the Amendment Date (the “Initial Advance”), and $50,000 of the Loan will be advanced in the event that the following conditions, among others, are satisfied: (a) the Borrower’s EBITDA (as defined in the Debenture) for any 90 day period is greater than or equal to 2.0 times the interest costs associated with the Initial Advance; and (b) the Borrower’s business plan for the 12 months following the applicable 90 day period supports an Interest Coverage Ratio (as defined in the Debenture) of at least 2.00:1.

The principal amount of the Loan will bear interest from the date of advance, compounded annually, and be payable on each anniversary of the date of the Debenture in cash in U.S. dollars at a rate of 6.1% per annum. The Loan will mature 10 years from the date of the Initial Advance.

The Loan must be used exclusively for U.S. hemp-related operations and on the express condition that such amount will not be used, directly or indirectly, in connection with or for the operation or benefit of any of the Borrower’s affiliates other than subsidiaries of the Borrower exclusively engaged in U.S. hemp-related operations and not directly or indirectly, towards the

F-27

ACREAGE HOLDINGS, INC.

NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(in thousands, except per share data)

operation or funding of any activities that are not permissible under applicable law. The Loan proceeds must be segregated in a distinct bank account and detailed records of debits to such distinct bank account will be maintained by the Borrower.

No payment due and payable to the Lender by the Borrower pursuant to the Debenture may be made using funds directly or indirectly derived from any cannabis or cannabis-related operations in the United States, unless and until the Triggering Event Date.

The Debenture includes usual and typical events of default for a financing of this nature, including, without limitation, if: (i) Acreage is in breach or default of any representation or warranty in any material respect pursuant to the Arrangement Agreement; (ii) the Non-Core Divestitures are not completed within 18 months from the Amendment Date; and (iii) Acreage fails to perform or comply with any covenant or obligation in the Arrangement Agreement which is not remedied within 30 days after written notice is given to the Borrower by the Lender. The Debenture also includes customary representations and warranties, positive covenants and negative covenants of the Borrower.

Advisor fee

In connection with the Prior Plan of Arrangement, the Company entered into an agreement with its financial advisor providing for a fee payment of $7,000 in either cash, Acreage shares or Canopy Growth shares, at the discretion of the Company, upon the successful acquisition of Acreage by Canopy Growth. Subsequent to September 30, 2022, the Company amended the terms of the agreement with its financial advisors providing for a fee payment of $3,000 in cash, less a $500 initial payment, and $2,000 in shares of the Company, upon the successful acquisition of Acreage by Canopy Growth.

Surety bonds

The Company has indemnification obligations with respect to surety bonds primarily used as security against non-performance in the amount of $5,000 as of September 30, 2022, for which no liabilities are recorded on the Unaudited Condensed Consolidated Statements of Financial Position.

The Company is subject to other capital commitments and similar obligations. As of September 30, 2022 and 2021, such amounts were not material.

CanWell Settlement

In November 2020, the Company entered into a final confidential settlement agreement with CanWell, LLC for certain outstanding proceedings. As part of that agreement, the Company accrued for $7,750 in Legal settlements, net on the Statements of Operations for the year ended December 31, 2020. In connection with this settlement agreement, the Company issued a promissory note in the amount of $7,750 to CanWell, which is non-interest bearing and is payable in periodic payments through December 31, 2024. Through September 30, 2022, the Company has paid $3,792 of the promissory note.

Contingencies

The Company’s operations are subject to a variety of local and state regulations. Failure to comply with one or more of those regulations could result in fines, restrictions on its operations, or losses of permits that could result in the Company’s applicable subsidiaries ceasing operations. While management of the Company believes that the Company’s subsidiaries are in compliance with applicable local and state regulations as of September 30, 2022, cannabis regulations continue to evolve and are subject to differing interpretations. As a result, the Company’s subsidiaries may be subject to regulatory fines, penalties, or restrictions in the future.

The Company and its subsidiaries may be, from time to time, subject to various administrative, regulatory and other legal proceedings arising in the ordinary course of business. Contingent liabilities associated with legal proceedings are recorded when a liability is probable, and the contingent liability can be reasonably estimated.

New York outstanding litigation

On November 2, 2018, EPMMNY LLC (“EPMMNY”) filed a complaint in the Supreme Court of the State of New York, County of New York, asserting claims against 16 defendants, including NYCANNA, Impire State Holdings LLC, NY Medicinal Research & Caring, LLC (each, a wholly-owned subsidiary of High Street) and High Street. The Index Number for the action is 655480/2018. EPMMNY alleges that it was wrongfully deprived of a minority equity interest and management

F-28

ACREAGE HOLDINGS, INC.

NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(in thousands, except per share data)

role in NYCANNA by its former partner, New Amsterdam Distributors, LLC, which attempted to directly or indirectly sell or transfer EPMMNY’s alleged interest in NYCANNA to other entities in 2016 and 2017, including Impire, NYMRC and High Street.

EPMMNY alleges that it is entitled to the value of its alleged minority interest in NYCANNA or minority ownership in NYCANNA. EPMMNY also alleges that certain defendants misused its alleged intellectual property and/or services, improperly solicited its employees, and aided and abetted or participated in the transfer of equity and/or business opportunities from EPMMNY.

High Street intends to vigorously defend this action, which the Company firmly believes is without merit. High Street is also entitled to full indemnity from the claims asserted against it by EPMMNY pursuant to the purchase agreement pertaining to its acquisition of NYCANNA and personal guarantee by the largest shareholders of the seller. High Street, along with the other defendants, filed a motion to dismiss on April 1, 2019. The motion was fully briefed and submitted to the Court as of July 18, 2019, and oral argument was heard on September 6, 2019. The motion remains pending before the Court. Following a hearing held the week of April 25-29, 2022, the Court ruled that Plaintiff had the capacity to bring this action on behalf of EPMMNY. The motions to dismiss remain pending on all other grounds.

14.    RELATED PARTY TRANSACTIONS

Transactions with related parties are entered into in the normal course of business and are measured at the amount established and agreed to by the parties.

Related party notes receivable

In May 2021, the Company sold two secured promissory notes totaling $28,000 received from the sale of Acreage Florida to Viridescent for cash proceeds of approximately $26,000. Viridescent is an entity controlled by Kevin Murphy, the Chairman of the board of directors. Refer to Note 6 for further discussion.

6.10% Secured debenture due September 2030

As disclosed in Note 10, “6.10% Secured debenture due September 2030”, on September 23, 2020, pursuant to the implementation of the Amended Arrangement, a subsidiary of Canopy Growth advanced gross proceeds of $50,000 (less transaction costs of approximately $4,025) to Universal Hemp, an affiliate of the Company, pursuant to the terms of a secured debenture. In accordance with the terms of the debenture, the funds cannot be used, directly or indirectly, in connection with or for any cannabis or cannabis-related operations in the United States, unless and until such operations comply with all applicable laws of the United States. Acreage then engaged an investment advisor (the “Investment Advisor”) which, under the Investment Advisor’s sole discretion, invested on behalf of Universal Hemp, $34,019 of the proceeds on September 28, 2020. During the three and nine months ended September 30, 2022, the Company incurred interest expense attributable to the 6.10% Secured debenture due September 2030 of $624 and $1,851, respectively.

As a result, Universal Hemp, a subsidiary of the Company, acquired 34,019 class B units, at $1 par value per unit, which represented 100% financial interest in an Investment Partnership, a Canada-based limited partnership. An affiliate of the Institutional Investor holds Class A Units of the Investment Partnership. The general partner of the Investment Partnership is also an affiliate of the Institutional Investor. The class B units are held by the Institutional Investor as agent for Universal Hemp. On September 28, 2020, the Company received gross proceeds of $33,000 (less transaction costs of approximately $959) from an affiliate of the Institutional Lender (the “Lender”) and used a portion of the proceeds of this loan to retire its short-term $11,000 convertible note and its short-term note aggregating approximately $18,000 in October 2020, with the remainder being used for working capital purposes. The Lender is controlled by the Institutional Lender. The Investment Partnership is the investor in the Lender.

F-29

ACREAGE HOLDINGS, INC.

NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(in thousands, except per share data)

Michigan consulting agreement

Pursuant to the Consulting Services Agreement by and between Kevin Michigan, LLC, a company controlled by Kevin Murphy, and High Street (the “Michigan Consulting Agreement”), High Street provides certain consulting services to Kevin Michigan, LLC, which includes, but is not limited to, services related to application support, provisioning center administration and operation, local and state regulatory filings, human resource matters, and marketing matters. The Michigan Consulting Agreement explicitly states that High Street is not able to direct or control the business of Kevin Michigan, LLC. Additionally, there are certain leases held by and between Kevin Michigan, LLC, as lessee and certain wholly owned subsidiaries of High Street, as lessors. As of September 30, 2022, Kevin Michigan, LLC is not operational, and no consulting fees or rents have been paid to High Street or its wholly owned subsidiaries. Kevin Michigan, LLC is owned and controlled by the Company’s Chairman, Kevin Murphy.

9.75% Credit facilities due January 2026

As disclosed in Note 10, on December 16, 2021, the Company entered into the 9.75% Credit facilities due January 2026 with a syndicate of lenders, including Viridescent Realty Trust, Inc. (“Viridescent”), an entity controlled by Kevin Murphy. Under the terms of the 9.75% Credit facilities due January 2026, a $75,000 initial draw was available immediately, an additional $25,000 delayed draw is available that must be advanced within 12 months, and a $50,000 committed accordion facility is available after December 1, 2022, provided certain financial covenants are met. Advances under the facilities bear interest at 9.75% per annum and undrawn amounts (excluding the committed accordion facility until it is available) bear interest at 3.0% per annum. In April 2022, the Company drew down on the additional $25,000 delayed draw under this facility.

Viridescent has committed $30,000 of the $100,000 drawn down under the Credit Facility, with third-party syndicated affiliates committing the additional $70,000. During the three and nine months ended September 30, 2022, the Company incurred interest expense attributable to Viridescent of $824 and $2,215, respectively. The loan is secured by first-lien mortgages on Acreage’s wholly owned real estate and other commercial security interests. A third-party syndicate served as Administrative Agent for the transaction. Subsequent to the balance sheet date, the 9.75% Credit facilities due January 2026 were amended (refer to Note 17 for further discussion).

15.    REPORTABLE SEGMENTS

The Company prepares its segment reporting on the same basis that its Chief Operating Decision Maker manages the business, and makes operating decisions. The Company operates under one operating segment, which is its only reportable segment: the production and sale of cannabis products. The Company’s measure of segment performance is net income, and derives its revenue primarily from the sale of cannabis products, as well as related management or consulting services which were not material in all periods presented. All of the Company’s operations are located in the United States.

16.    EARNINGS PER SHARE

Basic earnings per share are computed by dividing net loss attributable to common shareholders of the Company by the weighted average number of outstanding shares for the period. Diluted earnings per share are calculated based on the weighted number of outstanding common shares plus the dilutive effect of stock options and warrants, as if they were exercised, and restricted stock units and profits interests, as if they vested and NCI convertible units, as if they converted.

Basic and diluted loss per share is as follows:

	Three Months Ended September 30,				Nine Months Ended September 30,
	2022		2021		2022		2021
Net loss attributable to common shareholders of the Company	$	(22,214)	$	(12,296)	$	(44,837)	$	(22,657)
Weighted average shares outstanding - basic	111,200		106,332		108,795		104,524
Effect of dilutive securities	—		—		—		—
Weighted average shares - diluted	111,200		106,332		108,795		104,524
Net loss per share attributable to common shareholders of the Company - basic	$	(0.20)	$	(0.12)	$	(0.41)	$	(0.22)
Net loss per share attributable to common shareholders of the Company - diluted	$	(0.20)	$	(0.12)	$	(0.41)	$	(0.22)

F-30

ACREAGE HOLDINGS, INC.

NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(in thousands, except per share data)

During the three and nine months ended September 30, 2022, 5,817 Fixed warrants, 2,524 Floating warrants, 6,786 Fixed Share RSUs, 534 Floating Share RSUs, 7,337 Fixed Share stock options, 2,303 Floating Share stock options and 22,698 NCI convertible units were excluded from the calculation of net loss per share attributable to common shareholders of the Company - diluted, as they were anti-dilutive. During the three and nine months ended September 30, 2021, 7,131 Fixed warrants, 3,087 Floating warrants, 3,621 Fixed Share RSUs, 1,757 Floating Share RSUs, 1,530 Fixed Share stock options, 2,419 Floating Share stock options and 23,076 NCI convertible units were excluded from the calculation of net loss per share attributable to common shareholders of the Company - diluted, as they were anti-dilutive.

17.    SUBSEQUENT EVENTS

Acreage enters into new strategic arrangement with Canopy Growth

On October 24, 2022, the Company entered into an arrangement agreement (the “Floating Share Agreement”) with Canopy Growth and Canopy USA, LLC (“Canopy USA”), Canopy Growth’s newly-created U.S. domiciled holding company, pursuant to which, subject to approval of the holders of the Class D subordinate voting shares of Acreage (the “Floating Shares”) and the terms and conditions of the Floating Share Agreement, Canopy USA will acquire all of the issued and outstanding Floating Shares by way of court-approved plan of arrangement (the “Floating Share Arrangement”) for consideration of 0.4500 of a common share of Canopy Growth (each whole share a “Canopy Share”) in exchange for each Floating Share.

Concurrently with entering into of the Floating Share Agreement, Canopy Growth irrevocably waived its option to acquire the Floating Shares pursuant to the Amended Arrangement.

Subject to the provisions of the Floating Share Agreement, Canopy Growth has agreed to exercise the fixed option pursuant to the Amended Agreement to acquire all outstanding Fixed Shares, representing approximately 70% of the total shares of Acreage as at the date hereof, at a fixed exchange ratio of 0.3048 of a Canopy Share for each Fixed Share.

Completion of the Floating Share Agreement is subject to the satisfaction or waiver of certain closing conditions, including receipt of applicable regulatory and court approvals, the approval of at least (i) 66⅔% of the votes cast by Floating Shareholders, and (ii) a majority of the votes cast by Floating Shareholders excluding the votes cast by “interested parties” and “related parties” under Multilateral Instrument 61-101 - Protection of Minority Security Holders in Special Transactions (“MI 61-101”) of the Canadian Securities Administrators, at a special meeting of Acreage shareholders (the “Special Meeting”) expected to take place in January 2023.

Canopy Growth and Canopy USA have entered into voting support agreements with certain of the Company’s directors and current and former officers holding approximately 7.3% of the issued and outstanding Floating Shares pursuant to which they have agreed, among other things, to vote their Floating Shares in favor of the Floating Share Agreement.

Acreage expects the Floating Share Arrangement to close in the second half of 2023, subject to receipt of shareholder, court, and regulatory approvals, as well as the satisfaction or waiver of all conditions under the Floating Share Agreement and the Amended Arrangement. It is anticipated that the acquisition by Canopy USA of the Fixed Shares pursuant to the Fixed Option will be completed immediately following closing of the Floating Share Agreement. Refer to Note 13 for further discussion on the Prior Plan of Arrangement and the Amended Arrangement

Tax Receivable Account and Tax Receivable Bonus Plan Amendments

Concurrently with execution of the Floating Share Agreement, Canopy Growth agreed to issue (i) Canopy Shares with a value of approximately $30,500 to certain current or former unit holders of HSCP to acquire the right to all future payments under HSCP’s existing Tax Receivable Agreement, as amended (the “TRA”) and (ii) a payment with a value of approximately $19,500 in Canopy Shares to certain directors, officers or consultants of Acreage to satisfy obligations under HSCP’s existing Tax Receivable Bonus Plans, under further amendment to each. Canopy Shares with a value of approximately $15,300 will be issued to certain Holders as soon as practicable as the first installment under the amended TRA with a second payment of approximately $15,300 in Canopy Shares to occur on the earlier of (a) the second business day following the date on which the Floating Shareholders approve the Floating Share Arrangement; or (b) April 24, 2023. In addition, a final payment with a value of approximately $19,500 in Canopy Shares will be issued by Canopy Growth to certain eligible participants under the Tax Receivable Bonus Plans immediately prior to the completion of Floating Share Arrangement. Refer to Note 13 for further discussion on the Tax Receivable Agreement.

Credit Facility Amendment

On October 24, 2022, the Company amended its existing $150,000 credit facility (the “Amended Credit Facility”). Under the terms of the Amended Credit Facility, $25,000 is available for immediate draw by Acreage with a further $25,000 available in future periods under a committed accordion option once certain predetermined milestones are achieved. In conjunction with entering into the Amended Credit Facility, all financial debt covenants, except a minimum cash requirement, were waived until

F-31

ACREAGE HOLDINGS, INC.

NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(in thousands, except per share data)

December 31, 2023, and new covenants have been agreed upon in respect of all periods beginning on or after December 31, 2023. Finally, the Amended Credit Facility includes approval for Canopy USA to acquire control of Acreage without requiring repayment of all amounts outstanding under the Amended Credit Facility, provided certain conditions are satisfied. Acreage intends to use the proceeds of the Amended Credit Facility to fund expansion initiatives and provide additional working capital.

The Amended Credit Facility will bear interest at a variable rate of U.S. prime (“Prime”) plus 5.75% per annum, payable monthly in arrears, with a Prime floor of 5.50%, and a maturity date of January 1, 2026. Under the terms of the Amended Credit Facility, the Company has the option to extend the maturity date to January 1, 2027, for a fee equal to 1.0% of the total loan amount. Separately, the Company paid an amendment fee of $1,250 to the syndicate of lenders. Refer to Note 10 for further discussion on the 9.75% Credit facilities due January 2026.

Management has reviewed all other events subsequent to September 30, 2022 through the date of issuing these financial statements and determined that no further subsequent events require adjustment or disclosure.

F-32

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

Management’s Discussion and Analysis of Financial Condition and Results of Operations (“MD&A”) is intended to assist in the understanding and assessing the trends and significant changes in our results of operations and financial condition. Historical results may not be indicative of future performance. This discussion includes forward-looking statements that reflect our plans, estimates and beliefs. Such statements involve risks and uncertainties. Our actual results may differ materially from those contemplated by these forward-looking statements as a result of various factors, including those set forth in “Risk Factors” in Part I, Item 1A of the Annual Report on Form 10-K for the year ended December 31, 2021 (the “2021 Form 10-K”), and “Cautionary Statement Regarding Forward-Looking Statements” set forth below.

This MD&A should be read in conjunction with the Company’s unaudited condensed consolidated financial statements for the three month period ended September 30, 2022 and related notes appearing elsewhere in this Quarterly Report on Form 10-Q (this “Quarterly Report” or “Form 10-Q”) and the 2021 Form 10-K. Financial information presented in this MD&A is presented in thousands of U.S. dollars, unless otherwise indicated.

Cautionary Statement Regarding Forward Looking-Statements

This Quarterly Report of the Company contains statements that include forward-looking information and are forward-looking statements within the meaning of applicable Canadian and United States securities legislation (“forward-looking statements”), including the Private Securities Litigation Reform Act of 1995, that involve risks and uncertainties. All statements, other than statements of historical fact, included herein are forward-looking statements, including, for greater certainty, the on-going implications of the novel coronavirus (“COVID-19”) and statements regarding the proposed transactions with Canopy Growth Corporation (“Canopy Growth,”) and Canopy USA, LLC (“Canopy USA”), as applicable, including the anticipated benefits and likelihood of completion thereof.

Generally, forward-looking statements may be identified by the use of forward-looking terminology such as “plans”, “expects” or “does not expect”, “proposed”, “is expected”, “budgets”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases, or by the use of words or phrases which state that certain actions, events or results may, could, would, or might occur or be achieved. There can be no assurance that such forward-looking statements will prove to be accurate, and actual results and future events could differ materially from those anticipated in such forward-looking statements. Forward-looking statements reflect Acreage’s current beliefs and are based on information currently available to Acreage and on assumptions Acreage believes are reasonable. Forward-looking statements are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of Acreage to be materially different from those expressed or implied by such forward-looking statements. Such risks and other factors may include, but are not limited to:

•the future implications to the business, financial results and performance of the Company arising, directly or indirectly, from COVID-19;

•the anticipated benefits of the Amended Arrangement;

•the anticipated benefits of the Floating Share Arrangement;

•the ability of Acreage to meets its performance targets and financial thresholds agreed upon with Canopy Growth as part of the Amended Arrangement;

•the likelihood of Canopy Growth completing the acquisition of the Fixed Shares and timing thereof;

•the likelihood of Canopy USA completing the acquisition of the Floating Shares and timing thereof;

•the ability of the parties to the Floating Share Arrangement to receive, in a timely manner and on satisfactory terms, the necessary regulatory, court and shareholder approvals;

•the ability of the parties to satisfy, in a timely manner, the other conditions to the completion of the Floating Share Agreement;

•the ability of the parties to each of the Amending Agreement and the Floating Share Agreement to satisfy, in a timely manner, the conditions to closing of each of the Amended Arrangement and the Floating Share Arrangement, respectively;

•in the event that the Floating Share Arrangement is not adopted, the likelihood of completion of the acquisition of the Floating Shares pursuant to an alternative transaction;

•in the event that the Floating Share Arrangement is not adopted, the likelihood of Canopy Growth completing the acquisition of the Fixed Shares under the Amended Arrangements; risks related to the ability of the Company to finance its business and fund its obligations;

•other expectations and assumptions concerning the transactions contemplated between Canopy Growth and/or Canopy USA and Acreage;

•the available funds of Acreage and the anticipated use of such funds;

•the availability of financing opportunities for Acreage and the risks associated with the completion thereof;

•regulatory and licensing risks;

33

•changes in general economic, business and political conditions, including changes in the financial and stock markets;

•risks related to infectious diseases, including the impacts of COVID-19;

•legal and regulatory risks inherent in the cannabis industry;

•risks associated with economic conditions, dependence on management and currency risk;

•risks relating to U.S. regulatory landscape and enforcement related to cannabis, including political risks;

•risks relating to anti-money laundering laws and regulation;

•risks relating to shortages in materials and increased costs for transportation, energy, and raw material due in part to the negative impact of the Russia-Ukraine war on the global economy;

•other governmental and environmental regulation;

•public opinion and perception of the cannabis industry;

•risks related to contracts with third-party service providers;

•risks related to the enforceability of contracts and lack of access to U.S. bankruptcy protections;

•reliance on the expertise and judgment of senior management of Acreage;

•risks related to proprietary intellectual property and potential infringement by third parties;

•the concentrated voting control of Acreage’s founder and the unpredictability caused by Acreage’s capital structure;

•risks relating to the management of growth;

•increasing competition in the industry;

•risks inherent in an agricultural business;

•risks relating to energy costs;

•risks associated with cannabis products manufactured for human consumption including potential product recalls;

•reliance on key inputs, suppliers and skilled labor;

•cybersecurity risks;

•ability and constraints on marketing products;

•fraudulent activity by employees, contractors and consultants;

•tax and insurance related risks;

•risks related to the economy generally;

•risk of litigation;

•conflicts of interest;

•risks relating to certain remedies being limited and the difficulty of enforcement judgments and effecting service outside of Canada;

•risks related to future acquisitions or dispositions;

•sales by existing shareholders; and

•limited research and data relating to cannabis.

A description of additional assumptions used to develop such forward-looking statements and a description of additional risk factors that may cause actual results to differ materially from forward-looking statements can be found in Part I, Item 1A of the Company’s Annual Report on Form 10-K, under the heading “Risk Factors”, dated March 11, 2022, as filed with the Securities and Exchange Commission. Although Acreage has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements, there may be other factors that cause results not to be as anticipated, estimated or intended. Readers are cautioned that the foregoing list of factors is not exhaustive. Readers are further cautioned not to place undue reliance on forward-looking statements as there can be no assurance that the plans, intentions or expectations upon which they are placed will occur. Forward-looking statements contained in this Form 10-Q are expressly qualified by this cautionary statement. The forward-looking statements contained in this Form 10-Q represent the expectations of Acreage as of the date of this Form 10-Q and, accordingly, are subject to change after such date. However, Acreage expressly disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable securities law.

Management’s discussion and analysis of financial condition and results of operations is intended to help provide an understanding of the Company’s financial condition, changes in financial condition and results of operations. This discussion is organized as follows:

•Overview—This section provides a general description of the Company’s businesses, its strategic objectives, as well as developments that occurred during the three and nine months ended September 30, 2022 and 2021 that the Company believes are important in understanding its results of operations and financial condition or to disclose known trends.

•Results of Operations—This section provides an analysis of the Company’s results of operations for the three and nine months ended September 30, 2022 and 2021. This analysis is presented on a consolidated basis. In addition, a brief description is provided of significant transactions and events that impact the comparability of the results being analyzed.

34

•Liquidity and Capital Resources—This section provides an analysis of the Company’s cash flows for the three and nine months ended September 30, 2022 and 2021, as well as a discussion on the Company’s outstanding debt and commitments that existed as of September 30, 2022. Included in the discussion of outstanding debt is a discussion of the amount of financial capacity available to fund the Company’s future commitments and obligations, as well as a discussion of other financing arrangements.

Overview

Acreage, a vertically integrated, multi-state operator of cannabis licenses and assets in the U.S, was continued into the Province of British Columbia under the Business Corporations Act (British Columbia). Acreage Fixed Shares and Floating Shares (as such terms are defined at Note 13 of the unaudited condensed consolidated financial statements) are each listed on the Canadian Securities Exchange under the symbols “ACRG.A.U” and “ACRG.B.U”, respectively, and are quoted on the OTCQX® Best Market by OTC Markets Group under the symbols “ACRHF” and “ACRDF”, respectively and on the Open Market of the Frankfurt Stock Exchange under the symbols “0VZ1” and “0VZ2”, respectively. Acreage operates through its consolidated subsidiary High Street Capital Partners, LLC (“HSCP”), a Delaware limited liability company. HSCP, which does business as “Acreage Holdings”, was formed on April 29, 2014. The Company became an indirect parent of HSCP on November 14, 2018 in connection with a reverse takeover (“RTO”) transaction. The Company’s operations include (i) cultivating cannabis plants, (ii) manufacturing branded consumer products, (iii) distributing cannabis flower and manufactured products, and (iv) retailing high-quality, effective and dosable cannabis products to consumers. The Company appeals to medical and adult-use customers through brand strategies intended to build trust and loyalty.

As of September 30, 2022, Acreage owned and operated a total of twenty-three dispensaries - four in New York, three in New Jersey, three in Connecticut, two in Massachusetts, two in Illinois, five in Ohio, and four in Maine. As of September 30, 2022, Acreage owned and operated a total of nine cultivation and processing facilities, one each in California, Illinois, Maine, New Jersey, New York, Ohio and Pennsylvania, respectively, and two in Massachusetts.

Strategic Priorities

The Company believes its refocused strategy is the key to continued improvements in its financial results and shareholder value. The Company remains focused on three key strategic objectives - accelerating growth in its core markets, driving profitability, and strengthening the balance sheet.

Accelerating Growth in Core Markets: Through prior acquisitions and capital expenditures, management believes Acreage is well positioned for future success in several key markets as regulations regarding the use of cannabis continue to evolve. The Company will continue to focus its growth on its core markets where it can take advantage of and expand on the presence already established.

Driving Profitability: The Company's focus on improving operational and financial results has generally resulted in improving profitability. Management continues to diligently control costs, improve operational efficiencies, and accelerate organic growth in its core markets to continue to report improved profitability going forward.

Strengthening the Balance Sheet: Strengthening the balance sheet is key to both providing the Company with the necessary capital to achieve its operational plans and building shareholder confidence. The Company has worked to ensure that sufficient capital is available when needed. Going forward, the Company will monitor the capital markets and utilize opportunities to access additional debt or equity, or both, when it is necessary and advantageous to do so.

Highlights from the three and nine months ended September 30, 2022:

•Subsequent to the end of the quarter, the Company entered into a new strategic arrangement with Canopy Growth that would allow Canopy Growth to acquire 100% of Acreage by i) waiving its existing Floating Share option and entering into a new Floating Share acquisition agreement; and ii) committing to exercise its Fixed Share option, all subject to required approvals and terms of the related agreements.

•Subsequent to the end of the quarter, the Company amended its $150 million credit facility to provide immediate access to $25 million and increased flexibility through updated covenants.

•Subsequent to the end of the quarter, the Company’s social equity joint venture in Connecticut was approved for both a Disproportionately Impacted Area Cultivation License and an Adult-use Cannabis Retailer license.

•The Company achieved total consolidated revenue growth of 28% and 37% as compared with the three and nine months ended September 30, 2021, respectively.

•Adjusted EBITDA for the three and nine months ended September 30, 2022 was $8.8 million and $27.9 million, respectively, compared to adjusted EBITDA of $6.5 million and $16.2 million, respectively, during the same period in

35

2021. This marks seven consecutive quarters of positive adjusted EBITDA, further validating management's refocused strategic plan. Refer to section “Non-GAAP Information” in this Item 2 for discussion of Adjusted EBITDA as a non-GAAP measure.

•Launched Botanist Vape Cartridges and Disposables in Illinois as well as Superflux Cured Concentrates to build on reputation of national brand. Further, Superflux Won Best Vape Pen and Cartridge category in High Times Cannabis Cup Illinois with their Live Resin Margalope Cartridge.

•On July 5, 2022, the Company completed the sale of its four remaining Oregon dispensaries for total proceeds of $6.2 million with $5.85 million being satisfied by a 36 month promissory note bearing interest at a rate of 12% per annum.

•On May 3, 2022, the Company completed the sale of its cultivation facility in Medford, Oregon for total proceeds of $2.0 million.

•On May 1, 2022, the Company acquired and converted to adult use the final dispensary owned by our partner in Maine.

•On April 25, 2022, the Company commenced adult-use operations in New Jersey, offering a range of products from flagship brand The Botanist for adult-use sales.

Operational and Regulation Overview

The Company believes its operations are in material compliance with all applicable state and local laws, regulations and licensing requirements in the states in which it operates. However, cannabis is illegal under U.S. federal law. Substantially all of the Company’s revenue is derived from U.S. cannabis operations. For information about risks related to U.S. cannabis operations, please refer to Item 1A of the Company’s Annual Report on Form 10-K for the year ended December 31, 2021.

COVID-19

In December 2019, a novel strain of coronavirus (“COVID-19”) emerged in Wuhan, China. Since then, it has spread to other countries and infections have been reported around the world. On March 11, 2020, the World Health Organization declared the outbreak of COVID-19 a global pandemic.

In response to the outbreak, governmental authorities in the United States, Canada and internationally have introduced various recommendations and measures to try to limit the pandemic, including travel restrictions, border closures, non-essential business closures, quarantines, self-isolations, shelters-in-place and social distancing. The COVID-19 outbreak and the response of governmental authorities to try to limit it are having a significant impact on the private sector and individuals, including unprecedented business, employment and economic disruptions. Management has been closely monitoring the impact of COVID-19, with a focus in the health and safety of our employees, business continuity and supporting our communities. The Company implemented various measures at the height of the pandemic to reduce the spread of the virus, such as implementing social distancing measures at its facilities. Most of these measures are no longer considered to be necessary or required; however, the Company reserves the right to implement similar precautionary measures in the future as circumstances change.

Aside from minimal impact to our day-to-day operations at select locations, COVID-19 has had an immaterial impact overall on our Company’s performance as key performance metrics are trending positively, including, but not limited to, significant improvements to net revenue and net loss as well as positive adjusted EBITDA results.

Results of Operations

The following table presents selected financial data derived from the unaudited condensed consolidated financial statements of the Company for the three and nine months ended September 30, 2022 and 2021. The selected financial information set out below may not be indicative of the Company’s future performance.

Summary Results of Operations

36

					Better/(Worse)								Better/(Worse)
in thousands, except per share amounts	Three Months Ended September 30,				2022 vs. 2021				Nine Months Ended September 30,				2022 vs. 2021
	2022		2021		$		%		2022		2021		$		%
Revenues, net	$	61,419	$	48,152	$	13,267	28	%	$	179,649	$	130,762	$	48,887	37	%
Net operating loss	(16,435)		(6,494)		(9,941)		(153)		(15,847)		(11,444)		(4,403)		(38)
Net loss attributable to Acreage	(22,214)		(12,296)		(9,918)		(81)		(44,837)		(22,657)		(22,180)		(98)
Basic and diluted loss per share attributable to Acreage	$	(0.20)	$	(0.12)	$	(0.08)	(67)	%	$	(0.41)	$	(0.22)	$	(0.19)	(86)	%

Revenues, Cost of goods sold and Gross profit

The Company derives its revenues from sales of cannabis and cannabis-infused products through retail dispensary, wholesale and manufacturing and cultivation businesses, as well as from management or consulting fees from entities for whom the Company provides management or consulting services.

Gross profit is revenue less cost of goods sold. Cost of goods sold includes costs directly attributable to inventory sold such as direct material, labor, and overhead, including depreciation. Such costs are further affected by various state regulations that limit the sourcing and procurement of cannabis and cannabis-related products, which may create fluctuations in gross profit over comparative periods as the regulatory environment changes.

							Better/(Worse)										Better/(Worse)
in thousands	Three Months Ended September 30,						2022 vs. 2021				Nine Months Ended September 30,						2022 vs. 2021
	2022			2021			$		%		2022			2021			$		%
Retail revenue, net	$	48,314		$	30,795		$	17,519	57	%	$	136,426		$	85,038		$	51,388	60	%
Wholesale revenue, net	12,810			17,077			(4,267)		(25)		42,342			42,634			(292)		(1)
Other revenue, net	295			280			15		5		881			3,090			(2,209)		(71)
Total revenues, net	$	61,419		$	48,152		$	13,267	28	%	$	179,649		$	130,762		$	48,887	37	%
Cost of goods sold, retail	(26,097)			(16,279)			(9,818)		(60)		(70,331)			(43,412)			(26,919)		(62)
Cost of goods sold, wholesale	(14,096)			(8,069)			(6,027)		(75)		(27,968)			(19,049)			(8,919)		(47)
Total cost of goods sold	$	(40,193)		$	(24,348)		$	(15,845)	(65)	%	$	(98,299)		$	(62,461)		$	(35,838)	(57)	%
Gross profit	$	21,226		$	23,804		$	(2,578)	(11)	%	$	81,350		$	68,301		$	13,049	19	%
Gross margin	35		%	49		%			(14)	%	45		%	52		%			(7)	%
n/m - Not Meaningful

Three months ended September 30, 2022 vs. 2021

Total revenues for the three months ended September 30, 2022 grew by $13,267, or 28%, compared with 2021. On a comparative basis, total revenue increased by $14,208 due to i) the acquisitions of Greenleaf Ohio in October 2021 and ii) the acquisition of certain Maine operations and offset by iii) the disposition of the Company’s operations in Oregon in July 2022. Excluding these acquisitions and divestitures/closures, total revenue decreased by $941, or 2% for the three months ended September 30, 2022, as compared to 2021.

Retail revenue for the three months ended September 30, 2022 grew by $17,519, or 57%, compared with 2021. Excluding the impact of acquisitions and divestitures/closures, retail revenue increased by $4,730 or 16% for the three months ended September 30, 2022 compared to fiscal 2021. This organic growth was primarily driven by increased demand and production across various states, offset by price compression.

Wholesale revenue for the three months ended September 30, 2022 decreased by $4,267, or 25%, compared to fiscal 2021. The decreased wholesale revenue was primarily due to price compression and decreased wholesale demand in select markets, and somewhat offset by the acquisition of Greenleaf Ohio.

Retail cost of goods sold increased $9,818, or 60%, for the three months ended September 30, 2022 compared to 2021, which was generally consistent with the 57% increase in retail revenue. Price compression in select markets was offset by cost efficiencies.

Wholesale cost of goods sold increased $6,027, or 75%, for the three months ended September 30, 2022 compared to 2021, which outpaced the 25% increase in wholesale revenue. Wholesale cost of goods sold increased due to $6,286 of non-cash inventory adjustments made in the three months ended September 30, 2022 as a result of i) excess inventory in select markets

37

ii) reducing the carrying value of wholesale inventory to reflect the lower of cost and net realizable value and iii) increased costs due to inflation. Excluding these non-cash inventory adjustments, wholesale costs of goods sold decreased $259 or 3%.

Gross profit decreased $2,578, or 11%, for the three months ended September 30, 2022 to $21,226 from $23,804 in 2021. Gross margin decreased from 49% of revenue for the three months ended September 30, 2021 to 35% of revenue in 2022, or (14)%. Efficiencies gained from further economies of scale were unable to offset overall selling price declines, cost increases due to inflation, and the aforementioned wholesale non-cash inventory adjustments. Excluding these non-cash inventory adjustments, margin decreased to 45%.

Nine months ended September 30, 2022 vs. 2021

Total revenues for the nine months ended September 30, 2022 grew by $48,887, or 37%, compared with 2021. On a comparative basis, total revenue increased by $49,066 due to the acquisitions of (i) Greenleaf Ohio in October 2021, (ii) certain Maine operations and (iii) CWG in May 2021 and was offset by decreases of $3,428 due to the decreased performance and ultimate divestiture of the Company’s operations in Oregon in July 2022 and the divestiture of Acreage Florida in April 2021. Additionally, total revenue for the prior comparative nine months ended September 30, 2021 included (i) $2,530 of previously unrecognized management fees in New Hampshire, some of which related to prior periods and (ii) a bulk wholesale sale transaction of $1,500 that did not recur. Excluding these acquisitions and divestitures/closures, the impact of total revenue declines in the Company’s Oregon operations and the non-recurring transactions for the nine months ended September 30, 2021, total revenue increased by $3,249, or 3%, for the nine months ended September 30, 2022, as compared to fiscal 2021.

Retail revenue for the nine months ended September 30, 2022 grew by $51,388, or 60%, compared with 2021. Excluding the impact of acquisitions and divestitures/closures, as well as declines in the Company’s Oregon operations prior to their ultimate sale, retail revenue increased by $9,790, or 12%, for the nine months ended September 30, 2022 compared to the nine months ended 2021. This organic growth was primarily driven by increased demand and production across various states.

Wholesale revenue for the nine months ended September 30, 2022 decreased slightly by $292, or 1%, compared to fiscal 2021. The relatively flat wholesale revenue was primarily due to increased capacity, coupled with maturing operations offset by price compression and decreased wholesale demand in select markets. Additionally, wholesale revenue for the nine months ended September 30, 2022 increased by $4,040 due to acquisitions that have occurred over the prior 24 months which was somewhat offset by a bulk wholesale sale transaction of $1,500 in the second quarter of 2021 that did not recur.

Retail cost of goods sold increased $26,919, or 62%, for the nine months ended September 30, 2022 compared to 2021, which was generally consistent with the 60% increase in retail revenue. Price compression in select markets was offset by cost efficiencies.

Wholesale cost of goods sold increased $8,919, or 47%, for the nine months ended September 30, 2022 compared to 2021, which outpaced the 1% decrease in wholesale revenue. Wholesale cost of goods sold increased due to $6,286 of non-cash inventory adjustments made in the nine months ended September 30, 2022 as a result of i) excess inventory in select markets, ii) reducing the carrying value of wholesale inventory to reflect the lower of cost and net realizable value and iii) increased costs due to inflation. Excluding these non-cash inventory adjustments, wholesale costs of goods sold increased $2,633 or 14%.

Gross profit increased $13,049, or 19%, for the nine months ended September 30, 2022 to $81,350 from $68,301 in 2021, and Gross margin decreased from 52% of revenue for the nine months ended September 30, 2021 to 45% of revenue in 2022, or (7)%, due to the factors discussed above. Efficiencies gained from further economies of scale were unable to offset overall selling price declines, cost increases due to inflation, and the aforementioned wholesale non-cash inventory adjustments. Excluding these non-cash inventory adjustments, margin decreased to 49%.

Revenue by geography

While the Company operates under one operating segment for the production and sale of cannabis products, the below revenue breakout by geography is included as management believes it provides relevant and useful information to investors.

38

Revenue by region					Better/(Worse)								Better/(Worse)
in thousands	Three Months Ended September 30,				2022 vs. 2021				Nine Months Ended September 30,				2022 vs. 2021
	2022		2021		$		%		2022		2021		$		%
New England	$	16,481	$	19,893	$	(3,412)	(17)	%	$	49,293	$	56,070	$	(6,777)	(12)	%
Mid-Atlantic	21,235		14,694		6,541		45		56,125		43,474		12,651		29
Midwest	23,096		10,012		13,084		131		70,059		22,333		47,726		214
West	607		3,553		(2,946)		(83)		4,172		8,264		(4,092)		(50)
South	—		—		—		n/m		—		621		(621)		(100)
Total revenues, net	$	61,419	$	48,152	$	13,267	28	%	$	179,649	$	130,762	$	48,887	37	%
n/m - Not Meaningful

Total operating expenses

Total operating expenses consist primarily of loss on impairments, compensation expense at our corporate offices as well as operating subsidiaries, professional fees, which includes, but is not limited to, legal and accounting services, depreciation and other general and administrative expenses.

Operating expenses					Better/(Worse)								Better/(Worse)
in thousands	Three Months Ended September 30,				2022 vs. 2021				Nine Months Ended September 30,				2022 vs. 2021
	2022		2021		$		%		2022		2021		$		%
General and administrative	$	9,727	$	8,465	$	1,262	15	%	$	27,036	$	23,067	$	3,969	17	%
Compensation expense	15,271		10,699		4,572		43		42,045		32,236		9,809		30
Equity-based compensation expense	3,156		4,168		(1,012)		(24)		8,970		17,191		(8,221)		(48)
Marketing	735		583		152		26		2,396		992		1,404		142
Impairments, net	506		2,339		(1,833)		(78)		2,973		3,157		(184)		(6)
Loss on notes receivable	7,219		—		7,219		n/m		7,219		1,726		5,493		318
Write down (recovery) of assets held-for-sale	—		—		—		n/m		874		(8,616)		9,490		n/m
Legal settlements (recoveries)	—		—		—		n/m		(335)		322		(657)		n/m
Depreciation and amortization	1,047		4,044		(2,997)		(74)		6,019		9,670		(3,651)		(38)
Total operating expenses	$	37,661	$	30,298	$	7,363	24	%	$	97,197	$	79,745	$	17,452	22	%
n/m - Not Meaningful

Three months ended September 30, 2022 vs. 2021

Total operating expenses for the three months ended September 30, 2022 were $37,661, an increase of $7,363, or 24%, compared with 2021. The primary drivers of the increase in operating expenses were as follows:

•General and administrative expenses increased $1,262 during the three months ended September 30, 2022 compared with 2021, primarily due to (i) increased costs associated with the Company’s expanded operations from both organic growth and acquisitions, (ii) an increases in professional fees, which was driven by professional and consulting fees incurred, and (iii) an increase in the cost of insurance.

•Compensation expense increased $4,572 during the three months ended September 30, 2022 as compared with 2021, primarily due to increased headcount required to manage the Company’s expanded operations, including the acquisitions of Greenleaf during the period, as well as certain non-recurring retention payments made in the current period.

•Equity-based compensation expense decreased $1,012, or 24%, during the three months ended September 30, 2022 as compared with 2021, primarily due to benefits associated with reorganization efforts undertaken in prior periods, resulting in the acceleration of restricted share vesting for certain employees and previously issued awards becoming fully vested and cancelled in prior periods.

•Impairments, net decreased $1,833 for the nine months ended September 30, 2022 as compared with 2021, which was primarily driven by the non-recurrence of the write-off of $2,339 of capital assets at the Sewell, New Jersey locations resulting from damage by Hurricane Ida.

•Loss on notes receivable for the three months ended September 30, 2022 is due to the determination that the payment for certain notes receivables was doubtful based on the most recent information available to the Company.

39

•Depreciation and amortization expenses decreased by $2,997 during the three months ended September 30, 2022 compared with 2021, primarily due to an acceleration of the amortization of certain intangible assets as a result of a reduction in the expected useful lives of such assets during the three months ended September 30, 2021.

Nine months ended September 30, 2022 vs. 2021

Total operating expenses for the nine months ended September 30, 2022 were $97,197, an increase of $17,452, or 22%, compared with 2021. The primary drivers of the decrease in operating expenses were as follows:

•General and administrative expenses increased $3,969 during the nine months ended September 30, 2022 compared with 2021, primarily due to increases in (i) professional fees, which was driven by professional and consulting fees incurred, (ii) an increase in the cost of insurance, fees, permits and licenses and (iii) increased costs associated with the Company’s expanded operations from both organic growth and acquisitions.

•Compensation expense increased $9,809 during the nine months ended September 30, 2022 as compared with 2021, primarily due to increased headcount required to manage the Company’s expanded operations, including the acquisitions of certain Maine operations, CWG, and Greenleaf during the period, as well as certain non-recurring retention payments made in the current period.

•Equity-based compensation expense decreased $8,221, or 48%, during the nine months ended September 30, 2022 as compared with 2021, primarily due to benefits associated with reorganization efforts undertaken in prior periods, resulting in the acceleration of restricted share vesting for certain employees and previously issued awards becoming fully vested and cancelled in prior periods. Additionally, no annual grants were issued to employees under the Company’s normal long-term incentive plan until July 2022 for the current year-to-date period.

•The loss on notes receivable for the nine months ended September 30, 2022 and September 30, 2021 is due to the determination that the payment for certain notes receivables were doubtful based on the most recent information available to the Company.

•Write down (recovery) of assets held-for-sale of $874 for the nine months ended September 30, 2022 related to the Company’s Oregon operations, Write down (recovery) of assets held-for-sale of for the nine months ended September 30, 2021 were due to a recovery that was attributable to the Company agreeing on terms to sell Acreage Florida, and determining that the fair value less costs to sell its Acreage Florida disposal group increased $8,616 in excess of its previously written down value.

•Depreciation and amortization expenses decreased by $2,997 during the three months ended September 30, 2022 compared with 2021, primarily due to an acceleration of the amortization of certain intangible assets as a result of a reduction in the expected useful lives of such assets during the nine months ended September 30, 2021.

Total other income (loss)

Other income (loss)					Better/(Worse)								Better/(Worse)
in thousands	Three Months Ended September 30,				2022 vs. 2021				Nine Months Ended September 30,				2022 vs. 2021
	2022		2021		$		%		2022		2021		$		%
Income (loss) from investments, net	$	17	$	489	$	(472)	(97)	%	$	154	$	(777)	$	931	n/m
Interest income from loans receivable	474		1,067		(593)		(56)		1,256		4,125		(2,869)		(70)	%
Interest expense	(5,688)		(3,620)		(2,068)		(57)		(15,989)		(14,072)		(1,917)		(14)
Other income, net	4,743		80		4,663		n/m		5,019		7,825		(2,806)		(36)
Total other loss	$	(454)	$	(1,984)	$	1,530	77	%	$	(9,560)	$	(2,899)	$	(6,661)	(230)	%
n/m - Not Meaningful

Three months ended September 30, 2022 vs. 2021

Total other loss for the three months ended September 30, 2022 was $(454), a decrease of $1,530 compared with 2021. The primary drivers of the decrease in Total other income (loss) were as follows:

•Income from investments and interest income from loans receivable have declined due to the performance of certain investments held by the Company and a reduced balance of notes receivable due to repayments that have occurred over the past 15 months.

•Interest expense for the three months ended September 30, 2022 of $5,688 increased by $2,068 as a result of the Company having a larger debt balance as compared to 2021.

40

•Other income, net for the three months ended September 30, 2022 of $4,743 increased by $4,663 as compared with 2021. Other income, net for the three months ended September 30, 2022 was primarily related to a gain on the sale of the Company’s Oregon operations of $3,189.

Nine months ended September 30, 2022 vs. 2021

Total other loss for the nine months ended September 30, 2022 was $9,560, an increase of $6,661 compared with 2021. The primary drivers of the decrease in Total other income (loss) were as follows:

•Income (loss) from investments, net of $154 for the nine months ended September 30, 2022 has increased $931 as compared with 2021 due to improved performance of certain investments held by the Company.

•Interest income from loans receivable of $1,256 for the nine months ended September 30, 2022 has declined $2,869 as compared with 2021 due to a reduction in loans receivable outstanding during the comparative period.

•Interest expense for the nine months ended September 30, 2022 of $15,989 increased by $1,917 as a result of the Company having a larger debt balance as compared to 2021, somewhat offset by a lower over blended interest rate that is payable on the Company’s debt.

•Other income, net for the nine months ended September 30, 2022 of $5,019 decreased by $2,806 as compared with 2021. Other income, net for the nine months ended September 30, 2022 was primarily related to a gain on the sale of the Company’s Oregon operations of $3,189. Other income, net for the nine months ended September 30, 2021 was primarily related to a gain on the sale of Acreage Florida of $11,682 and was partially offset by the loss on the subsequent sale of notes receivable received as consideration from the buyer of Acreage Florida of approximately $2,000 and by losses related to the disposal of capital assets related to Form Factory.

Net loss

Net loss					Better/(Worse)								Better/(Worse)
in thousands	Three Months Ended September 30,				2022 vs. 2021				Nine Months Ended September 30,				2022 vs. 2021
	2022		2021		$		%		2022		2021		$		%
Net loss	$	(24,998)	$	(14,057)	$	(10,941)	(78)	%	$	(49,512)	$	(26,004)	$	(23,508)	(90)	%
Less: net loss attributable to non-controlling interests	(2,784)		(1,761)		(1,023)		(58)		(4,675)		(3,347)		(1,328)		(40)
Net loss attributable to Acreage Holdings, Inc.	$	(22,214)	$	(12,296)	$	(9,918)	(81)	%	$	(44,837)	$	(22,657)	$	(22,180)	(98)	%
n/m - Not Meaningful

The changes in net loss are driven by the factors discussed above.

Non-GAAP Information

This statement includes Adjusted EBITDA, which is a non-GAAP performance measure that we use to supplement our results presented in accordance with U.S. GAAP. The Company uses Adjusted EBITDA to evaluate its actual operating performance and for planning and forecasting future periods. The Company believes that the adjusted results presented provide relevant and useful information for investors because they clarify the Company’s actual operating performance, make it easier to compare our results with those of other companies and allow investors to review performance in the same way as our management. Since these measures are not calculated in accordance with U.S. GAAP, they should not be considered in isolation of, or as a substitute for, net loss or our other reported results of operations as reported under U.S. GAAP as indicators of our performance, and they may not be comparable to similarly named measures from other companies.

The Company defines Adjusted EBITDA as net income before interest, income taxes and, depreciation and amortization and excluding the following: (i) income from investments, net (the majority of the Company's investment income relates to remeasurement to net asset value of previously-held interests in connection with our roll-up of affiliates, and the Company expects income from investments to be a non-recurring item as its legacy investment holdings diminish), (ii) equity-based compensation expense, (iii) non-cash impairment losses, (iv) transaction costs, (v) non-cash inventory adjustments and (vi) other non-recurring expenses (other expenses and income not expected to recur).

41

Adjusted EBITDA					Better/(Worse)								Better/(Worse)
in thousands	Three Months Ended September 30,				2022 vs. 2021				Nine Months Ended September 30,				2022 vs. 2021
	2022		2021		$		%		2022		2021		$		%
Net loss (U.S. GAAP)	$	(24,998)	$	(14,057)					$	(49,512)	$	(26,004)
Income tax expense	8,109		5,579						24,105		11,661
Interest expense, net	5,214		2,553						14,733		9,947
Depreciation and amortization(1)	2,583		4,590						9,930		11,384
EBITDA (non-GAAP)	$	(9,092)	$	(1,335)	$	(7,757)	n/m		$	(744)	$	6,988	$	(7,732)	(111)	%
Adjusting items:
Loss (income) from investments, net	(17)		(489)						(154)		777
Impairments, net	506		—						2,596		818
Non-cash inventory adjustments	6,286		—						6,286		—
Loss on extraordinary events(2)	—		2,339						376		2,339
Loss on notes receivable	7,219		—						7,219		1,726
Write down (recovery) of assets held-for-sale	—		—						874		(8,616)
Legal settlements, net	—		—						(335)		322
Gain on business divestiture	(3,200)		(109)						(3,496)		(11,791)
Equity-based compensation expense	3,156		4,168						8,970		17,191
Other non-recurring expenses(3)	3,989		1,924						6,267		6,425
Adjusted EBITDA (non-GAAP)	$	8,847	$	6,498	$	2,349	36	%	$	27,859	$	16,179	$	11,680	72	%
n/m - Not Meaningful

(1) Depreciation and amortization as of September 30, 2021 contains depreciation and amortization included in cost of goods sold.

(2) Extraordinary items are events and transactions that are distinguished by their unusual nature and by the infrequency of their occurrence.

(3) Other non-recurring expenses relates to certain compensation, general and administrative, and other miscellaneous expenses. The Company excludes these items as they are not expected to recur.

The increases in adjusted EBITDA are driven by the factors discussed above.

LIQUIDITY AND CAPITAL RESOURCES

Liquidity

Sources and uses of cash

The Company’s primary uses of capital include operating expenses, capital expenditures and the servicing of outstanding debt. The Company’s primary sources of capital include funds generated by cannabis sales as well as financing activities. Through September 30, 2022, the Company had primarily used private financing as a source of liquidity for short-term working capital needs and general corporate purposes.

As of September 30, 2022, the Company had cash of $26,476 (not including $95 of restricted cash). The Company’s ability to fund its operations, capital expenditures, acquisitions, and other obligations depends on its future operating performance and ability to obtain financing, which are subject to prevailing economic conditions, as well as financial, business and other factors, some of which are beyond the Company’s control.

The Company’s future contractual obligations include the following:

Leases

As of September 30, 2022, the Company had future operating lease obligations and future finance lease obligations of $38,866 and $21,365, respectively, with $1,147 and $5,858 payable within the remaining three months, respectively. The Company leases land, buildings, equipment and other capital assets which it plans to use for corporate purposes in addition to the production and sale of cannabis products. Leases with an initial term of 12 months or less are not recorded on the Unaudited Condensed Consolidated Statements of Financial Position and are expensed in the Unaudited Condensed Consolidated Statements of Operations on the straight-line basis over the lease term. The Company does not have any material variable lease payments, and accounts for non-lease components separately from leases. Refer to Note 8 of the Unaudited Condensed Consolidated Financial Statements for further discussion.

42

Debt

As of September 30, 2022, the Company had outstanding debt with varying maturities for an aggregate principal amount of $202,092, with $6,426 payable within the remaining three months. The Company has related future interest payments of $65,469, with $4,134 payable within the remaining three months. Refer to Note 10 of the Unaudited Condensed Consolidated Financial Statements for further discussion.

The Company expects that its total readily available funds of $26,476 as of September 30, 2022 and its further ability to obtain private and/or public financing, will be adequate to support the future obligations discussed above as well as the capital needs of the existing operations and expansion plans over the next twelve months. Additionally, subsequent to the end of the quarter, the Company amended its $150 million credit facility to provide immediate access to $25 million of the committed accordion with further access to the remaining $25 million of the committed accordion available on January 1, 2023 provided certain predetermined milestones are achieved. Refer to Note 2 of the Unaudited Condensed Consolidated Financial Statements for further discussion.

Cash flows

Cash and cash equivalents, restricted cash, and cash held for sale were $26,571 as of September 30, 2022, which represents a net decrease of $17,930 for the nine months ended September 30, 2022. The following table details the change in cash, cash equivalents, restricted cash and cash related to assets held for sale for the nine months ended September 30, 2022 and 2021.

Cash flows					Better/(Worse)
in thousands	Nine Months Ended September 30,				2022 vs. 2021
	2022		2021		$		%
Net cash used in operating activities	$	(30,473)	$	(18,312)	$	(12,161)	(66)	%
Net cash provided by (used in) investing activities	(5,328)		34,152		(39,480)		n/m
Net cash provided by (used in) financing activities	17,871		(40,995)		58,866		n/m
Net decrease in cash, cash equivalents, restricted cash, and cash held for sale	$	(17,930)	$	(25,155)	$	7,225	29	%
n/m - Not Meaningful

Net cash used in operating activities

During the nine months ended September 30, 2022, the Company used $30,473 of net cash in operating activities, which represented an increase of $12,161, or 66%, when compared with 2021. Although the reported net loss increased by $23,508 during the nine months ended September 30, 2022 when compared to the same period of 2021, the net loss excluding non-cash items such as impairments, equity based compensation, write-offs and recoveries, gains and losses on disposals and depreciation and amortization increased by $10,044 when compared to the same period of 2021. Additionally, cash used in operating activities for the nine months ended September 30, 2021 benefited from a difference in the timing of tax payments.

Net cash provided by (used in) investing activities

During the nine months ended September 30, 2022, the Company used $5,328 of net cash through investing activities compared to $34,152 of net cash provided by investing activities for the nine months ended September 30, 2021, which represented a change of $39,480. Net cash used in investing activities for the nine months ended September 30, 2022 included (i) $12,582 on the purchase of capital assets and intangibles and (ii) $3,400 paid for short-term investments, which was partially offset by (iii) the collection of notes receivable of $7,106. Net cash provided by investing activities for the nine months ended September 30, 2021 included (i) proceeds from the sale of promissory notes for $26,000, (ii) proceeds from business divestitures if $24,407, and (iii) the collection of notes receivable of $13,225, which was partially offset by (iv) $27,535 on the purchase of capital assets and intangibles.

43

Net cash provided by (used in) financing activities

During the nine months ended September 30, 2022, the Company had $17,871 of net cash provided by financing activities compared to $40,995 of net cash used in financing activities for the nine months ended September 30, 2021, which represented a change of $58,866. Net cash provided by financing activities for the nine months ended September 30, 2022 included (i) $24,489 of net proceeds from financing and was partially offset by (ii) $5,534 of capital distributions to non-controlling interest repayments of debt, and (iii) $1,084 of repayments of debt. Net cash used in financing activities for the nine months ended September 30, 2021 included (i) 46,321 of repayments of debt and was partially offset by (ii) $6,301 of net proceeds from financing.

Capital Resources

Capital structure and debt

Our debt outstanding as of September 30, 2022 and December 31, 2021 is as follows:

Debt balances	September 30, 2022		December 31, 2021
Financing liability (failed sale-leaseback)	$	15,253	$	15,253
Finance lease liabilities	10,925		5,245
7.50% Loan due April 2026	31,156		30,763
6.10% Secured debenture due September 2030	46,388		46,050
Note due December 2024	3,958		4,750
9.75% Credit facilities due January 2026	94,412		68,673
Total debt	$	202,092	$	170,734
Less: current portion of debt	7,218		1,583
Total long-term debt	$	194,874	$	169,151

Commitments and contingencies

Commitments

The Company provides revolving lines of credit to several third parties. Refer to Note 6 of the Unaudited Condensed Consolidated Financial Statements for further discussion.

Arrangement with Canopy Growth

On June 19, 2019, the shareholders of the Company and of Canopy Growth separately approved the Prior Plan of Arrangement involving the two companies. Subsequently, on September 23, 2020, Acreage and Canopy Growth entered into an amending agreement and the Amended Arrangement became effective on September 23, 2020.

Subsequent to September 30, 2022,the Company entered into a new strategic arrangement with Canopy Growth that, would allow Canopy Growth to acquire 100% of Acreage by i) waiving its existing Floating Share option and entering into a new Floating Share acquisition agreement; and ii) committing to exercise its Fixed Share option, all subject to required approvals and terms of the related agreements.

Refer to Notes 13 and 17 of the Unaudited Condensed Consolidated Financial Statements for further discussion.

Advisor fee

In connection with the Prior Plan of Arrangement, the Company entered into an agreement with its financial advisor providing for a fee payment of $7,000 in either cash, Acreage shares or Canopy Growth shares, at the discretion of the Company, upon the successful acquisition of Acreage by Canopy Growth. Subsequent to September 30, 2022, the Company amended the terms of the agreement with its financial advisors providing for a fee payment of $3,000 in cash, less a $500 initial payment, and $2,000 in shares of the Company, upon the successful acquisition of Acreage by Canopy Growth.

Tax Receivable Agreement

The Company is a party to i) a tax receivable agreement dated November 14, 2018 and subsequently amended (the “Tax Receivable Agreement”) between the Company and certain current and former unit holders of HSCP and ii) tax receivable bonus plans dated November 14, 2018 and subsequently amended (the “Tax Receivable Bonus Plans”) between the Company

44

and certain directors, officers and consultants of the Company (together the “Tax Receivable Recipients”). Under the Tax Receivable Agreement and the Tax Receivable Bonus Plans, the Company is required to make cash payments to the Tax Receivable Recipients equal to 85% of the tax benefits, if any, that the Company actually realizes, or in certain circumstances is deemed to realize, as a result of (i) the increases in its share of the tax basis of assets of HSCP resulting from any redemptions or exchanges of Units from the HSCP Members, and (ii) certain other tax benefits related to the Company making payments under the Tax Receivable Agreement and the Tax Receivable Bonus Plan.

Surety bonds

The Company has indemnification obligations with respect to surety bonds primarily used as security against non-performance in the amount of $5,000 as of September 30, 2022, for which no liabilities are recorded on the Unaudited Condensed Consolidated Statements of Financial Position.

The Company is subject to other capital commitments and similar obligations. As of September 30, 2022, such amounts were not material.

Contingencies

The Company’s operations are subject to a variety of local and state regulations. Failure to comply with one or more of those regulations could result in fines, restrictions on its operations, or losses of permits that could result in the Company’s applicable subsidiaries ceasing operations. While management of the Company believes that the Company’s subsidiaries are in compliance with applicable local and state regulations as of September 30, 2022, cannabis regulations continue to evolve and are subject to differing interpretations. As a result, the Company’s subsidiaries may be subject to regulatory fines, penalties, or restrictions in the future.

The Company and its subsidiaries may be, from time to time, subject to various administrative, regulatory and other legal proceedings arising in the ordinary course of business. Contingent liabilities associated with legal proceedings are recorded when a liability is probable, and the contingent liability can be reasonably estimated. Refer to Note 13 of the Unaudited Condensed Consolidated Financial Statements for further discussion.

Critical accounting policies and estimates

We have adopted various accounting policies to prepare the Unaudited Condensed Consolidated Financial Statements in accordance with GAAP. Certain of our accounting policies require the application of significant judgment by management in selecting the appropriate assumptions for calculating financial estimates. In our 2021 Annual Report on Form 10-K, we identified the critical accounting policies which affect our more significant estimates and assumptions used in preparing our consolidated financial statements.

As of September 30, 2022 there have been no material changes to our critical accounting policies and estimates from those previously disclosed in our 2021 Annual Report on Form 10-K for the year ended December 31, 2021.

Item 3. Quantitative and Qualitative Disclosures About Market Risk (presented in thousands, except share amounts).

The Company has exposure to certain risks, including market, credit, liquidity, asset forfeiture, banking and interest rate risk, and assesses the impact and likelihood of those risks. However, there have been no material changes in our market risk during the three and nine months ended September 30, 2022. For additional information, refer to our 2021 Annual Report on Form 10-K for the year ended December 31, 2021.

Item 4. Controls and Procedures.

Evaluation of Disclosure Controls and Procedures

Based on an evaluation under the supervision and with the participation of the Company’s management, and due to the material weakness in internal controls over financial reporting described below, the Company’s principal executive officer and principal financial officer have concluded that the Company’s disclosure controls and procedures as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act were not effective for the period ending September 30, 2022 to provide reasonable assurance that information required to be disclosed by the Company in reports that it files or submits under the Exchange Act is (i) recorded, processed, summarized and reported within the time periods specified in the SEC rules and forms and (ii) accumulated and communicated to the Company’s management, including its principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure.

45

Inherent Limitations Over Internal Controls

The Company’s internal control over financial reporting is designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with U.S. GAAP. The Company’s internal control over financial reporting includes those policies and procedures that:

(i)    pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the Company’s assets;

(ii)    provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with U.S. GAAP, and that the Company’s receipts and expenditures are being made only in accordance with authorizations of the Company’s management and directors; and

(iii)    provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the Company’s assets that could have a material effect on the financial statements.

Management, including the Company’s Chief Executive Officer and Chief Financial Officer, does not expect that the Company’s internal controls will prevent or detect all errors and all fraud. A control system, no matter how well designed and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of internal controls can provide absolute assurance that all control issues and instances of fraud, if any, have been detected. Also, any evaluation of the effectiveness of controls in future periods are subject to the risk that those internal controls may become inadequate because of changes in business conditions, or that the degree of compliance with the policies or procedures may deteriorate.

In accordance with guidance issued by the SEC, companies are permitted to exclude acquisitions from their final assessment of internal control over financial reporting for the first fiscal year in which the acquisition occurred. Management, including the Chief Executive Officer and Chief Financial Officer, has limited the evaluation of the Company’s internal controls over financial reporting to exclude controls, policies and procedures and internal controls over financial reporting of the recently acquired operations of:

•Greenleaf Apothecaries, Greenleaf Gardens, and Greenleaf Therapeutics, collectively “Greenleaf” (acquired October 1, 2021).

The operations of Greenleaf represents approximately 11% of the Company’s total assets as of September 30, 2022 and 25% of the Company’s gross revenue for the three and nine months ended September 30, 2022.

Material Weaknesses in Internal Control Over Financial Reporting

A material weakness in internal controls over financial reporting is a deficiency, or a combination of deficiencies, in internal controls over financial reporting, such that there is a reasonable possibility that a material misstatement of the Company’s annual or interim financial statements will not be prevented or detected on a timely basis.

The review, testing and evaluation of key internal controls over financial reporting completed by the Company resulted in the Company’s principal executive officer and principal financial officer concluding that as of September 30, 2022, a material weakness existed in the Company’s internal controls over financial reporting. Specifically, as a result of turnover and the availability of resources with the appropriate level of technical capabilities (including the impacts on staffing and recruiting and the general global labor shortage brought about by the global COVID-19 pandemic), the Company did not have effective staffing levels and adequate segregation of duties within several finance and accounting processes. Further, and as a result of this material weakness, the Company’s financial disclosures for the quarterly period ending June 30, 2021 incorrectly disclosed certain debt that was due 11 months after the balance sheet date as long-term rather than as current liabilities. Additionally, and as a result of this material weakness, the Company’s financial disclosures for the quarterly and annual periods ended June 30, 2020, September 30, 2020, December 31, 2020, March 31, 2021, June 30, 2021, and September 30, 2021 incorrectly reported the weighted average shares outstanding which resulted in an incorrect determination of earnings per share and diluted earnings per share.

The Company has begun to address the material weakness described above through the following actions, which are expected to be completed by the second half of 2023:

46

a.Engaging third-party consultants with appropriate expertise to assist the finance and accounting department on an interim basis until key roles are filled;

b.Assessing finance and accounting resources to identify the areas and functions that lack sufficient personnel and recruiting for experienced personnel to assume these roles;

c.Further centralization of key accounting processes to enable greater segregation of duties;

d.Developing further training on segregation of duties; and

e.Designing and implementing additional compensating controls where necessary.

The Company is working diligently to remediate this material weakness by hiring qualified and capable personnel. Further, we will continue to evaluate and assess the staffing needs of the Company as the landscape and needs of the Company continue to evolve. While we are working diligently to remediate this material weakness, there is no assurance that this material weakness will be fully remediated by the second half of 2023 given continuing lasting impacts of COVID-19 on staffing and labor for companies within our industry and otherwise.

Changes in Internal Control Over Financial Reporting

Other than the changes discussed above in connection with our implementation of the remediation plan, there were no changes in our internal control over financial reporting (as such term is defined in Rules 13a–15(f) and 15d–15(f) under the Exchange Act) that occurred during our most recent quarter, that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

PART II

Item 1. Legal Proceedings.

For information on legal proceedings, refer to Note 13 to the Unaudited Condensed Consolidated Financial Statements included this report.

Item 1A. Risk Factors.

There have been no material changes to the risk factors described in the section titled “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

None.

Item 3. Defaults Upon Senior Securities.

None.

Item 4. Mine Safety Disclosures.

Not applicable.

Item 5. Other Information.

Not applicable.

47

Item 6. Exhibits.

		Incorporated by Reference
Exhibit No.	Description of Document	Schedule Form	File Number	Exhibit/Form	Filing Date	Filed or Furnished Herewith
10.1	Arrangement Agreement, dated October 24, 2022, by and among Acreage Holdings, Inc., Canopy Growth Corporation and Canopy USA, LLC.	8-K	000-56021	10.1	10/31/2022
10.2	Form of Voting Support Agreement dated October 24, 2022.	8-K	000-56021	10.2	10/31/2022
10.3+	First Amendment to Credit Agreement and Incremental Increase Activation Notice, dated October 24, 2022 by and among High Street Capital Partners, LLC, Acreage Holdings, Inc., each lender identified on the signature pages thereto, AFC Agent LLC, as co-agent for the lenders and VRT Agent LLC, as co-agent for the lenders.	8-K	000-56021	10.3	10/31/2022
10.4+	Third Amendment to Tax Receivable Agreement, dated October 24, 2022, by and among Acreage Holdings America, Inc., High Street Capital Partners, LLC, the members signatory thereto, Canopy Growth Corporation and Canopy USA LLC.	8-K	000-56021	10.4	10/31/2022
10.5	Fourth Amendment to Third Amended and Restated Limited Liability Agreement of High Street Capital Partners, LLC, dated October 24, 2022.	8-K	000-56021	10.5	10/31/2022
31.1	Certification of Periodic Report by Principal Executive Officer under Section 302 of the Sarbanes-Oxley Act of 2002.					X
31.2	Certification of Periodic Report by Principal Financial Officer under Section 302 of the Sarbanes-Oxley Act of 2002.					X
32.1	Certification of Chief Executive Officer and Chief Financial Officer Pursuant to 18 U.S.C. Section 1350 as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.*					X
101	Attached as Exhibit 101 to this report are the following documents formatted in iXBRL (Extensible Business Reporting Language):): (i) Consolidated Statements of Financial Position as of September 30, 2022 (unaudited) and December 31, 2021 (audited), (ii) Unaudited Condensed Consolidated Statements of Operations for the three and nine months ended September 30, 2022 and September 30, 2021, (iii) Unaudited Condensed Consolidated Statements of Cash Flows for the nine months ended September 30, 2022 and September 30, 2021, (iv) Unaudited Condensed Consolidated Statements of Shareholders’ Equity for the three and nine months ended September 30, 2022 and September 30, 2021 and (v) Notes to Unaudited Condensed Consolidated Financial Statements.					X

48

* Document has been furnished, is not deemed filed and is not to be incorporated by reference into any of the Company’s filings under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, irrespective of any general incorporation language contained in any such filing.

+ Portions of this exhibit are redacted pursuant to Item 601(b)(10)(iv) of Regulation S-K.

49

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date: November 9, 2022

Acreage Holdings, Inc.
By:	/s/ Steve Goertz
	Steve Goertz
	Chief Financial Officer

50

EX-31.1

Exhibit 31.1

Certification of Chief Executive Officer Pursuant to Section 302 of the

Sarbanes-Oxley Act and Rule 13a-14(a) or 15d-14(a)

Under the Securities and Exchange Act of 1934

I, Peter Caldini, certify that:

1.    I have reviewed this Quarterly report on Form 10-Q for the period ended September 30, 2022 of Acreage Holdings, Inc.;

2.    Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.    Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.    The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)     Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)     Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)     Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)     Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.    The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a)    All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize, and report financial information; and

(b)     Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: November 9, 2022

By: /s/ Peter Caldini

Peter Caldini

Chief Executive Officer

EX-31.2

Exhibit 31.2

Certification of Chief Financial Officer Pursuant to Section 302 of the

Sarbanes-Oxley Act and Rule 13a-14(a) or 15d-14(a)

Under the Securities and Exchange Act of 1934

I, Steve Goertz, certify that:

1.    I have reviewed this Quarterly report on Form 10-Q for the period ended September 30, 2022 of Acreage Holdings, Inc.;

2.    Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.    Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.    The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)     Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)     Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)     Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)     Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.    The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a)    All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize, and report financial information; and

(b)     Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: November 9, 2022

By: /s/ Steve Goertz

Steve Goertz

Chief Financial Officer

EX-32.1

Exhibit 32.1

Certifications of the

Chief Executive Officer and Chief Financial Officer

Pursuant to 18 U.S.C. Section 1350

Solely for the purposes of complying with 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, we, the undersigned Chief Executive Officer and Chief Financial Officer of Acreage Holdings, Inc. (the “Company”), hereby certify, based on our knowledge, that the Quarterly Report on Form 10-Q of the Company for the period ended September 30, 2022 (the “Report”) fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934 and that information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ Peter Caldini

Peter Caldini

Chief Executive Officer

/s/ Steve Goertz

Steve Goertz

Chief Financial Officer

Date: November 9, 2022

XML

Cover Page - shares	9 Months Ended
	Sep. 30, 2022	Nov. 02, 2022
Entity Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Sep. 30, 2022
Document Transition Report	false
Entity File Number	000-56021
Entity Registrant Name	ACREAGE HOLDINGS, INC.
Entity Incorporation, State or Country Code	A1
Entity Tax Identification Number	98-1463868
Entity Address, Address Line One	366 Madison Ave, 14th floor
Entity Address, City or Town	New York
Entity Address, State or Province	NY
Entity Address, Postal Zip Code	10017
City Area Code	646
Local Phone Number	600-9181
Title of 12(g) Security	Class D Subordinate Voting Shares, no par value; Class E Subordinate Voting Shares, no par value.
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Shell Company	false
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2022
Entity Central Index Key	0001762359
Class E Subordinate Voting Shares
Entity Information [Line Items]
Entity Common Stock, Shares Outstanding		79,046,738
Class D Subordinate Voting Shares
Entity Information [Line Items]
Entity Common Stock, Shares Outstanding		34,114,596
Class F Multiple Voting Shares
Entity Information [Line Items]
Entity Common Stock, Shares Outstanding		117,600

XML

CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
ASSETS
Cash and cash equivalents	$ 26,476	$ 43,180
Restricted cash	95	1,098
Accounts receivable, net	9,466	8,202
Inventory	50,892	41,804
Notes receivable, current	2,500	7,104
Assets held-for-sale	0	8,952
Other current assets	3,843	2,639
Total current assets	93,272	112,979
Long-term investments	34,328	35,226
Notes receivable, non-current	27,343	27,563
Capital assets, net	135,362	126,797
Operating lease right-of-use assets	22,730	24,598
Intangible assets, net	135,807	119,695
Goodwill	30,492	43,310
Other non-current assets	3,563	1,383
Total non-current assets	389,625	378,572
TOTAL ASSETS	482,897	491,551
LIABILITIES AND SHAREHOLDERS’ EQUITY
Accounts payable and accrued liabilities	26,082	23,861
Taxes payable	29,240	24,572
Interest payable	1,167	1,432
Operating lease liability, current	2,298	2,145
Debt, current	7,218	1,583
Non-refundable deposits on sale	0	1,000
Liabilities related to assets held for sale	0	1,867
Other current liabilities	10,500	10,333
Total current liabilities	76,505	66,793
Debt, non-current	194,874	169,151
Operating lease liability, non-current	22,324	24,255
Deferred tax liability	29,875	27,082
Other liabilities	1,125	0
Total non-current liabilities	248,198	220,488
TOTAL LIABILITIES	324,703	287,281
Commitments and contingencies
Common stock, no par value - unlimited authorized, 112,147 and 106,903 issued and outstanding, respectively	0	0
Additional paid-in capital	761,684	756,536
Treasury stock, 842 common stock held in treasury	(21,054)	(21,054)
Accumulated deficit	(583,052)	(538,215)
Total Acreage Shareholders' equity	157,578	197,267
Non-controlling interests	616	7,003
TOTAL EQUITY	158,194	204,270
TOTAL LIABILITIES AND EQUITY	$ 482,897	$ 491,551

XML

CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION (Parenthetical) - shares shares in Thousands	Sep. 30, 2022	Dec. 31, 2021
Statement of Financial Position [Abstract]
Common stock, issued (in shares)	112,147	106,903
Common stock, shares, outstanding (in shares)	112,147	106,903
Treasury stock (in shares)	842	842

XML

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands	3 Months Ended			9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021		Sep. 30, 2022	Sep. 30, 2021
REVENUE
Total revenues, net	$ 61,419	$ 48,152		$ 179,649	$ 130,762
Total cost of goods sold	(40,193)	(24,348)		(98,299)	(62,461)
Gross profit	21,226	23,804		81,350	68,301
OPERATING EXPENSES
General and administrative	9,727	8,465		27,036	23,067
Compensation expense	15,271	10,699		42,045	32,236
Equity-based compensation expense	3,156	4,168		8,970	17,191
Marketing	735	583		2,396	992
Impairments, net	506	2,339		2,973	3,157
Loss on notes receivable	7,219	0		7,219	1,726
Write down (recovery) of assets held-for-sale	0	0		874	(8,616)
Legal settlements (recoveries)	0	0		(335)	322
Depreciation and amortization	1,047	4,044		6,019	9,670
Total operating expenses	37,661	30,298		97,197	79,745
Net operating loss	(16,435)	(6,494)		(15,847)	(11,444)
Income (loss) from investments, net	17	489		154	(777)
Interest income from loans receivable	474	1,067		1,256	4,125
Interest expense	(5,688)	(3,620)		(15,989)	(14,072)
Other income, net	4,743	80		5,019	7,825
Total other income (loss)	(454)	(1,984)		(9,560)	(2,899)
Loss before income taxes	(16,889)	(8,478)		(25,407)	(14,343)
Income tax expense	(8,109)	(5,579)		(24,105)	(11,661)
Net loss	(24,998)	(14,057)		(49,512)	(26,004)
Less: net loss attributable to non-controlling interests	(2,784)	(1,761)		(4,675)	(3,347)
Net loss attributable to Acreage Holdings, Inc.	$ (22,214)	$ (12,296)		$ (44,837)	$ (22,657)
Net loss per share attributable to Acreage Holdings, Inc. Basic (USD per share)	$ (0.20)	$ (0.12)	[1]	$ (0.41)	$ (0.22)	[1]
Net loss per share attributable to Acreage Holdings, Inc, Diluted (USD per share)	$ (0.20)	$ (0.12)	[1]	$ (0.41)	$ (0.22)	[1]
Weighted average shares outstanding basic (in share)	111,200	106,332	[1]	108,795	104,524	[1]
Weighted average shares outstanding diluted (in share)	111,200	106,332	[1]	108,795	104,524	[1]
Retail
REVENUE
Total revenues, net	$ 48,314	$ 30,795		$ 136,426	$ 85,038
Total cost of goods sold	(26,097)	(16,279)		(70,331)	(43,412)
Wholesale
REVENUE
Total revenues, net	12,810	17,077		42,342	42,634
Total cost of goods sold	(14,096)	(8,069)		(27,968)	(19,049)
Other
REVENUE
Total revenues, net	$ 295	$ 280		$ 881	$ 3,090

[1] Presentation of September 30, 2021 figures have been revised.

XML

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY - USD ($) shares in Thousands, $ in Thousands	Total	Share Capital	Treasury Stock	Accumulated Deficit	Shareholders’ Equity	Non-controlling Interests	LLC Membership Units	Pubco Shares (as converted)
Beginning balance (in shares) at Dec. 31, 2020							3,861	101,250
Beginning balance at Dec. 31, 2020	$ 259,709	$ 737,290	$ (21,054)	$ (475,205)	$ 241,031	$ 18,678
Increase (Decrease) in Stockholders' Equity
Purchase of non-controlling interest in subsidiary	(286)	(272)			(272)	(14)
NCI adjustments for changes in ownership (in shares)								400
NCI adjustments for changes in ownership	0	601			601	(601)
Capital distributions, net	(30)					(30)
Other equity transactions (in shares)								97
Other equity transactions	300	300			300
Equity-based compensation expense and related issuances (in shares)								1,693
Equity-based compensation expense and related issuances	6,042	6,042			6,042
Net loss	(8,642)			(7,809)	(7,809)	(833)
Ending balance (in shares) at Mar. 31, 2021							3,861	103,440
Ending balance at Mar. 31, 2021	257,093	743,961	(21,054)	(483,014)	239,893	17,200
Beginning balance (in shares) at Dec. 31, 2020							3,861	101,250
Beginning balance at Dec. 31, 2020	259,709	737,290	(21,054)	(475,205)	241,031	18,678
Increase (Decrease) in Stockholders' Equity
NCI adjustments for changes in ownership						862
Net loss	(26,004)
Ending balance (in shares) at Sep. 30, 2021							3,861	106,403
Ending balance at Sep. 30, 2021	248,448	753,840	(21,054)	(497,864)	234,922	13,526
Beginning balance (in shares) at Mar. 31, 2021							3,861	103,440
Beginning balance at Mar. 31, 2021	257,093	743,961	(21,054)	(483,014)	239,893	17,200
Increase (Decrease) in Stockholders' Equity
NCI adjustments for changes in ownership (in shares)								666
NCI adjustments for changes in ownership	0	(1,463)			(1,463)	1,463
Capital distributions, net	(2,547)					(2,547)
Other equity transactions (in shares)								1
Other equity transactions	117	117			117
Equity-based compensation expense and related issuances (in shares)								1,595
Equity-based compensation expense and related issuances	6,981	6,981			6,981
Net loss	(3,306)			(2,553)	(2,553)	(753)
Ending balance (in shares) at Jun. 30, 2021							3,861	105,702
Ending balance at Jun. 30, 2021	258,338	749,596	(21,054)	(485,567)	242,975	15,363
Increase (Decrease) in Stockholders' Equity
NCI adjustments for changes in ownership (in shares)								0
NCI adjustments for changes in ownership	0	76			76	(76)
Equity-based compensation expense and related issuances (in shares)								701
Equity-based compensation expense and related issuances	4,168	4,168			4,168
Net loss	(14,057)			(12,297)	(12,297)	(1,761)
Ending balance (in shares) at Sep. 30, 2021							3,861	106,403
Ending balance at Sep. 30, 2021	248,448	753,840	(21,054)	(497,864)	234,922	13,526
Beginning balance (in shares) at Dec. 31, 2021							3,861	106,903
Beginning balance at Dec. 31, 2021	204,270	756,536	(21,054)	(538,215)	197,267	7,003
Increase (Decrease) in Stockholders' Equity
NCI adjustments for changes in ownership (in shares)								0
NCI adjustments for changes in ownership	0	5			5	(5)
Equity-based compensation expense and related issuances (in shares)								508
Equity-based compensation expense and related issuances	4,159	4,159			4,159
Net loss	(13,911)			(12,694)	(12,694)	(1,217)
Ending balance (in shares) at Mar. 31, 2022							3,861	107,411
Ending balance at Mar. 31, 2022	194,518	760,700	(21,054)	(550,909)	188,737	5,781
Beginning balance (in shares) at Dec. 31, 2021							3,861	106,903
Beginning balance at Dec. 31, 2021	204,270	756,536	(21,054)	(538,215)	197,267	7,003
Increase (Decrease) in Stockholders' Equity
NCI adjustments for changes in ownership						55
Net loss	(49,512)
Ending balance (in shares) at Sep. 30, 2022							3,861	112,147
Ending balance at Sep. 30, 2022	158,194	761,684	(21,054)	(583,052)	157,578	616
Beginning balance (in shares) at Mar. 31, 2022							3,861	107,411
Beginning balance at Mar. 31, 2022	194,518	760,700	(21,054)	(550,909)	188,737	5,781
Increase (Decrease) in Stockholders' Equity
NCI adjustments for changes in ownership	0	(4,524)			(4,524)	4,524
Capital distributions, net	(5,534)					(5,534)
Equity-based compensation expense and related issuances (in shares)								1,778
Equity-based compensation expense and related issuances	1,655	1,655			1,655
Net loss	(10,603)			(9,929)	(9,929)	(674)
Ending balance (in shares) at Jun. 30, 2022							3,861	109,189
Ending balance at Jun. 30, 2022	180,036	757,831	(21,054)	(560,838)	175,939	4,097
Increase (Decrease) in Stockholders' Equity
NCI adjustments for changes in ownership	0	697			697	(697)
Other equity transactions (in shares)								378
Other equity transactions	0
Equity-based compensation expense and related issuances (in shares)								2,580
Equity-based compensation expense and related issuances	3,156	3,156			3,156
Net loss	(24,998)			(22,214)	(22,214)	(2,784)
Ending balance (in shares) at Sep. 30, 2022							3,861	112,147
Ending balance at Sep. 30, 2022	$ 158,194	$ 761,684	$ (21,054)	$ (583,052)	$ 157,578	$ 616

XML

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	3 Months Ended				9 Months Ended			12 Months Ended
	Sep. 30, 2022	Mar. 31, 2022	Sep. 30, 2021	Mar. 31, 2021	Sep. 30, 2022	Sep. 30, 2021		Dec. 31, 2021
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (24,998)	$ (13,911)	$ (14,057)	$ (8,642)	$ (49,512)	$ (26,004)
Adjustments for:
Depreciation and amortization	1,047		4,044		6,019	9,670
Depreciation and amortization included in COGS					4,840	1,714
Equity-based compensation expense					8,970	17,607
Gain on business divestiture					(3,490)	(11,681)
Loss on disposal of capital assets					49	1,690
Loss on impairment					2,973	9,947
Loss on notes receivable					7,219	3,726
Recovery on notes receivable					(1,107)	0
Bad debt expense					22	(1,060)	[1]
Non-cash interest expense					2,301	3,154
Non-cash operating lease expense					223	(572)
Loss on lease termination					297	0
Deferred tax (income) expense					(889)	(8,125)
Non-cash loss from investments, net					895	778
Other non-cash (income) expense, net					0	(2,500)
Write-down (recovery) of assets held-for-sale					874	(8,616)
Change, net of acquisitions in:
Accounts receivable, net					(2,787)	(11,128)	[1]
Inventory					(8,715)	(11,864)
Other assets					(1,240)	9,514	[1]
Interest receivable					(1,125)	(1,031)	[1]
Accounts payable and accrued liabilities					(279)	1,238
Taxes payable					4,668	12,935
Interest payable					(265)	(2,060)
Other liabilities					(414)	(5,644)
Net cash used in operating activities					(30,473)	(18,312)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of capital assets					(12,582)	(27,535)
Investments in notes receivable					0	(3,918)
Collection of notes receivable					7,106	13,225
Proceeds from business divestiture					0	24,407
Proceeds from sale of capital assets					0	5
Business acquisitions, net of cash acquired					0	541
Purchases of intangible assets					(900)	0
Distributions from investments					1,048	1,427
Proceeds from sale of promissory notes					0	26,000
Cash paid for short-term investment					(3,400)	0
Proceeds from disposal of short-term investments					3,400	0
Net cash provided by (used in) investing activities					(5,328)	34,152
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from financing					25,000	6,301
Deferred financing costs paid					(511)	(975)
Repayment of debt					(1,084)	(46,321)
Capital distributions - non-controlling interests					(5,534)	0
Net cash provided by (used in) financing activities					17,871	(40,995)
Net decrease in cash, cash equivalents, restricted cash, and cash held for sale					(17,930)	(25,155)
Cash, cash equivalents, restricted cash, and cash held for sale - Beginning of period		$ 44,501		$ 54,639	44,501	54,639		$ 54,639
Cash, cash equivalents, restricted cash, and cash held for sale - End of period	26,571		29,484		26,571	29,484		44,501
RECONCILIATION OF CASH FLOW INFORMATION:
Cash and cash equivalents	26,476		27,868		26,476	27,868		43,180
Restricted cash	95		1,098		95	1,098		1,098
Cash held for sale	0		518		0	518
Total cash, cash equivalents, restricted cash, and cash held for sale at end of period	26,571		29,484		26,571	29,484		$ 44,501
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
Interest paid - non-lease					12,730	11,444
Income taxes paid					21,742	6,346
OTHER NON-CASH INVESTING AND FINANCING ACTIVITIES:
Capital assets not yet paid for					6,242	4,063
Promissory note conversion					0	10,880
Insurance proceeds not yet received					0	6,790
Non-cash proceeds from business divestiture					7,850	34,475
Non-cash proceeds from finance lease					5,785	0
Loss on impairment	$ 506		$ 2,339		$ 2,973	$ 3,157

[1] Presentation of September 30, 2021 figures have been revised, refer to Note 2 for further discussion

XML

NATURE OF OPERATIONS

9 Months Ended

Sep. 30, 2022

Organization, Consolidation and Presentation of Financial Statements [Abstract]

NATURE OF OPERATIONS

NATURE OF OPERATIONS

Acreage Holdings, Inc. (the “Company”, “Pubco” or “Acreage”) is a vertically integrated, multi-state operator in the United States (“U.S.”) cannabis industry and has contractual relationships with cannabis cultivation facilities, dispensaries and other cannabis-related companies in the U.S. The Company’s operations include (i) cultivating and processing cannabis plants, (ii) manufacturing branded consumer products, (iii) distributing cannabis flower and manufactured products, and (iv) retailing dosable cannabis products to consumers. The Company’s products appeal to medical and adult recreational use customers through brand strategies intended to build trust and loyalty. The Company’s Class E subordinate voting shares (“Fixed Shares”) and Class D subordinate voting shares (“Floating Shares”) are listed on the Canadian Securities Exchange under the symbols “ACRG.A.U” and “ACRG.B.U”, respectively, quoted on the OTCQX under the symbols “ACRHF” and “ACRDF”, respectively, and traded on the Frankfurt Stock Exchange under the symbols “0VZ1” and “0VZ2”, respectively.

High Street Capital Partners, LLC, a Delaware limited liability company doing business as “Acreage Holdings” (“HSCP”), was formed on April 29, 2014. The Company became the indirect parent of HSCP on November 14, 2018 in connection with the reverse takeover (“RTO”) transaction described below.

The Company’s principal place of business is located at 366 Madison Ave, 14th floor, New York, New York in the U.S. The Company’s registered and records office address is Suite 2800, Park Place, 666 Burrard Street, Vancouver, British Columbia in Canada.

The RTO transaction

On September 21, 2018, the Company, HSCP, HSCP Merger Corp. (a wholly-owned subsidiary of the Company), Acreage Finco B.C. Ltd. (a special purpose corporation) (“Finco”), Acreage Holdings America, Inc. (“USCo”) and Acreage Holdings WC, Inc. (“USCo2”) entered into a business combination agreement (the “Business Combination Agreement”) whereby the parties thereto agreed to combine their respective businesses, which would result in the RTO of Pubco by the security holders of HSCP, which was deemed to be the accounting acquiror. On November 14, 2018, the parties to the Business Combination Agreement completed the RTO.

Canopy Growth Corporation transaction

On June 27, 2019, the Company and Canopy Growth Corporation (“Canopy Growth” or “CGC”) implemented the Prior Plan of Arrangement (as defined in Note 13) contemplated by the Original Arrangement Agreement (as defined in Note 13). Pursuant to the Prior Plan of Arrangement, Canopy Growth was granted an option to acquire all of the issued and outstanding shares of the Company in exchange for the payment of 0.5818 of a common share in the capital of Canopy Growth for each Class A subordinate voting share (each, a “SVS”) held (with the Class B proportionate voting shares (the “PVS”) and Class C multiple voting shares (the “MVS”) being automatically converted to SVS immediately prior to consummation of the Acquisition (as defined in Note 13), which original exchange ratio was subject to adjustment in accordance with the Original Arrangement Agreement. Canopy Growth was required to exercise the option upon a change in federal laws in the United States to permit the general cultivation, distribution and possession of marijuana (as defined in the relevant legislation) or to remove the regulation of such activities from the federal laws of the United States (the “Triggering Event”) and, subject to the satisfaction or waiver of certain closing conditions set out in the Original Arrangement Agreement, Canopy Growth was required to acquire all of the issued and outstanding SVS (following the mandatory conversion of the PVS and MVS into SVS).

On June 24, 2020, Canopy Growth and the Company entered into an agreement to, among other things, amend the terms of the Original Arrangement Agreement and the terms of the Prior Plan of Arrangement (the “Amended Arrangement”). On September 16, 2020, the Company’s shareholders voted in favor of a special resolution authorizing and approving the terms of, among other things, the Amended Arrangement. Subsequently, on September 18, 2020, the Company obtained a final order from the Supreme Court of British Columbia approving the Amended Arrangement, and on September 23, 2020 the Company and Canopy Growth entered into the Amending Agreement (as defined in Note 13) and implemented the Amended Arrangement. Pursuant to the Amended Arrangement, the Company’s articles were amended to create the Fixed Shares, the Floating Shares and the Class F multiple voting shares (the “Fixed Multiple Shares”), and each outstanding SVS was exchanged for 0.7 of a Fixed Share and 0.3 of a Floating Share, each outstanding PVS was exchanged for 28 Fixed Shares and 12 Floating Shares; and each outstanding MVS was exchanged for 0.7 of a Fixed Multiple Share and 0.3 of a Floating Share. Refer to Note 13 for further discussion.

Pursuant to the implementation of the Amended Arrangement, on September 23, 2020, a subsidiary of Canopy Growth advanced gross proceeds of $50,000 to Universal Hemp, LLC, an affiliate of the Company. The debenture bears interest at a rate of 6.1% per annum. Refer to Note 10 for further discussion.

Subsequent to the balance sheet date, the Company entered into a new arrangement agreement with Canopy Growth regarding the acquisition of the Company’s Floating Shares. Refer to Note 17 for further discussion.

COVID-19

In December 2019, a novel strain of coronavirus (“COVID-19”) emerged in Wuhan, China. Since then, it has spread to other countries and infections have been reported around the world. On March 11, 2020, the World Health Organization declared the outbreak of COVID-19 a global pandemic.

In response to the outbreak, governmental authorities in the United States, Canada and internationally have introduced various recommendations and measures to try to limit the pandemic, including travel restrictions, border closures, non-essential business closures, quarantines, self-isolations, shelters-in-place and social distancing. The COVID-19 outbreak and the response of governmental authorities to try to limit it are having a significant impact on the private sector and individuals, including unprecedented business, employment and economic disruptions. Management has been closely monitoring the impact of COVID-19, with a focus on the health and safety of the Company’s employees, business continuity and supporting the communities where the Company operates. The Company implemented various measures at the height of the pandemic to reduce the spread of the virus, such as implementing social distancing measures at its facilities. Most of these measures are no longer considered to be necessary or required; however, the Company reserves the right to implement similar precautionary measures in the future as circumstances change.

Despite some impact to our day-to-day operations at select locations from time-to-time, COVID-19 has had a minimal impact overall on the Company’s performance.

XML

SIGNIFICANT ACCOUNTING POLICIES

9 Months Ended

Sep. 30, 2022

Accounting Policies [Abstract]

SIGNIFICANT ACCOUNTING POLICIES

SIGNIFICANT ACCOUNTING POLICIES

Basis of presentation and going concern

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. In the opinion of management, all adjustments consisting only of normal recurring adjustments necessary for a fair presentation have been reflected in these unaudited condensed consolidated financial statements. Operating results for the interim periods presented are not necessarily indicative of the results that may be expected for the fiscal year ending December 31, 2022, or any other period.

As reflected in the unaudited condensed consolidated financial statements, the Company had an accumulated deficit as of September 30, 2022, as well as a net loss and negative cash flow from operating activities for the nine months ended September 30, 2022. These factors raise substantial doubt about the Company’s ability to continue as a going concern for at least one year from the issuance of these financial statements.

However, management believes that substantial doubt about the Company’s ability to meet its obligations for the next twelve months from the date these financial statements were issued has been alleviated due to, but not limited to, (i) access to future capital commitments, (ii) continued sales growth from the Company’s consolidated operations, (iii) latitude as to the timing and amount of certain operating expenses as well as capital expenditures, (iv) restructuring plans that have already been put in place to improve the Company’s profitability, (v) the AFC-VRT credit facilities (refer to Notes 10 and 17 for further discussion), and (vi) access to the U.S. and Canadian public equity markets.

If the Company is unable to raise additional capital whenever necessary, it may be forced to decelerate or curtail its footprint build-out or other operational activities until such time as additional capital becomes available. Such limitation of the Company’s activities would allow it to slow its rate of spending and extend its use of cash until additional capital is raised. However, management cannot provide any assurances that the Company will be successful in accomplishing any of its plans. Management also cannot provide any assurance as to unforeseen circumstances that could occur at any time within the next twelve months or thereafter which could increase the Company’s need to raise additional capital on an immediate basis.

These interim unaudited condensed consolidated financial statements and notes thereto should be read in conjunction with the audited consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021, dated March 11, 2022, as filed with the Securities and Exchange Commission (the “2021 Form 10-K”).

Use of estimates

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”). Preparation of financial statements in conformity with GAAP requires management to make estimates, judgments and assumptions that affect the reported amounts of assets and liabilities as of the dates presented and the reported amounts of revenues and expenses during the periods presented. Actual results could differ from those estimates. Significant estimates inherent in the preparation of the accompanying unaudited condensed consolidated financial statements include the fair value of assets acquired and liabilities assumed in business combinations, assumptions relating to equity-based compensation expense, estimated useful lives for property, plant and equipment and intangible assets, the valuation allowance against deferred tax assets and the assessment of potential charges on goodwill, intangible assets and investments in equity and notes receivable.

Emerging growth company

The Company is an “emerging growth company” as defined in the Jumpstart Our Business Startups Act (the “JOBS Act”). Under the JOBS Act, emerging growth companies can delay adopting new or revised accounting standards until such time as those standards apply to private companies.

Functional and presentation currency

The unaudited condensed consolidated financial statements and the accompanying notes are expressed in U.S. dollars. Financial metrics are presented in thousands. Other metrics, such as shares outstanding, are presented in thousands unless otherwise noted.

Basis of consolidation

The Company’s unaudited condensed consolidated financial statements include the accounts of Acreage, its subsidiaries and variable interest entities (“VIEs”) where the Company is considered the primary beneficiary, if any, after elimination of intercompany accounts and transactions. Investments in business entities in which Acreage lacks control but is able to exercise significant influence over operating and financial policies are accounted for using the equity method. The Company’s proportionate share of net income or loss of the entity is recorded in Income (loss) from investments, net in the Unaudited Condensed Consolidated Statements of Operations.

VIEs

In determining whether the Company is the primary beneficiary of a VIE, the Company assesses whether it has the power to direct matters that most significantly impact the activities of the VIE and have the obligation to absorb losses or the right to receive benefits from the VIE that could potentially be significant to the VIE. There were no material consolidated VIEs as of September 30, 2022 or December 31, 2021.

Non-controlling interests (“NCI”)

Non-controlling interests represent ownership interests in consolidated subsidiaries by parties that are not shareholders of Pubco. They are shown as a component of Total equity in the Unaudited Condensed Consolidated Statements of Financial Position, and the share of loss attributable to non-controlling interests is shown as a component of Net loss in the Unaudited Condensed Consolidated Statements of Operations. Changes in the parent company’s ownership that do not result in a loss of control are accounted for as equity transactions.

Restricted cash

Restricted cash represents funds contractually held for specific purposes and, as such, not available for general corporate purposes.

Cash and restricted cash, as presented on the Unaudited Condensed Consolidated Statements of Cash Flows, consists of $26,476 and $95 as of September 30, 2022, respectively, and $27,868 and $1,098 as of September 30, 2021, respectively.

Accounts receivable valuations and reclassifications

Accounts receivable are stated at their net realizable value. The allowance against gross trade receivables reflects the best estimate of probable losses inherent in the receivables portfolio determined on the basis of historical experience, specific allowances for known troubled accounts and other currently available information. As of September 30, 2022 and December 31, 2021, the Company’s allowance for doubtful accounts was $63 and $445, respectively.

Income taxes

The Company has unrecognized tax benefits (“UTBs”) of $6,161 and $7,695 as of September 30, 2022 and December 31, 2021, respectively, which are included in Other current liabilities in the Consolidated Statements of Financial Position. UTBs arise as a result of differences existing between a tax position taken or expected to be taken on a tax return and the benefit recognized and measured.

Net loss per share

Net loss per share represents the net loss attributable to shareholders divided by the weighted average number of shares outstanding during the period on an as converted basis. Basic and diluted loss per share are the same as of September 30, 2022, 2021 and 2020, as the issuance of shares upon conversion, exercise or vesting of outstanding units would be anti-dilutive in each period. There were 47,999 and 42,621 anti-dilutive shares outstanding as of September 30, 2022 and 2021, respectively.

Change in presentation

Note that certain items presented on the nine months ended September 30, 2021, Unaudited Condensed Consolidated Statement of Cash Flows, includes a change in presentation to conform to the current year presentation. There was no impact to our Consolidated Financial Statements as a result of this reclassification.

Accounting Pronouncements Recently Adopted

As of January 1, 2022, the Company adopted ASU 2019-12 - Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes (ASU 2019-12). ASU 2019-12 attempts to simplify aspects of accounting for franchise taxes and enacted changes in tax laws or rates and clarifies the accounting for transactions that result in a step-up in the tax basis of goodwill. The adoption of ASU 2019-12 did not have a material effect on the Company’s unaudited condensed consolidated financial statements.

As of January 1, 2022, the Company adopted ASU 2020-01 - Investments-Equity Securities (Topic 321), Investments-Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815). The new standard clarifies the interaction of accounting for the transition into and out of the equity method. The new standard also clarifies the accounting for measuring certain purchased options and forward contracts to acquire investments. The adoption of ASU 2020-01 did not have a material effect on the Company’s unaudited condensed consolidated financial statements.

As of January 1, 2022, the Company adopted ASU 2021-04 - Earnings Per Share (Topic 260), Debt - Modifications and Extinguishments (Topic 470-50), Compensation - Stock Compensation (Topic 718), and Derivatives and Hedging - Contracts in Entity's Own Equity (Subtopic 815-40), which clarifies existing guidance for freestanding written call options which are equity classified and remain so after they are modified or exchanged in order to reduce diversity in practice. The standard applies prospectively to modifications or exchanges that occur after it is adopted. The adoption of ASU 2021-04 did not have a material effect on the Company’s unaudited condensed consolidated financial statements.

Accounting Pronouncements Not Yet Adopted

In June 2016, the FASB issued ASU 2016-13 - Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (“ASU 2016-13”), which was subsequently revised by ASU 2018-19 and ASU 2020-02. The ASU introduces a new model for assessing impairment on most financial assets. Entities will be required to use a forward-looking expected loss model, which will replace the current incurred loss model, which will result in earlier recognition of allowance for losses. The ASU will be effective for the Company’s first interim period of fiscal 2023. The Company continues to evaluate the impact of this ASU on its unaudited condensed consolidated financial statements.

In October 2021, the FASB issued ASU 2021-08 - Business Combinations (Topic 805), Accounting for Contract Assets and Contract Liabilities from Contracts with Customers. The new standard improves the accounting for acquired revenue contracts with customers in a business combination by addressing diversity in practice and inconsistency. The new standard requires an entity to recognize and measure contract assets and contract liabilities acquired in a business combination in accordance with ASC 606 - Revenue from Contracts with Customers. The ASU will be effective for the Company’s first interim period of fiscal 2024. The standard should be applied prospectively to business combinations occurring on or after the effective date of the amendments. The Company does not anticipate a material impact on the Company’s unaudited condensed consolidated financial statements upon adoption.

XML

ACQUISITIONS, DIVESTITURES AND ASSETS HELD FOR SALE

9 Months Ended

Sep. 30, 2022

Business Combinations, Discontinued Operations And Disposal Groups [Abstract]

ACQUISITIONS, DIVESTITURES AND ASSETS HELD FOR SALE

ACQUISITIONS, DIVESTITURES AND ASSETS HELD FOR SALE

Acquisitions

During the nine-month period ended September 30, 2022, the Company did not complete any business acquisitions. During the year ended December 31, 2021, the Company completed the following business acquisitions, and has allocated the purchase price as follows:

Purchase Price Allocation	Greenleaf		CWG		Total
Assets acquired:
Cash and cash equivalents	$	1,209	$	828	$	2,037
Inventory	2,692		1,200		3,892
Other current assets	1,520		347		1,867
Capital assets, net	22,923		3,312		26,235
Operating lease right-of-use asset	2,819		1,584		4,403
Goodwill	1,819		1,482		3,301
Intangible assets, net - cannabis licenses	16,800		3,200		20,000
Intangible assets, net - customer relationships	—		1,000		1,000
Other non-current assets	189		40		229
Liabilities assumed:
Accounts payable and accrued liabilities	(1,829)		(464)		(2,293)
Taxes payable	(33)		(68)		(101)
Operating lease liability, current	(315)		(193)		(508)
Other current liabilities	(294)		3		(291)
Operating lease liability, non-current	(2,504)		(1,391)		(3,895)
Fair value of net assets acquired	$	44,996	$	10,880	$	55,876
Consideration paid:
Settlement of pre-existing relationship	44,996		10,880		$	55,876
Total consideration	$	44,996	$	10,880	$	55,876

Greenleaf

On October 1, 2021, a subsidiary of the Company acquired of 100% of Greenleaf Apothecaries, Greenleaf Gardens, and Greenleaf Therapeutics, collectively known as “Greenleaf.” Greenleaf consists of cannabis cultivation, processing, and dispensary operations in the state of Ohio. The completion of this acquisition established Acreage’s footprint in the Ohio cannabis market.

On July 2, 2018, the Company entered into purchase agreements for Greenleaf for the total purchase price of approximately $8,245 in cash, $6,096 in seller notes payable and 1.2 million shares of HSCP with an average fair value of $7.73 per share, which are convertible into shares of the Company. In addition, the Company extended a $31,200 line of credit and issued $12,500 in promissory notes to the Greenleaf entities. The consideration paid was made in exchange for: (a) the rights to acquire the Greenleaf entities upon state regulatory approval and; (b) master services agreements (“MSAs”) to operate the entities until such approval was granted and ownership interests were transferred. The purchase consideration paid represents the fair value of the intangible asset related to the MSA that was recorded on the Company’s Statement of Financial Position at the time of the transaction. The intangible asset was amortized over the life of the MSAs.

Upon closing, the Company repaid the remaining $3,300 worth of sellers notes payable and accrued interest and assumed $42,043 in notes and interest receivable owed to the Company by Greenleaf that was eliminated upon consolidation. Total consideration for the asset transfer transaction was $44,996, representing the sum of the $2,953 carrying value of intangible assets from the 2018 transaction and the liabilities assumed. As the Company owns 100% of Greenleaf, the subsidiary is accounted for on a consolidated basis as of the closing date.

The purchase price allocation is based upon final valuations within the measurement period (generally one year from the acquisition date)

CWG

On April 30, 2021, a subsidiary of the Company acquired 100% of CWG Botanicals, Inc. (“CWG”), an adult-use cannabis cultivation and processing operations in the state of California.

The consideration paid for CWG consisted of the settlement of a pre-existing relationship, which included a line of credit of $9,321 and the related interest receivable of $1,559, which were both previously recorded in Notes receivable, non-current on the Statements of Financial Position.

The purchase price allocation is based upon final valuations within the measurement period (generally one year from the acquisition date).

NCCRE

On March 19, 2021, a subsidiary of the Company, HSC Solutions, LLC entered into an assignment of membership agreement to acquire the remaining non-controlling interests of its subsidiary, NCC Real Estate, LLC (“NCCRE”), based primarily on the fair value of property held by NCCRE estimated in the amount of $850. The consideration paid to the non-controlling interest sellers of $286 was recorded in Additional paid-in capital and Non-controlling interests on the Statements of Financial Position. Additionally, the Company subsequently repaid the outstanding principal balance of the NCCRE secured loan.

Divestitures

In February 2021, a subsidiary of the Company entered into a definitive agreement and management services agreement to sell an indoor cultivation facility in Medford, Oregon ("Medford"), and a retail dispensary in Powell, Oregon ("Powell"), for total consideration of $3,000. In March 2022, the total consideration was reduced to $2,000. In April 2022, the Company sold all equity interests in Medford for an aggregate sale price of $2,000 and recognized a gain on sale of $290 for the nine months ended September 30, 2022 which was recorded in Other income, net in the Unaudited Condensed Consolidated Statements of Operations. The aggregate sales price consisted of $750 paid to the Company in February 2021 and $1,250 of promissory notes (refer to Note 6 for further discussion). In conjunction with the sale, the Company closed its dispensary in Powell. Further, the Company derecognized deferred tax liabilities of $375 related to Medford.

In September 2021, a subsidiary of the Company entered into a definitive agreement and management services agreements to sell, upon regulatory approval, four retail dispensaries in Oregon for total consideration of $6,500. In July 2022, the Company executed and closed an amendment to its previously announced asset purchase and services agreement for the sale of its four Oregon retail dispensaries (the “Amended Agreement”). Under the terms of the Amended Agreement, the sale price was reduced to $6,200 and the Company recognized a gain on sale of $3,189 for the nine months ended September 30, 2022 which was recorded in Other income, net in the Unaudited Condensed Consolidated Statements of Operations. The aggregate sales price consisted of a $250 payment previously made at the signing of the Original Agreement, plus an additional $100 in cash at closing. The remaining amount of $5,850 has been satisfied by a 36-month secured promissory note bearing interest at a rate of 12% per annum (the “Note”). Under the terms of the Note, quarterly interest payments commence on January 1, 2023, principal payments of $1,000 are due on January 1, 2024 and January 1, 2025, and the remaining principal is due on January 1, 2026.

During the nine months ended September 30, 2021, a subsidiary of the Company sold all equity interests in Acreage Florida, Inc. (“Acreage Florida”), for an aggregate sale price of $60,000. Acreage Florida is licensed to operate medical cannabis dispensaries, a processing facility and a cultivation facility in the state of Florida. The aggregate sales price consisted of approximately $21,500 in cash, $7,000 of the buyer’s common stock, subject to a rolling lock up restriction period ending one year after the disposition date, with the lock up expiring in monthly 1/6th increments beginning October 27, 2021, and secured promissory notes totaling approximately $31,500. This resulted in a gain on sale of $11,682 recorded in Other income, net on the Consolidated Statements of Operations for the nine months ended September 30, 2021. The Company subsequently sold the promissory notes and recognized a net loss of $2,000 as discussed in Note 6. Further, the Company de-recognized deferred tax liabilities related to indefinite-lived intangible lived assets held by Acreage Florida of $6,044 as a result of the disposition in Other income, net on the Unaudited Condensed Consolidated Statements of Operations for the nine months ended September 30, 2021.

Assets Held for Sale

As of September 30, 2022, the Company did not have any business or assets that met the held-for-sale criteria. As of December 31, 2021 the Company determined certain businesses and assets met the held-for-sale criteria. As such, the related assets and liabilities within these disposal groups were transferred into Assets held-for-sale and Liabilities related to assets held for sale on the Unaudited Condensed Consolidated Statements of Financial Position.

During the nine months ended September 30, 2022, the Company tested each disposal group for impairment and recognized charges of $874 within Write down (recovery) of assets held-for-sale on the Unaudited Condensed Consolidated Statements of Operations related to Medford and Powell. During the nine months ended September 30, 2021, the Company recognized a recovery of assets held-for-sale of $8,616 related to the Acreage Florida disposal group within Write down (recovery) of assets held-for-sale on the Unaudited Condensed Consolidated Statements of Operations.

The table below presents the assets and liabilities classified as held for sale on the Unaudited Condensed Consolidated Statements of Financial Position for the year ended December 31, 2021 and is subject to change based on developments during the sales process.

	December 31, 2021
	Michigan(1)		Oregon		Total
Cash	$	—	$	223	$	223
Inventory	—		445		445
Notes receivable, current	—		31		31
Other current assets	—		9		9
Total current assets classified as held-for-sale	—		708		708
Capital assets, net	1,907		2,342		4,249
Operating lease right-of-use assets	—		1,695		1,695
Goodwill	—		2,191		2,191
Non-current assets	—		109		109
Total assets classified as held for sale	$	1,907	$	7,045	$	8,952
Accounts payable and accrued liabilities	$	—	$	(639)	$	(639)
Operating lease liability, current	—		(441)		(441)
Total current liabilities classified as held-for-sale	—		(1,080)		(1,080)
Operating lease liability, non-current	—		(787)		(787)
Total liabilities classified as held-for-sale	$	—	$	(1,867)	$	(1,867)

(1) During the nine months ended September 30, 2022, the Company was unsuccessful in finding a satisfactory buyer for certain of its Michigan locations. As a result, the assets at these specific locations no longer meet the criteria for being classified as held-for-sale (refer to Note 7 for further discussion).

XML

INTANGIBLE ASSETS AND GOODWILL

9 Months Ended

Sep. 30, 2022

Goodwill and Intangible Assets Disclosure [Abstract]

INTANGIBLE ASSETS AND GOODWILL

INTANGIBLE ASSETS AND GOODWILL

Intangible assets

The following table details the intangible asset balances by major asset classes:

Intangibles	September 30, 2022		December 31, 2021
Finite-lived intangible assets:
Management contracts	$	1,808	$	1,511
Customer relationships	1,000		1,000
Total finite-lived intangible assets	2,808		2,511
Accumulated amortization on finite-lived intangible assets:
Management contracts	(931)		(493)
Customer relationships	(850)		—
Total accumulated amortization on finite-lived intangible assets	(1,781)		(493)
Finite-lived intangible assets, net	1,027		2,018
Indefinite-lived intangible assets
Cannabis licenses	134,780		117,677
Total intangibles, net	$	135,807	$	119,695

The intangible assets balance as of December 31, 2021 excludes intangible assets reclassified to assets held-for-sale (refer to Note 3 for further discussion). The average useful life of finite-lived intangible assets as of September 30, 2022 ranges from 0.3 to 1.5 years, with 0.3 and 1.5 years being the average useful life for customer relationships and management contracts, respectively.

During the three and nine months ended September 30, 2022, the Company amended the purchase price allocation related to its acquisition of Greenleaf based upon final valuations within the measurement period (refer to Note 3 for further discussion). As a result, $16,800 was re-allocated from Goodwill to Intangible assets, net on the Unaudited Condensed Consolidated Statements of Financial Position.

Impairment of intangible assets

The Company assessed whether any events or changes in circumstances ("triggering events") indicated finite-lived intangible assets to be held-and-used would not be recovered. During the three and nine months ended September 30, 2022, the Company did not identify any triggering events. During the nine months ended September 30, 2021, the Company identified a triggering event for its management contract owned by Prime Alternative Treatment Center Consulting, LLC ("PATCC"). The Company evaluated the recoverability of the asset by comparing the carrying value of the asset to the future net undiscounted cash flows expected to be generated by the asset. The carrying value was determined to not be recoverable and the Company proceeded to test the asset for impairment. The Company recognized an impairment charge of $818 due to changes in expected cash flows pursuant to a revised consulting services agreement. These charges are recognized in Impairments, net on the Unaudited Condensed Consolidated Statements of Operations. The impairment resulted in the recognition of a tax provision benefit and an associated reversal of deferred tax liabilities of $207 during the nine months ended September 30, 2021.

During the three and nine months ended September 30, 2021, the Company de-recognized deferred tax liabilities related to indefinite-lived intangible assets held by Acreage Florida of $6,044 in Other income (loss), net on the Unaudited Condensed Consolidated Statements of Operations. Refer to Note 3 for further discussion.

Amortization expense associated with the Company’s intangible assets was $296 and $1,288 for the three and nine months ended September 30, 2022, respectively, and $3,117 and $7,588 for the three and nine months ended September 30, 2021, respectively.

Expected annual amortization expense for existing intangible assets subject to amortization as of September 30, 2022 is as follows for each of the next five fiscal years:

Amortization of Intangibles	2022		2023		2024		2025		2026
Amortization expense	$	297	$	584	$	146	$	—	$	—

Goodwill

The following table details the changes in the carrying amount of goodwill:

Goodwill	Total
December 31, 2021	$	43,310
Adjustment to purchase price allocation	(16,500)
Other Adjustments(1)	3,682
September 30, 2022	$	30,492

(1) Represents adjustments related to the remeasurement of certain deferred tax assets and related adjustments within the measurement period.

During the three and nine months ended September 30, 2022, the Company amended the purchase price allocation related to its acquisition of Greenleaf based upon final valuations within the measurement period (refer to Note 3 for further discussion). As a result, $16,800 was re-allocated from Goodwill to Intangible assets, net on the Unaudited Condensed Consolidated Statements of Financial Position.

XML

INVESTMENTS

9 Months Ended

Sep. 30, 2022

Investments [Abstract]

INVESTMENTS

INVESTMENTS

The carrying values of the Company’s investments in the Unaudited Condensed Consolidated Statements of Financial Position as of September 30, 2022 and December 31, 2021 are as follows:

Investments	September 30, 2022		December 31, 2021
Investments held at FV-NI	$	34,328	$	35,226
Total long-term investments	$	34,328	$	35,226

Income (loss) from investments, net in the Unaudited Condensed Consolidated Statements of Operations during the three and nine months ended September 30, 2022 and 2021 is as follows:

Investment income (loss)	Three Months Ended September 30,				Nine Months Ended September 30,
	2022		2021		2022		2021
Short-term investments	$	1	$	—	$	4	$	—
Investments held at FV-NI	16		489		150		(777)
Income (loss) from investments, net	$	17	$	489	$	154	$	(777)

Investments held at FV-NI

The Company has investments in equity of several companies that do not result in significant influence or control. These investments are carried at fair value, with gains and losses recognized in the Unaudited Condensed Consolidated Statements of Operations.

As further described under the “6.10% Secured debenture due September 2030” in Note 10, on September 23, 2020, a subsidiary of the Company, Universal Hemp, LLC ("Universal Hemp") was advanced gross proceeds of $50,000 (less transaction costs) pursuant to the terms of a secured debenture. The Company subsequently engaged an investment advisor, which under the investment advisor's sole discretion, on September 28, 2020 invested $34,019 of these proceeds on behalf of Universal Hemp. As a result, Universal Hemp acquired 34,019 class B units, at $1 par value per unit, which represented 100% financial interest in an Investment Partnership, a Canada-based limited partnership. An affiliate of the Institutional Investor holds Class A units of the Investment Partnership. The general partner of the Investment Partnership is also an affiliate of the Institutional Investor. The Class B units are held by the Investment Advisor as an agent for Universal Hemp.

XML

NOTES RECEIVABLE

9 Months Ended

Sep. 30, 2022

Receivables [Abstract]

NOTES RECEIVABLE

NOTES RECEIVABLE

Notes receivable as of September 30, 2022 and December 31, 2021 consisted of the following:

	September 30, 2022		December 31, 2021
Promissory notes receivable	$	34,257	$	27,260
Line of credit receivable	6,831		12,609
Interest receivable	3,524		2,834
Allowance for notes and interest receivables	(14,769)		(8,036)
Total notes receivable	$	29,843	$	34,667
Less: Notes receivable, current	2,500		7,104
Notes receivable, non-current	$	27,343	$	27,563

Interest income on notes receivable during the three and nine months ended September 30, 2022 was $474 and $1,256, respectively, and $1,067 and $4,125 for the three and nine months ended September 30, 2021, respectively.

The Company determined that the collectability of certain notes receivables is doubtful based on information available. As of September 30, 2022 and December 31, 2021, the Company’s allowance for notes receivable of $14,769 and $8,036, respectively, included $12,292 and $6,046 of principal outstanding and $2,477 and $1,990 of accrued interest, respectively, and represents the full value of such loan balances.

Activity during the nine months ended September 30, 2022

In February 2022, the Company received a $5,279 cash payment in full on a line of credit due from Patient Centric Martha’s Vineyard, and subsequently closed the line of credit.

In April 2022, the Company executed and closed its previously announced asset purchase agreement for the sale of Medford and Powell in Oregon. Part of the total consideration was satisfied by a 12-month $1,250 secured promissory note bearing interest at a rate of 12.5% per annum, refer to Note 3 for further discussion. In August 2022, the secured promissory note was replaced with a $500 secured promissory note bearing interest at a rate of 12.5% per annum and a $750 non-interest bearing secured promissory note, with both secured promissory notes due on May 1, 2023.

In July 2022, the Company executed and closed an amendment to its previously announced asset purchase and services agreement for the sale of its four Oregon retail dispensaries (the “Amended Agreement”). Part of the total consideration was satisfied by a 36-month $5,850 secured promissory note bearing interest at a rate of 12% per annum, refer to Note 3 for further discussion.

Activity during the nine months ended September 30, 2021

In March 2021, the Company entered into a revised consulting services and line of credit agreement with PATCC, whereby previously unrecognized management fees were settled for $2,500, which was recognized in Other revenue, net on Unaudited

Condensed Consolidated Statements of Operations during the three and nine months ended September 30, 2021. Pursuant to the revised line of credit agreement, the line of credit is non-interest bearing and will be repaid on a payment schedule with seven payments in the aggregate amount of $7,150 through June 2023.

In April 2021, the Company received three secured promissory notes in the aggregate amount of $31,500 related to the sale of Acreage Florida. Of the $31,500 in promissory notes, a promissory note for $3,500 was collected during the year ended December 31, 2021. In June 2021, the remaining two promissory notes totaling $28,000 were sold in a related party transaction to Viridescent Realty Trust, Inc. (“Viridescent”) for cash proceeds of $26,000. This sale resulted in a loss of $2,000 recorded in Other income, net on the Unaudited Condensed Consolidated Statements of Operations. Refer to Notes 3 and 14 for further discussion.

In April 2021, a subsidiary of the Company acquired 100% of CWG, and the amounts outstanding under the line of credit were converted into equity in CWG. Refer to Note 3 for further discussion.

XML

CAPITAL ASSETS, net

9 Months Ended

Sep. 30, 2022

Property, Plant and Equipment [Abstract]

CAPITAL ASSETS, net

CAPITAL ASSETS, net

Net property, plant and equipment consisted of:

	September 30, 2022		December 31, 2021
Land	$	3,828	$	3,777
Building	57,935		43,921
Right-of-use asset, finance leases	10,731		5,077
Furniture, fixtures and equipment	31,587		31,325
Leasehold improvements	37,399		51,646
Construction in progress	17,409		7,644
Capital assets, gross	$	158,889	$	143,390
Less: accumulated depreciation	(23,527)		(16,593)
Capital assets, net	$	135,362	$	126,797

Depreciation of capital assets for the three and nine months ended September 30, 2022 is comprised of $751 and $4,731 of depreciation expense, and $1,963 and $5,679 that was capitalized to inventory, respectively, and $928 and $2,083 of depreciation expense and $876 and $2,567 that was capitalized to inventory for the three and nine months ended September 30, 2021, respectively.

During the nine months ended September 30, 2022, the Company determined that it was unable to find a satisfactory buyer for the held-for-sale assets related to its Michigan operations and, as such, these assets were reclassified as held-and-used. This conclusion was considered a triggering event for capital asset impairment testing. Upon assessment, these specific capital assets were not considered to have future economic value. As such, the fair value of the assets was considered to be nil and the Company recognized an impairment charge of $1,907 within Impairments, net on the Statements of Operations during the nine months ended September 30, 2022. Refer to Note 3 for further discussion on changes in held-for-sale entities.

In August 2021, the Company’s Sewell facility in New Jersey was negatively impacted by a tornado formation from Hurricane Ida. The unusually severe weather conditions caused widespread damage and resulted in a $9,130 loss to capital assets, which has been offset by insurance proceeds of $7,000. The net loss of $2,130 was recognized in Impairments, net on the Statements of Operations for the three months ended September 30, 2021.

XML

LEASES

9 Months Ended

Sep. 30, 2022

Leases [Abstract]

LEASES

LEASES

The Company leases land, buildings, equipment and other capital assets which it plans to use for corporate purposes in addition to the production and sale of cannabis products. Leases with an initial term of 12 months or less are not recorded on the Unaudited Condensed Consolidated Statements of Financial Position and are expensed in the Unaudited Condensed Consolidated Statements of Operations on the straight-line basis over the lease term. The Company does not have any material variable lease payments and accounts for non-lease components separately from leases.

Balance Sheet Information	Classification	September 30, 2022		December 31, 2021
Right-of-use assets
Operating	Operating lease right-of-use assets	$	22,730	$	24,598
Finance	Capital assets, net	9,986		4,522
Total right-of-use assets		$	32,716	$	29,120
Lease liabilities
Current
Operating	Operating lease liability, current	$	2,298	$	2,145
Financing	Debt, current	5,635		—
Non-current
Operating	Operating lease liability, non-current	22,324		24,255
Financing	Debt, non-current	5,290		5,245
Total lease liabilities		$	35,547	$	31,645

		Three Months Ended September 30,				Nine Months Ended September 30,
Statement of Operations Information	Classification	2022		2021		2022		2021
Short-term lease expense	General and administrative	$	(28)	$	(40)	$	190	$	17
Operating lease expense	General and administrative	1,221		1,038		3,613		3,175
Finance lease expense:
Amortization of right of use asset	Depreciation and amortization	63		63		190		190
Interest expense on lease liabilities	Interest expense	314		190		855		561
Sublease income	Other income (loss), net	—		—		—		(3)
Net operating and finance lease cost		$	1,598	$	1,291	$	4,658	$	3,923

		Nine Months Ended September 30,
Statement of Cash Flows Information	Classification	2022		2021
Cash paid for operating leases	Net cash used in operating activities	$	3,390	$	3,747
Cash paid for finance leases - interest	Net cash used in operating activities	$	843	$	508

The following represents the Company’s future minimum payments required under existing leases with initial terms of one year or more as of September 30, 2022:

Maturity of lease liabilities	Operating Leases		Finance Leases
2022	$	1,147	$	5,858
2023	4,349		722
2024	4,310		743
2025	4,347		766
2026	4,428		789
Thereafter	20,285		12,487
Total lease payments	$	38,866	$	21,365
Less: interest	14,244		10,440
Present value of lease liabilities	$	24,622	$	10,925
Weighted average remaining lease term (years)	8		2
Weighted average discount rate	10%		12%

As of September 30, 2022, there have been no leases entered into that have not yet commenced.

LEASES

LEASES

The Company leases land, buildings, equipment and other capital assets which it plans to use for corporate purposes in addition to the production and sale of cannabis products. Leases with an initial term of 12 months or less are not recorded on the Unaudited Condensed Consolidated Statements of Financial Position and are expensed in the Unaudited Condensed Consolidated Statements of Operations on the straight-line basis over the lease term. The Company does not have any material variable lease payments and accounts for non-lease components separately from leases.

Balance Sheet Information	Classification	September 30, 2022		December 31, 2021
Right-of-use assets
Operating	Operating lease right-of-use assets	$	22,730	$	24,598
Finance	Capital assets, net	9,986		4,522
Total right-of-use assets		$	32,716	$	29,120
Lease liabilities
Current
Operating	Operating lease liability, current	$	2,298	$	2,145
Financing	Debt, current	5,635		—
Non-current
Operating	Operating lease liability, non-current	22,324		24,255
Financing	Debt, non-current	5,290		5,245
Total lease liabilities		$	35,547	$	31,645

		Three Months Ended September 30,				Nine Months Ended September 30,
Statement of Operations Information	Classification	2022		2021		2022		2021
Short-term lease expense	General and administrative	$	(28)	$	(40)	$	190	$	17
Operating lease expense	General and administrative	1,221		1,038		3,613		3,175
Finance lease expense:
Amortization of right of use asset	Depreciation and amortization	63		63		190		190
Interest expense on lease liabilities	Interest expense	314		190		855		561
Sublease income	Other income (loss), net	—		—		—		(3)
Net operating and finance lease cost		$	1,598	$	1,291	$	4,658	$	3,923

		Nine Months Ended September 30,
Statement of Cash Flows Information	Classification	2022		2021
Cash paid for operating leases	Net cash used in operating activities	$	3,390	$	3,747
Cash paid for finance leases - interest	Net cash used in operating activities	$	843	$	508

The following represents the Company’s future minimum payments required under existing leases with initial terms of one year or more as of September 30, 2022:

Maturity of lease liabilities	Operating Leases		Finance Leases
2022	$	1,147	$	5,858
2023	4,349		722
2024	4,310		743
2025	4,347		766
2026	4,428		789
Thereafter	20,285		12,487
Total lease payments	$	38,866	$	21,365
Less: interest	14,244		10,440
Present value of lease liabilities	$	24,622	$	10,925
Weighted average remaining lease term (years)	8		2
Weighted average discount rate	10%		12%

As of September 30, 2022, there have been no leases entered into that have not yet commenced.

XML

INVENTORY

9 Months Ended

Sep. 30, 2022

Inventory Disclosure [Abstract]

INVENTORY

INVENTORY

The Company’s inventory balance consists of the following:

	September 30, 2022		December 31, 2021
Retail inventory	$	4,116	$	3,331
Wholesale inventory	37,143		28,643
Cultivation inventory	6,492		6,367
Supplies & other	3,141		3,463
Total	$	50,892	$	41,804

Inventory is valued at the lower of cost and net realizable value (“NRV”), defined as estimated selling price in the ordinary course of business, less estimated costs of disposal. During the nine months ended September 30, 2022, the Company analyzed its inventory balances, and recorded wholesale inventory adjustments as a result of (i) having excess inventory and (ii) reducing the carrying value to ensure inventory balances are properly recorded at the lower of cost and NRV. The Company recognized $6,286 of wholesale inventory adjustments within Cost of goods sold, wholesale on the Statements of Operations during the three and nine months ended September 30, 2022.

XML

DEBT

9 Months Ended

Sep. 30, 2022

Debt Disclosure [Abstract]

DEBT

DEBT

The Company’s debt balances consist of the following:

Debt balances	September 30, 2022		December 31, 2021
Financing liability (failed sale-leaseback)	$	15,253	$	15,253
Finance lease liabilities	10,925		5,245
7.50% Loan due April 2026	31,156		30,763
6.10% Secured debenture due September 2030	46,388		46,050
Note due December 2024	3,958		4,750
9.75% Credit facilities due January 2026	94,412		68,673
Total debt	$	202,092	$	170,734
Less: current portion of debt	7,218		1,583
Total long-term debt	$	194,874	$	169,151

Scheduled maturities of debt, excluding amortization of discount and issuance costs, are as follows:

2022	$	6,426
2023	1,583
2024	1,584
2025	—
2026	133,011
Thereafter	70,532
Total payments (excluding amortization of discount and issuance costs)	$	213,136

During the three and nine months ended September 30, 2022, the Company incurred interest expense of $5,688 and $15,989, respectively, and $3,620 and $14,072 during the three and nine months ended September 30, 2021, respectively, on the Unaudited Condensed Consolidated Statements of Operations. Interest expense for the three and nine months ended September 30, 2022 included debt discount amortization of $381 and $1,132, respectively, and amortization of debt issuance costs of $297 and $849, respectively. Interest expense for the three and nine months ended September 30, 2021 included debt discount amortization of $298 and $821, respectively, and amortization of debt issuance costs of $493 and $2,914, respectively. As of September 30, 2022 and December 31, 2021, the Company had unamortized discount $5,062 and $6,194, respectively, and debt issuance costs of $5,982 and $6,320, respectively, which is netted against the gross carrying value of long-term debt in Debt, non-current on Unaudited Condensed Unaudited Condensed Consolidated Statements of Financial Position. Additionally, as of September 30, 2022 and December 31, 2021, the Company had accrued interest of $1,167 and $1,432, respectively, within Interest payable on the Unaudited Condensed Consolidated Statements of Financial Position.

Financing liability (failed sales leaseback)

In connection with the Company’s failed sale-leaseback transaction in November 2020, a financing liability was recognized equal to the cash proceeds received. The Company will recognize the cash payments made on the lease as interest expense, and the principal will be de-recognized upon expiration of the lease.

6.10% Secured debenture due September 2030

On September 23, 2020, pursuant to the implementation of the Amended Arrangement (Refer to Note 13 for further discussion), a subsidiary of Canopy Growth advanced gross proceeds of $50,000 (less transaction costs of approximately $4,025) to Universal Hemp, an affiliate of the Company, pursuant to the terms of a secured debenture (“6.1% Loan”). In accordance with the terms of the debenture, the funds cannot be used, directly or indirectly, in connection with or for any cannabis or cannabis-related operations in the United States, unless and until such operations comply with all applicable laws of the United States. An additional $50,000 may be advanced pursuant to the debenture subject to the satisfaction of certain conditions by Universal Hemp. The debenture bears interest at a rate of 6.1% per annum, matures 10 years from the date hereof or such earlier date in accordance with the terms of the debenture and all interest payments made pursuant to the debenture are payable in cash by Universal Hemp. The debenture is secured by substantially all of the assets of Universal Hemp and its subsidiaries and, further, is not convertible and is not guaranteed by Acreage.

With a portion of the proceeds for the 6.1% Loan received by Universal Hemp, Acreage engaged an Investment Advisor which, under the Investment Advisor’s sole discretion, invested on behalf of Universal Hemp $34,019 on September 28, 2020. As a result, Universal Hemp acquired 34,019 class B units, at $1.00 par value per unit, which represented 100% financial interest in the Investment Partnership, a Canada-based limited partnership. An affiliate of the Institutional Investor holds class A units of the Investment Partnership. The general partner of the Investment Partnership is also an affiliate of the Institutional Investor. The class B units are held by the Investment Advisor as an agent for Universal Hemp. Upon execution of the limited partnership agreement, $1,019 was distributed to the class A unit holders of the Investment Partnership.

7.50% Loan due April 2026

On September 28, 2020, the Company received gross proceeds of $33,000 (less transaction costs of approximately $959) from an affiliate of the Institutional Investor (the “Lender”) and used a portion of the proceeds of this loan to retire its short-term $11,000 convertible note (as described above) and its short-term note aggregating approximately $18,000 in October 2020, with the remainder being used for working capital purposes. The loan is unsecured, matures in 3 years and bears interest at a 7.5% annual interest rate. The Lender is controlled by the Institutional Investor. The Investment Partnership is the investor in the Lender. On December 16, 2021, the Company paid an amendment fee of $413 to extend the maturity date from September 28, 2023 to April 2, 2026. The amendment was treated as a debt extinguishment.

Note due December 2024

In November 2020, the Company issued a promissory note with a third party, which is non-interest bearing and payable based on a payment schedule with ten payments in the aggregate amount of $7,750 through December 31, 2024, as a result of a settlement described under the “CanWell Dispute” in Note 13.

9.75% Credit facilities due January 2026

On December 16, 2021, the Company entered into a $150,000 senior secured credit facility with a syndicate of lenders consisting of a $75,000 initial draw, a $25,000 delayed draw that must be advanced within 12 months and a $50,000 committed accordion facility that is available after December 1, 2022, provided certain financial covenants are met, and with a maturity of January 1, 2026. Upon closing, gross proceeds of $75,000 were drawn (before origination discounts and issuance costs of approximately $4,000 and $1,500, respectively, which were capitalized). In April 2022, the Company drew down on the remaining $25,000 under this facility. Refer to Note 14 for further discussion of the syndicated related party lender.

The loan is secured by pledged equity interests and substantially all of the assets of the Company. Advances under the facility bear interest at 9.75% per annum (plus an additional 1.0% per annum until certain collateral assignment agreements are delivered) and undrawn amounts (excluding the committed accordion facility until it is available) bear interest at 3.0% per annum.

The loan is subject to various financial covenants, including a fixed charge coverage ratio and two leverage ratios. The Company obtained a waiver of these covenants for the three month periods ended March 31, 2022 and June 30, 2022. This waiver included a $500 waiver fee that was paid to the lenders. Subsequent to the balance sheet date, the 9.75% Credit facilities due January 2026 were amended (refer to Note 17 for further discussion).

Commencing with the receipt of the of the loan, mandatory prepayments are required from net proceeds of certain sale or disposition activities provided these proceeds are not invested in additional capital assets within 12 months of the disposition date, as defined by the Credit Agreement.

XML

SHAREHOLDERS’ EQUITY AND NON-CONTROLLING INTERESTS

9 Months Ended

Sep. 30, 2022

Equity [Abstract]

SHAREHOLDERS’ EQUITY AND NON-CONTROLLING INTERESTS

SHAREHOLDERS’ EQUITY AND NON-CONTROLLING INTERESTS

The table below details the change in Pubco shares outstanding by class for the three and nine months ended September 30, 2022:

Shareholders’ Equity	Fixed Shares	Floating Shares	Fixed Shares Held in Treasury	Floating Shares Held in Treasury	Fixed Multiple Shares	Total Shares Outstanding
December 31, 2021	74,665	32,962	(589)	(253)	118	106,903
Issuances	3,897	969	—	—	—	4,866
NCI conversions	265	113	—	—	—	378
September 30, 2022	78,827	34,044	(589)	(253)	118	112,147

Warrants

A summary of the warrants activity outstanding is as follows:

Warrants	Fixed Shares	Floating Shares
December 31, 2021	5,817	2,524
Expired	—	—
September 30, 2022	5,817	2,524

The exercise price of each Fixed Share warrant ranged from $3.15 to $4.00, respectively, and the exercise price of each Floating Share warrant ranged from $3.01 to $4.00, respectively. The warrants are exercisable for a period of 4 years. The weighted-average remaining contractual life of the warrants outstanding is approximately 2.4 years. There was no aggregate intrinsic value for warrants outstanding as of September 30, 2022.

Non-controlling interests - convertible units

The Company has NCIs in consolidated subsidiaries USCo2 and HSCP. The non-voting shares of USCo2 and HSCP units make up substantially all of the NCI balance as of September 30, 2022 and are convertible for either 0.7 of a Fixed Share and 0.3 of a Floating Share of Pubco or cash, as determined by the Company. Summarized financial information of HSCP is presented below. USCo2 does not have discrete financial information separate from HSCP.

HSCP net asset reconciliation	September 30, 2022			December 31, 2021
Current assets	$	93,253		$	113,011
Non-current assets	385,138			375,807
Current liabilities	(18,429)			(29,256)
Non-current liabilities	(220,299)			(195,791)
Other NCI balances	(723)			(718)
Accumulated equity-settled expenses	(239,592)			(226,596)
Net assets	$	(652)		$	36,457
HSCP/USCo2 ownership % of HSCP	16.36		%	17.24		%
Net assets allocated to USCo2/HSCP	$	(107)		$	6,285
Net assets attributable to other NCIs	723			718
Total NCI	$	616		$	7,003

	Three Months Ended September 30,						Nine Months Ended September 30,
HSCP Summarized Statement of Operations	2022			2021			2022			2021
Net loss allocable to HSCP/USCo2	$	(16,549)		$	(10,052)		$	(27,589)		$	(18,882)
HSCP/USCo2 weighted average ownership % of HSCP	16.84		%	17.57		%	16.96		%	17.80		%
Net loss allocated to HSCP/USCo2	$	(2,787)		$	(1,766)		$	(4,679)		$	(3,361)
Net loss allocated to other NCIs	3			5			4			14
Net loss attributable to NCIs	$	(2,784)		$	(1,761)		$	(4,675)		$	(3,347)

As of September 30, 2022, USCo2’s non-voting shares owned approximately 0.22% of HSCP units. USCo2’s capital structure is comprised of voting shares, all of which are held by the Company, and of non-voting shares held by certain former HSCP members. Certain executive employees and profits interests holders own approximately 16.14% of HSCP units. The remaining 83.64% interest in HSCP is held by USCo and represents the members’ equity attributable to shareholders of the parent.

During the nine months ended September 30, 2022 and 2021, the Company had several transactions with HSCP and USCo2 that changed its ownership interest in the subsidiaries but did not result in loss of control. These transactions included business acquisitions and the redemption of HSCP and USCo2 convertible units for Pubco shares (as shown in the table below), and

resulted in a $55 allocation from shareholders' equity to NCI and $862 allocation from NCI to shareholders' equity for the nine months ended September 30, 2022 and 2021, respectively.

A reconciliation of the beginning and ending amounts of convertible units is as follows:

Convertible Units	September 30, 2022	December 31, 2021
Beginning balance	23,076	24,142
NCI units converted to Pubco	(378)	(1,066)
Ending balance	22,698	23,076

XML

EQUITY-BASED COMPENSATION EXPENSE

9 Months Ended

Sep. 30, 2022

Share-Based Payment Arrangement [Abstract]

EQUITY-BASED COMPENSATION EXPENSE

EQUITY-BASED COMPENSATION EXPENSE

Amended Arrangement with Canopy Growth

On September 23, 2020, the Company announced the implementation of the Amended Arrangement (as defined in Note 13). Pursuant to the Amended Arrangement, the Company’s articles have been amended to create new Fixed Shares, Floating Shares and Fixed Multiple Shares. Consequently, the Company’s equity-based compensation was modified into new equity awards of the Company. Refer to Note 13 for further discussion.

Equity-based compensation - Plan (Acreage Holdings, Inc. Omnibus Incentive Plan)

In connection with the RTO transaction, the Company’s Board of Directors adopted an Omnibus Incentive Plan, as amended September 23, 2020 (the “Plan”), which permits the issuance of stock options, stock appreciation rights, stock awards, share units, performance shares, performance units and other stock-based awards up to an amount equal to 15% of the issued and outstanding Subordinate Voting Shares of the Company.

Pursuant to the Amended Arrangement, the Company retained the Plan described above, the upper limit of issuances being up to an amount equal to 15% of the issued and outstanding Fixed Shares and Floating Shares of the Company. As of September 30, 2022, the Company had 3,199 shares authorized and available for grant under the Plan.

Restricted Share Units (“RSUs”)

	Fixed Shares			Floating Shares
Restricted Share Units (Fair value information expressed in whole dollars)	RSUs	Weighted Average Grant Date Fair Value		RSUs	Weighted Average Grant Date Fair Value
Unvested, January 1, 2022	3,188	$	7.30	1,262	$	7.39
Granted	7,717	$	0.67	95	$	1.19
Forfeited	(533)	$	2.07	(83)	$	2.54
Vested	(3,811)	$	4.08	(764)	$	7.90
Unvested, September 30, 2022	6,561	$	1.80	510	$	6.27
Vested and unreleased(1)	225	$	5.80	24	$	15.15
Outstanding, September 30, 2022	6,786	$	1.93	534	$	6.67

(1) RSUs that are vested and unreleased represent RSUs that are pending delivery.

RSUs of the Company generally vest over a period of three years and RSUs granted to certain executives vest based on achievement of specific performance conditions. In certain situations for specified individuals, RSUs vest on an accelerated basis on separation. The fair value for RSUs is based on the Company’s share price on the date of the grant. The Company recorded $2,256 and $7,645 as Equity-based compensation expense on Unaudited Condensed Consolidated Statements of Operations during the three and nine months ended September 30, 2022, respectively, and $3,092 and $14,044 during the three and nine months ended September 30, 2021, respectively. The fair value of RSUs vested during the three and nine months ended September 30, 2022 was $1,427 and $4,760, respectively, and $718 and $15,045 during the three and nine months ended September 30, 2021, respectively.

The total weighted average remaining contractual life and aggregate intrinsic value of unvested RSUs as of September 30, 2022 was approximately 2 years and $3,856, respectively. Unrecognized compensation expense related to these awards at September 30, 2022 was $13,005 and is expected to be recognized over a weighted average period of approximately 1 year.

Stock options

	Fixed Shares			Floating Shares
Stock Options (Exercise price expressed in whole dollars)	Options	Weighted Average Exercise Price		Options	Weighted Average Exercise Price
Options outstanding, January 1, 2022	1,529	$	11.07	2,414	$	3.06
Granted	5,849	$	0.59	—	$	—
Forfeited	(41)	$	5.66	(91)	$	2.57
Expired	—	$	—	(20)	$	2.55
Options outstanding, September 30, 2022	7,337	$	2.75	2,303	$	3.09
Options exercisable, September 30, 2022	1,229	$	12.85	1,925	$	3.14

Stock options of the Company generally vest over a period of three years and options granted to certain executives vest based on achievement of specific performance conditions. Stock options of the Company have an expiration period of 5 or 10 years from the date of grant. The weighted average contractual life remaining for Fixed Share options outstanding and exercisable as of September 30, 2022 was approximately 5 and 6 years, respectively. The weighted average contractual life remaining for Floating Share options outstanding and exercisable as of September 30, 2022 was approximately 4 and 4 years, respectively. The Company recorded $300 and $725 as Equity-based compensation expense on Unaudited Condensed Consolidated Statements of Operations during the three and nine months ended September 30, 2022 and $1,076 and $3,147 during the three and nine months ended September 30, 2021, respectively, in connection with these awards.

As of September 30, 2022, unamortized expense related to stock options totaled $2,182 and is expected to be recognized over a weighted-average period of approximately 2 years. As of September 30, 2022, the aggregate intrinsic value for unvested options and for vested and exercisable options was nil, respectively.

Equity-based compensation - other

In May 2022, the Company granted 301 Fixed Shares and 127 Floating Shares and recorded $600 as Equity-based compensation expense on Unaudited Condensed Consolidated Statements of Operations during the for the three and nine months ended September 30, 2022 in settlement of post-employment expenses.

XML

COMMITMENTS AND CONTINGENCIES

9 Months Ended

Sep. 30, 2022

Commitments and Contingencies Disclosure [Abstract]

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES

Commitments

The Company provides revolving lines of credit to several of its portfolio companies. As of September 30, 2022, the maximum obligation under these arrangements was $15,150 (refer to Note 6 for further discussion).

Prior Plan of Arrangement with Canopy Growth

On June 19, 2019, the shareholders of the Company and of Canopy Growth separately approved the proposed plan of arrangement (the “Prior Plan of Arrangement”) involving the two companies, and on June 21, 2019, the Supreme Court of British Columbia granted a final order approving the Prior Plan of Arrangement. Effective June 27, 2019, the articles of the Company were amended pursuant to the Prior Plan of Arrangement to provide that, upon the occurrence (or waiver by Canopy Growth) of the Triggering Event, subject to the satisfaction of the conditions set out in the arrangement agreement entered into between Acreage and Canopy Growth on April 18, 2019, as amended on May 15, 2019 (the “Original Arrangement Agreement”), Canopy Growth will acquire (the “Acquisition”) all of the issued and outstanding shares in the capital of the Company (each, an “Acreage Share”).

Second Amendment to the Arrangement Agreement with Canopy Growth

On September 23, 2020, Acreage and Canopy Growth entered into an amending agreement (the “Amending Agreement” or “Amended Arrangement”) (and together with the Original Arrangement Agreement and any further amendments thereto, the “Amended Plan of Arrangement”) and the Amended Arrangement became effective at 12:01 a.m. (Vancouver time) (the “Amendment Time”) on September 23, 2020 (the “Amendment Date”). Pursuant to the Amended Plan of Arrangement, Canopy Growth made a cash payment of $37,500 which was delivered to Acreage’s shareholders and certain holders of securities convertible or exchangeable into shares of Acreage. Acreage also completed a capital reorganization (the “Capital Reorganization”) effective as of the Amendment Time whereby: (i) each existing SVS was exchanged for 0.7 of a Fixed Share and 0.3 of a Floating Share; (ii) each issued and outstanding PVS was exchanged for 28 Fixed Shares and 12 Floating Shares; and (iii) each issued and outstanding MVS was exchanged for 0.7 of a Fixed Multiple Share and 0.3 of a Floating Share.

At the Amendment Time, each option, restricted share unit, compensation option, and warrant to acquire existing SVS (each a “Security”) that was outstanding immediately prior to the Amendment Time, was exchanged for a replacement Security to acquire Fixed Shares (a “Fixed Share Replacement Security”) and a replacement Security to acquire Floating Shares (a “Floating Share Replacement Security”) to account for the Capital Reorganization.

Pursuant to the Amended Plan of Arrangement, upon the occurrence or waiver (at the discretion of Canopy Growth) of the Triggering Event (the “Triggering Event Date”), Canopy Growth will, subject to the satisfaction or waiver of certain closing conditions set out in the Arrangement Agreement: (i) acquire all of the issued and outstanding Fixed Shares (following the mandatory conversion of the Fixed Multiple Shares into Fixed Shares) on the basis of 0.3048 of a common share of Canopy Growth (each whole common share, a “Canopy Growth Share”) for each Fixed Share held (the “Fixed Exchange Ratio”) at the time of the acquisition of the Fixed Shares (the “Acquisition Time”), subject to adjustment in accordance with the terms of the Amended Plan of Arrangement (the “Canopy Call Option”); and (ii) have the right (but not the obligation) (the “Floating Call Option”), exercisable for a period of 30 days following the Triggering Event Date to acquire all of the issued and outstanding Floating Shares at a price to be determined based upon the 30 day volume-weighted average trading price of the Floating Shares, subject to a minimum price of $6.41, as may be adjusted in accordance with the terms of the Amended Plan of Arrangement, to be payable, at the option of Canopy Growth, in cash, Canopy Growth Shares or a combination thereof. If any portion is paid in Canopy Growth Shares, the number of Canopy Growth Shares to be exchanged for each Floating Share shall be determined on the basis of a 30 day volume-weighted average calculation using the Floating Shares (the “Floating Ratio”). The closing of the acquisition of the Floating Shares pursuant to the Floating Call Option, if exercised, will take place concurrently with the closing of the acquisition of the Fixed Shares pursuant to the Canopy Call Option, if exercised. The Canopy Call Option and the Floating Call Option will expire 10 years from the Amendment Time.

At the Acquisition Time, on the terms and subject to the conditions of the Amended Plan of Arrangement, each Fixed Share Replacement Security will be exchanged for a replacement Security from Canopy Growth equal to: (i) the number of Fixed Shares that were issuable upon exercise of such Fixed Share Replacement Security immediately prior to the Acquisition Time, multiplied by (ii) the Fixed Exchange Ratio in effect immediately prior to the Acquisition Time (provided that if the foregoing would result in the issuance of a fraction of a Canopy Growth Share, then the number of Canopy Growth Shares to be issued will be rounded down to the nearest whole number).

In the event that the Floating Call Option is exercised and Canopy Growth acquires the Floating Shares at the Acquisition Time, on the terms and subject to the conditions of the Amended Plan of Arrangement, each Floating Share Replacement Security will be exchanged for a replacement Security from Canopy Growth equal to: (i) the number of Floating Shares that were issuable upon exercise of such Floating Share Replacement Security immediately prior to the Acquisition Time, multiplied by (ii) the Floating Ratio (if the foregoing would result in the issuance of a fraction of a Canopy Growth Share, then the number of Canopy Growth Shares to be issued will be rounded down to the nearest whole number). In the event that the Floating Call Option is exercised and Canopy Growth acquires the Floating Shares at the Acquisition Time, Acreage will be a wholly-owned subsidiary of Canopy Growth.

The Amended Plan of Arrangement provides for, among other things, Amendments to the definition of Purchaser Approved Share Threshold (as defined therein) to change the number of shares of Acreage available to be issued by Acreage without an adjustment in the Fixed Exchange Ratio such that Acreage may issue a maximum of 32,700 shares. Furthermore, Acreage generally may not issue any equity securities without Canopy Growth’s prior consent. Additionally, the Amended Plan of Arrangement allows for various Canopy Growth rights that extend beyond the Acquisition Date, including, among others: (i) rights to nominate a majority of Acreage’s Board of Directors following the Acquisition Time; (ii) restrictive covenants in respect of the business conduct in favor of Canopy Growth; (iii) termination of non-competition and exclusivity rights granted to Acreage by Canopy Growth in the event that Acreage does not meet certain specified financial targets; (iv) implementation of further restrictions on Acreage’s ability to operate its business in the event that Acreage does not meet certain specified

financial targets; and (v) termination of the Amended Plan of Arrangement in the event that Acreage does not meet certain specified financial targets in the trailing 12 month period. Each of the financial targets referred to above is specified in the Amending Agreement and related to the performance of Acreage relative to a business plan for Acreage for each fiscal year ended December 31, 2020 through December 31, 2029 set forth in the Proposal Agreement (the “Initial Business Plan”).

Further, the Amended Plan of Arrangement imposes restrictions on Acreage entering into any contracts in respect of Company Debt if: (i) such contract would be materially inconsistent with market standards for companies operating in the United States cannabis industry; (ii) such contract prohibits a prepayment of the principal amount of such Company Debt; and (iii) such contract would provide for interest payments to be paid through the issuance of securities as opposed to cash, among other restrictions. The Amended Plan of Arrangement also provides for the following: (i) certain financial reporting obligations to Canopy Growth; (ii) certain specified criteria related to any new directors or officers of Acreage, and (iii) a limit to Acreage’s operations to the Identified States (as defined therein).

Subsequent to the balance sheet date, the Company entered into a new arrangement agreement with Canopy Growth regarding the acquisition of the Company’s Floating Shares. Refer to Note 17 for further discussion.

Tax Receivable Agreement and Tax Receivable Bonus Plans

The Company is a party to i) a tax receivable agreement dated November 14, 2018 and subsequently amended (the “Tax Receivable Agreement”) between the Company and certain current and former unit holders of HSCP and ii) tax receivable bonus plans dated November 14, 2018 and subsequently amended (the “Tax Receivable Bonus Plans”) between the Company and certain directors, officers and consultants of the Company (together the “Tax Receivable Recipients”). Under the Tax Receivable Agreement and the Tax Receivable Bonus Plans, the Company is required to make cash payments to the Tax Receivable Recipients equal to 85% of the tax benefits, if any, that the Company actually realizes, or in certain circumstances is deemed to realize, as a result of (i) the increases in its share of the tax basis of assets of HSCP resulting from any redemptions or exchanges of Units from the HSCP Members, and (ii) certain other tax benefits related to the Company making payments under the Tax Receivable Agreement and the Tax Receivable Bonus Plan. Although the actual timing and amount of any payments that the Company makes to the Tax Receivable Recipients can not be estimated, it expects those payments will be significant. Any payments made by the Company to the Tax Receivable Recipients may generally reduce the amount of overall cash flow that might have otherwise been available to it. Payments under the Tax Receivable Agreement are not conditioned on any Tax Receivable Recipient’s continued ownership of Units or our shares after the completion of the RTO. Payments under the Tax Receivable Bonus Plan may, at times, be conditioned on the Tax Receivable Recipient’s continued employment by the Company.

In connection with the Amended Arrangement, the Company amended the terms of the Tax Receivable Agreement and the Tax Receivable Bonus Plans. Additionally, subsequent to the balance sheet date, the Company agreed to further amendments to The Tax Receivable Agreement and the Tax Receivable Bonus Plan. Refer to Note 17 for further discussion.

Debenture

In connection with the implementation of the Amended Arrangement, pursuant to a secured debenture dated September 23, 2020 (the “Debenture”) issued by Universal Hemp, LLC, an affiliate of Acreage that operates solely in the hemp industry in full compliance with all applicable laws (the “Borrower”), to 11065220 Canada Inc., an affiliate of Canopy Growth (the “Lender”), the Lender agreed to provide a loan of up to $100,000 (the “Loan”), $50,000 of which was advanced on the Amendment Date (the “Initial Advance”), and $50,000 of the Loan will be advanced in the event that the following conditions, among others, are satisfied: (a) the Borrower’s EBITDA (as defined in the Debenture) for any 90 day period is greater than or equal to 2.0 times the interest costs associated with the Initial Advance; and (b) the Borrower’s business plan for the 12 months following the applicable 90 day period supports an Interest Coverage Ratio (as defined in the Debenture) of at least 2.00:1.

The principal amount of the Loan will bear interest from the date of advance, compounded annually, and be payable on each anniversary of the date of the Debenture in cash in U.S. dollars at a rate of 6.1% per annum. The Loan will mature 10 years from the date of the Initial Advance.

The Loan must be used exclusively for U.S. hemp-related operations and on the express condition that such amount will not be used, directly or indirectly, in connection with or for the operation or benefit of any of the Borrower’s affiliates other than subsidiaries of the Borrower exclusively engaged in U.S. hemp-related operations and not directly or indirectly, towards the

operation or funding of any activities that are not permissible under applicable law. The Loan proceeds must be segregated in a distinct bank account and detailed records of debits to such distinct bank account will be maintained by the Borrower.

No payment due and payable to the Lender by the Borrower pursuant to the Debenture may be made using funds directly or indirectly derived from any cannabis or cannabis-related operations in the United States, unless and until the Triggering Event Date.

The Debenture includes usual and typical events of default for a financing of this nature, including, without limitation, if: (i) Acreage is in breach or default of any representation or warranty in any material respect pursuant to the Arrangement Agreement; (ii) the Non-Core Divestitures are not completed within 18 months from the Amendment Date; and (iii) Acreage fails to perform or comply with any covenant or obligation in the Arrangement Agreement which is not remedied within 30 days after written notice is given to the Borrower by the Lender. The Debenture also includes customary representations and warranties, positive covenants and negative covenants of the Borrower.

Advisor fee

In connection with the Prior Plan of Arrangement, the Company entered into an agreement with its financial advisor providing for a fee payment of $7,000 in either cash, Acreage shares or Canopy Growth shares, at the discretion of the Company, upon the successful acquisition of Acreage by Canopy Growth. Subsequent to September 30, 2022, the Company amended the terms of the agreement with its financial advisors providing for a fee payment of $3,000 in cash, less a $500 initial payment, and $2,000 in shares of the Company, upon the successful acquisition of Acreage by Canopy Growth.

Surety bonds

The Company has indemnification obligations with respect to surety bonds primarily used as security against non-performance in the amount of $5,000 as of September 30, 2022, for which no liabilities are recorded on the Unaudited Condensed Consolidated Statements of Financial Position.

The Company is subject to other capital commitments and similar obligations. As of September 30, 2022 and 2021, such amounts were not material.

CanWell Settlement

In November 2020, the Company entered into a final confidential settlement agreement with CanWell, LLC for certain outstanding proceedings. As part of that agreement, the Company accrued for $7,750 in Legal settlements, net on the Statements of Operations for the year ended December 31, 2020. In connection with this settlement agreement, the Company issued a promissory note in the amount of $7,750 to CanWell, which is non-interest bearing and is payable in periodic payments through December 31, 2024. Through September 30, 2022, the Company has paid $3,792 of the promissory note.

Contingencies

The Company’s operations are subject to a variety of local and state regulations. Failure to comply with one or more of those regulations could result in fines, restrictions on its operations, or losses of permits that could result in the Company’s applicable subsidiaries ceasing operations. While management of the Company believes that the Company’s subsidiaries are in compliance with applicable local and state regulations as of September 30, 2022, cannabis regulations continue to evolve and are subject to differing interpretations. As a result, the Company’s subsidiaries may be subject to regulatory fines, penalties, or restrictions in the future.

The Company and its subsidiaries may be, from time to time, subject to various administrative, regulatory and other legal proceedings arising in the ordinary course of business. Contingent liabilities associated with legal proceedings are recorded when a liability is probable, and the contingent liability can be reasonably estimated.

New York outstanding litigation

On November 2, 2018, EPMMNY LLC (“EPMMNY”) filed a complaint in the Supreme Court of the State of New York, County of New York, asserting claims against 16 defendants, including NYCANNA, Impire State Holdings LLC, NY Medicinal Research & Caring, LLC (each, a wholly-owned subsidiary of High Street) and High Street. The Index Number for the action is 655480/2018. EPMMNY alleges that it was wrongfully deprived of a minority equity interest and management

role in NYCANNA by its former partner, New Amsterdam Distributors, LLC, which attempted to directly or indirectly sell or transfer EPMMNY’s alleged interest in NYCANNA to other entities in 2016 and 2017, including Impire, NYMRC and High Street.

EPMMNY alleges that it is entitled to the value of its alleged minority interest in NYCANNA or minority ownership in NYCANNA. EPMMNY also alleges that certain defendants misused its alleged intellectual property and/or services, improperly solicited its employees, and aided and abetted or participated in the transfer of equity and/or business opportunities from EPMMNY.

High Street intends to vigorously defend this action, which the Company firmly believes is without merit. High Street is also entitled to full indemnity from the claims asserted against it by EPMMNY pursuant to the purchase agreement pertaining to its acquisition of NYCANNA and personal guarantee by the largest shareholders of the seller. High Street, along with the other defendants, filed a motion to dismiss on April 1, 2019. The motion was fully briefed and submitted to the Court as of July 18, 2019, and oral argument was heard on September 6, 2019. The motion remains pending before the Court. Following a hearing held the week of April 25-29, 2022, the Court ruled that Plaintiff had the capacity to bring this action on behalf of EPMMNY. The motions to dismiss remain pending on all other grounds.

XML

RELATED PARTY TRANSACTIONS

9 Months Ended

Sep. 30, 2022

Related Party Transactions [Abstract]

RELATED PARTY TRANSACTIONS

RELATED PARTY TRANSACTIONS

Transactions with related parties are entered into in the normal course of business and are measured at the amount established and agreed to by the parties.

Related party notes receivable

In May 2021, the Company sold two secured promissory notes totaling $28,000 received from the sale of Acreage Florida to Viridescent for cash proceeds of approximately $26,000. Viridescent is an entity controlled by Kevin Murphy, the Chairman of the board of directors. Refer to Note 6 for further discussion.

6.10% Secured debenture due September 2030

As disclosed in Note 10, “6.10% Secured debenture due September 2030”, on September 23, 2020, pursuant to the implementation of the Amended Arrangement, a subsidiary of Canopy Growth advanced gross proceeds of $50,000 (less transaction costs of approximately $4,025) to Universal Hemp, an affiliate of the Company, pursuant to the terms of a secured debenture. In accordance with the terms of the debenture, the funds cannot be used, directly or indirectly, in connection with or for any cannabis or cannabis-related operations in the United States, unless and until such operations comply with all applicable laws of the United States. Acreage then engaged an investment advisor (the “Investment Advisor”) which, under the Investment Advisor’s sole discretion, invested on behalf of Universal Hemp, $34,019 of the proceeds on September 28, 2020. During the three and nine months ended September 30, 2022, the Company incurred interest expense attributable to the 6.10% Secured debenture due September 2030 of $624 and $1,851, respectively.

As a result, Universal Hemp, a subsidiary of the Company, acquired 34,019 class B units, at $1 par value per unit, which represented 100% financial interest in an Investment Partnership, a Canada-based limited partnership. An affiliate of the Institutional Investor holds Class A Units of the Investment Partnership. The general partner of the Investment Partnership is also an affiliate of the Institutional Investor. The class B units are held by the Institutional Investor as agent for Universal Hemp. On September 28, 2020, the Company received gross proceeds of $33,000 (less transaction costs of approximately $959) from an affiliate of the Institutional Lender (the “Lender”) and used a portion of the proceeds of this loan to retire its short-term $11,000 convertible note and its short-term note aggregating approximately $18,000 in October 2020, with the remainder being used for working capital purposes. The Lender is controlled by the Institutional Lender. The Investment Partnership is the investor in the Lender.

Michigan consulting agreement

Pursuant to the Consulting Services Agreement by and between Kevin Michigan, LLC, a company controlled by Kevin Murphy, and High Street (the “Michigan Consulting Agreement”), High Street provides certain consulting services to Kevin Michigan, LLC, which includes, but is not limited to, services related to application support, provisioning center administration and operation, local and state regulatory filings, human resource matters, and marketing matters. The Michigan Consulting Agreement explicitly states that High Street is not able to direct or control the business of Kevin Michigan, LLC. Additionally, there are certain leases held by and between Kevin Michigan, LLC, as lessee and certain wholly owned subsidiaries of High Street, as lessors. As of September 30, 2022, Kevin Michigan, LLC is not operational, and no consulting fees or rents have been paid to High Street or its wholly owned subsidiaries. Kevin Michigan, LLC is owned and controlled by the Company’s Chairman, Kevin Murphy.

9.75% Credit facilities due January 2026

As disclosed in Note 10, on December 16, 2021, the Company entered into the 9.75% Credit facilities due January 2026 with a syndicate of lenders, including Viridescent Realty Trust, Inc. (“Viridescent”), an entity controlled by Kevin Murphy. Under the terms of the 9.75% Credit facilities due January 2026, a $75,000 initial draw was available immediately, an additional $25,000 delayed draw is available that must be advanced within 12 months, and a $50,000 committed accordion facility is available after December 1, 2022, provided certain financial covenants are met. Advances under the facilities bear interest at 9.75% per annum and undrawn amounts (excluding the committed accordion facility until it is available) bear interest at 3.0% per annum. In April 2022, the Company drew down on the additional $25,000 delayed draw under this facility.

Viridescent has committed $30,000 of the $100,000 drawn down under the Credit Facility, with third-party syndicated affiliates committing the additional $70,000. During the three and nine months ended September 30, 2022, the Company incurred interest expense attributable to Viridescent of $824 and $2,215, respectively. The loan is secured by first-lien mortgages on Acreage’s wholly owned real estate and other commercial security interests. A third-party syndicate served as Administrative Agent for the transaction. Subsequent to the balance sheet date, the 9.75% Credit facilities due January 2026 were amended (refer to Note 17 for further discussion).

XML

REPORTABLE SEGMENTS	9 Months Ended
	Sep. 30, 2022
Segment Reporting [Abstract]
REPORTABLE SEGMENTS	REPORTABLE SEGMENTSThe Company prepares its segment reporting on the same basis that its Chief Operating Decision Maker manages the business, and makes operating decisions. The Company operates under one operating segment, which is its only reportable segment: the production and sale of cannabis products. The Company’s measure of segment performance is net income, and derives its revenue primarily from the sale of cannabis products, as well as related management or consulting services which were not material in all periods presented. All of the Company’s operations are located in the United States.

XML

EARNINGS PER SHARE

9 Months Ended

Sep. 30, 2022

Earnings Per Share [Abstract]

EARNINGS PER SHARE

EARNINGS PER SHARE

Basic earnings per share are computed by dividing net loss attributable to common shareholders of the Company by the weighted average number of outstanding shares for the period. Diluted earnings per share are calculated based on the weighted number of outstanding common shares plus the dilutive effect of stock options and warrants, as if they were exercised, and restricted stock units and profits interests, as if they vested and NCI convertible units, as if they converted.

Basic and diluted loss per share is as follows:

	Three Months Ended September 30,				Nine Months Ended September 30,
	2022		2021		2022		2021
Net loss attributable to common shareholders of the Company	$	(22,214)	$	(12,296)	$	(44,837)	$	(22,657)
Weighted average shares outstanding - basic	111,200		106,332		108,795		104,524
Effect of dilutive securities	—		—		—		—
Weighted average shares - diluted	111,200		106,332		108,795		104,524
Net loss per share attributable to common shareholders of the Company - basic	$	(0.20)	$	(0.12)	$	(0.41)	$	(0.22)
Net loss per share attributable to common shareholders of the Company - diluted	$	(0.20)	$	(0.12)	$	(0.41)	$	(0.22)

During the three and nine months ended September 30, 2022, 5,817 Fixed warrants, 2,524 Floating warrants, 6,786 Fixed Share RSUs, 534 Floating Share RSUs, 7,337 Fixed Share stock options, 2,303 Floating Share stock options and 22,698 NCI convertible units were excluded from the calculation of net loss per share attributable to common shareholders of the Company - diluted, as they were anti-dilutive. During the three and nine months ended September 30, 2021, 7,131 Fixed warrants, 3,087 Floating warrants, 3,621 Fixed Share RSUs, 1,757 Floating Share RSUs, 1,530 Fixed Share stock options, 2,419 Floating Share stock options and 23,076 NCI convertible units were excluded from the calculation of net loss per share attributable to common shareholders of the Company - diluted, as they were anti-dilutive.

XML

SUBSEQUENT EVENTS

9 Months Ended

Sep. 30, 2022

Subsequent Events [Abstract]

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS

Acreage enters into new strategic arrangement with Canopy Growth

On October 24, 2022, the Company entered into an arrangement agreement (the “Floating Share Agreement”) with Canopy Growth and Canopy USA, LLC (“Canopy USA”), Canopy Growth’s newly-created U.S. domiciled holding company, pursuant to which, subject to approval of the holders of the Class D subordinate voting shares of Acreage (the “Floating Shares”) and the terms and conditions of the Floating Share Agreement, Canopy USA will acquire all of the issued and outstanding Floating Shares by way of court-approved plan of arrangement (the “Floating Share Arrangement”) for consideration of 0.4500 of a common share of Canopy Growth (each whole share a “Canopy Share”) in exchange for each Floating Share.

Concurrently with entering into of the Floating Share Agreement, Canopy Growth irrevocably waived its option to acquire the Floating Shares pursuant to the Amended Arrangement.

Subject to the provisions of the Floating Share Agreement, Canopy Growth has agreed to exercise the fixed option pursuant to the Amended Agreement to acquire all outstanding Fixed Shares, representing approximately 70% of the total shares of Acreage as at the date hereof, at a fixed exchange ratio of 0.3048 of a Canopy Share for each Fixed Share.

Completion of the Floating Share Agreement is subject to the satisfaction or waiver of certain closing conditions, including receipt of applicable regulatory and court approvals, the approval of at least (i) 66⅔% of the votes cast by Floating Shareholders, and (ii) a majority of the votes cast by Floating Shareholders excluding the votes cast by “interested parties” and “related parties” under Multilateral Instrument 61-101 - Protection of Minority Security Holders in Special Transactions (“MI 61-101”) of the Canadian Securities Administrators, at a special meeting of Acreage shareholders (the “Special Meeting”) expected to take place in January 2023.

Canopy Growth and Canopy USA have entered into voting support agreements with certain of the Company’s directors and current and former officers holding approximately 7.3% of the issued and outstanding Floating Shares pursuant to which they have agreed, among other things, to vote their Floating Shares in favor of the Floating Share Agreement.

Acreage expects the Floating Share Arrangement to close in the second half of 2023, subject to receipt of shareholder, court, and regulatory approvals, as well as the satisfaction or waiver of all conditions under the Floating Share Agreement and the Amended Arrangement. It is anticipated that the acquisition by Canopy USA of the Fixed Shares pursuant to the Fixed Option will be completed immediately following closing of the Floating Share Agreement. Refer to Note 13 for further discussion on the Prior Plan of Arrangement and the Amended Arrangement

Tax Receivable Account and Tax Receivable Bonus Plan Amendments

Concurrently with execution of the Floating Share Agreement, Canopy Growth agreed to issue (i) Canopy Shares with a value of approximately $30,500 to certain current or former unit holders of HSCP to acquire the right to all future payments under HSCP’s existing Tax Receivable Agreement, as amended (the “TRA”) and (ii) a payment with a value of approximately $19,500 in Canopy Shares to certain directors, officers or consultants of Acreage to satisfy obligations under HSCP’s existing Tax Receivable Bonus Plans, under further amendment to each. Canopy Shares with a value of approximately $15,300 will be issued to certain Holders as soon as practicable as the first installment under the amended TRA with a second payment of approximately $15,300 in Canopy Shares to occur on the earlier of (a) the second business day following the date on which the Floating Shareholders approve the Floating Share Arrangement; or (b) April 24, 2023. In addition, a final payment with a value of approximately $19,500 in Canopy Shares will be issued by Canopy Growth to certain eligible participants under the Tax Receivable Bonus Plans immediately prior to the completion of Floating Share Arrangement. Refer to Note 13 for further discussion on the Tax Receivable Agreement.

Credit Facility Amendment

On October 24, 2022, the Company amended its existing $150,000 credit facility (the “Amended Credit Facility”). Under the terms of the Amended Credit Facility, $25,000 is available for immediate draw by Acreage with a further $25,000 available in future periods under a committed accordion option once certain predetermined milestones are achieved. In conjunction with entering into the Amended Credit Facility, all financial debt covenants, except a minimum cash requirement, were waived until

December 31, 2023, and new covenants have been agreed upon in respect of all periods beginning on or after December 31, 2023. Finally, the Amended Credit Facility includes approval for Canopy USA to acquire control of Acreage without requiring repayment of all amounts outstanding under the Amended Credit Facility, provided certain conditions are satisfied. Acreage intends to use the proceeds of the Amended Credit Facility to fund expansion initiatives and provide additional working capital.

The Amended Credit Facility will bear interest at a variable rate of U.S. prime (“Prime”) plus 5.75% per annum, payable monthly in arrears, with a Prime floor of 5.50%, and a maturity date of January 1, 2026. Under the terms of the Amended Credit Facility, the Company has the option to extend the maturity date to January 1, 2027, for a fee equal to 1.0% of the total loan amount. Separately, the Company paid an amendment fee of $1,250 to the syndicate of lenders. Refer to Note 10 for further discussion on the 9.75% Credit facilities due January 2026.

Management has reviewed all other events subsequent to September 30, 2022 through the date of issuing these financial statements and determined that no further subsequent events require adjustment or disclosure.

XML

SIGNIFICANT ACCOUNTING POLICIES (Policies)

9 Months Ended

Sep. 30, 2022

Accounting Policies [Abstract]

Basis of presentation and going concern

Basis of presentation and going concern

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. In the opinion of management, all adjustments consisting only of normal recurring adjustments necessary for a fair presentation have been reflected in these unaudited condensed consolidated financial statements. Operating results for the interim periods presented are not necessarily indicative of the results that may be expected for the fiscal year ending December 31, 2022, or any other period.

As reflected in the unaudited condensed consolidated financial statements, the Company had an accumulated deficit as of September 30, 2022, as well as a net loss and negative cash flow from operating activities for the nine months ended September 30, 2022. These factors raise substantial doubt about the Company’s ability to continue as a going concern for at least one year from the issuance of these financial statements.

However, management believes that substantial doubt about the Company’s ability to meet its obligations for the next twelve months from the date these financial statements were issued has been alleviated due to, but not limited to, (i) access to future capital commitments, (ii) continued sales growth from the Company’s consolidated operations, (iii) latitude as to the timing and amount of certain operating expenses as well as capital expenditures, (iv) restructuring plans that have already been put in place to improve the Company’s profitability, (v) the AFC-VRT credit facilities (refer to Notes 10 and 17 for further discussion), and (vi) access to the U.S. and Canadian public equity markets.

If the Company is unable to raise additional capital whenever necessary, it may be forced to decelerate or curtail its footprint build-out or other operational activities until such time as additional capital becomes available. Such limitation of the Company’s activities would allow it to slow its rate of spending and extend its use of cash until additional capital is raised. However, management cannot provide any assurances that the Company will be successful in accomplishing any of its plans. Management also cannot provide any assurance as to unforeseen circumstances that could occur at any time within the next twelve months or thereafter which could increase the Company’s need to raise additional capital on an immediate basis.

These interim unaudited condensed consolidated financial statements and notes thereto should be read in conjunction with the audited consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021, dated March 11, 2022, as filed with the Securities and Exchange Commission (the “2021 Form 10-K”).

Use of estimates

Use of estimates

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”). Preparation of financial statements in conformity with GAAP requires management to make estimates, judgments and assumptions that affect the reported amounts of assets and liabilities as of the dates presented and the reported amounts of revenues and expenses during the periods presented. Actual results could differ from those estimates. Significant estimates inherent in the preparation of the accompanying unaudited condensed consolidated financial statements include the fair value of assets acquired and liabilities assumed in business combinations, assumptions relating to equity-based compensation expense, estimated useful lives for property, plant and equipment and intangible assets, the valuation allowance against deferred tax assets and the assessment of potential charges on goodwill, intangible assets and investments in equity and notes receivable.

Emerging growth company

Emerging growth company

The Company is an “emerging growth company” as defined in the Jumpstart Our Business Startups Act (the “JOBS Act”). Under the JOBS Act, emerging growth companies can delay adopting new or revised accounting standards until such time as those standards apply to private companies.

Functional and presentation currency

Functional and presentation currency

The unaudited condensed consolidated financial statements and the accompanying notes are expressed in U.S. dollars. Financial metrics are presented in thousands. Other metrics, such as shares outstanding, are presented in thousands unless otherwise noted.

Basis of consolidation

Basis of consolidation

The Company’s unaudited condensed consolidated financial statements include the accounts of Acreage, its subsidiaries and variable interest entities (“VIEs”) where the Company is considered the primary beneficiary, if any, after elimination of intercompany accounts and transactions. Investments in business entities in which Acreage lacks control but is able to exercise significant influence over operating and financial policies are accounted for using the equity method. The Company’s proportionate share of net income or loss of the entity is recorded in Income (loss) from investments, net in the Unaudited Condensed Consolidated Statements of Operations.

VIEs

VIEs

In determining whether the Company is the primary beneficiary of a VIE, the Company assesses whether it has the power to direct matters that most significantly impact the activities of the VIE and have the obligation to absorb losses or the right to receive benefits from the VIE that could potentially be significant to the VIE. There were no material consolidated VIEs as of September 30, 2022 or December 31, 2021.

Non-controlling interests (“NCI”)

Non-controlling interests (“NCI”)

Non-controlling interests represent ownership interests in consolidated subsidiaries by parties that are not shareholders of Pubco. They are shown as a component of Total equity in the Unaudited Condensed Consolidated Statements of Financial Position, and the share of loss attributable to non-controlling interests is shown as a component of Net loss in the Unaudited Condensed Consolidated Statements of Operations. Changes in the parent company’s ownership that do not result in a loss of control are accounted for as equity transactions.

Restricted cash

Restricted cashRestricted cash represents funds contractually held for specific purposes and, as such, not available for general corporate purposes.

Accounts receivable valuations and reclassifications

Accounts receivable valuations and reclassificationsAccounts receivable are stated at their net realizable value. The allowance against gross trade receivables reflects the best estimate of probable losses inherent in the receivables portfolio determined on the basis of historical experience, specific allowances for known troubled accounts and other currently available information.

Income taxes

Income taxesThe Company has unrecognized tax benefits (“UTBs”) of $6,161 and $7,695 as of September 30, 2022 and December 31, 2021, respectively, which are included in Other current liabilities in the Consolidated Statements of Financial Position. UTBs arise as a result of differences existing between a tax position taken or expected to be taken on a tax return and the benefit recognized and measured

Net loss per share

Net loss per shareNet loss per share represents the net loss attributable to shareholders divided by the weighted average number of shares outstanding during the period on an as converted basis. Basic and diluted loss per share are the same as of September 30, 2022, 2021 and 2020, as the issuance of shares upon conversion, exercise or vesting of outstanding units would be anti-dilutive in each period.

Change in presentation

Change in presentation

Note that certain items presented on the nine months ended September 30, 2021, Unaudited Condensed Consolidated Statement of Cash Flows, includes a change in presentation to conform to the current year presentation. There was no impact to our Consolidated Financial Statements as a result of this reclassification.

Accounting Pronouncements Recently Adopted

Accounting Pronouncements Recently Adopted

As of January 1, 2022, the Company adopted ASU 2019-12 - Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes (ASU 2019-12). ASU 2019-12 attempts to simplify aspects of accounting for franchise taxes and enacted changes in tax laws or rates and clarifies the accounting for transactions that result in a step-up in the tax basis of goodwill. The adoption of ASU 2019-12 did not have a material effect on the Company’s unaudited condensed consolidated financial statements.

As of January 1, 2022, the Company adopted ASU 2020-01 - Investments-Equity Securities (Topic 321), Investments-Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815). The new standard clarifies the interaction of accounting for the transition into and out of the equity method. The new standard also clarifies the accounting for measuring certain purchased options and forward contracts to acquire investments. The adoption of ASU 2020-01 did not have a material effect on the Company’s unaudited condensed consolidated financial statements.

As of January 1, 2022, the Company adopted ASU 2021-04 - Earnings Per Share (Topic 260), Debt - Modifications and Extinguishments (Topic 470-50), Compensation - Stock Compensation (Topic 718), and Derivatives and Hedging - Contracts in Entity's Own Equity (Subtopic 815-40), which clarifies existing guidance for freestanding written call options which are equity classified and remain so after they are modified or exchanged in order to reduce diversity in practice. The standard applies prospectively to modifications or exchanges that occur after it is adopted. The adoption of ASU 2021-04 did not have a material effect on the Company’s unaudited condensed consolidated financial statements.

Accounting Pronouncements Not Yet Adopted

In June 2016, the FASB issued ASU 2016-13 - Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (“ASU 2016-13”), which was subsequently revised by ASU 2018-19 and ASU 2020-02. The ASU introduces a new model for assessing impairment on most financial assets. Entities will be required to use a forward-looking expected loss model, which will replace the current incurred loss model, which will result in earlier recognition of allowance for losses. The ASU will be effective for the Company’s first interim period of fiscal 2023. The Company continues to evaluate the impact of this ASU on its unaudited condensed consolidated financial statements.

In October 2021, the FASB issued ASU 2021-08 - Business Combinations (Topic 805), Accounting for Contract Assets and Contract Liabilities from Contracts with Customers. The new standard improves the accounting for acquired revenue contracts with customers in a business combination by addressing diversity in practice and inconsistency. The new standard requires an entity to recognize and measure contract assets and contract liabilities acquired in a business combination in accordance with ASC 606 - Revenue from Contracts with Customers. The ASU will be effective for the Company’s first interim period of fiscal 2024. The standard should be applied prospectively to business combinations occurring on or after the effective date of the amendments. The Company does not anticipate a material impact on the Company’s unaudited condensed consolidated financial statements upon adoption.

XML

ACQUISITIONS, DIVESTITURES AND ASSETS HELD FOR SALE (Tables)

9 Months Ended

Sep. 30, 2022

Business Combinations, Discontinued Operations And Disposal Groups [Abstract]

Schedule of Purchase Price Allocations

During the nine-month period ended September 30, 2022, the Company did not complete any business acquisitions. During the year ended December 31, 2021, the Company completed the following business acquisitions, and has allocated the purchase price as follows:

Purchase Price Allocation	Greenleaf		CWG		Total
Assets acquired:
Cash and cash equivalents	$	1,209	$	828	$	2,037
Inventory	2,692		1,200		3,892
Other current assets	1,520		347		1,867
Capital assets, net	22,923		3,312		26,235
Operating lease right-of-use asset	2,819		1,584		4,403
Goodwill	1,819		1,482		3,301
Intangible assets, net - cannabis licenses	16,800		3,200		20,000
Intangible assets, net - customer relationships	—		1,000		1,000
Other non-current assets	189		40		229
Liabilities assumed:
Accounts payable and accrued liabilities	(1,829)		(464)		(2,293)
Taxes payable	(33)		(68)		(101)
Operating lease liability, current	(315)		(193)		(508)
Other current liabilities	(294)		3		(291)
Operating lease liability, non-current	(2,504)		(1,391)		(3,895)
Fair value of net assets acquired	$	44,996	$	10,880	$	55,876
Consideration paid:
Settlement of pre-existing relationship	44,996		10,880		$	55,876
Total consideration	$	44,996	$	10,880	$	55,876

Schedule of Assets and Liabilities Held for Sale

The table below presents the assets and liabilities classified as held for sale on the Unaudited Condensed Consolidated Statements of Financial Position for the year ended December 31, 2021 and is subject to change based on developments during the sales process.

	December 31, 2021
	Michigan(1)		Oregon		Total
Cash	$	—	$	223	$	223
Inventory	—		445		445
Notes receivable, current	—		31		31
Other current assets	—		9		9
Total current assets classified as held-for-sale	—		708		708
Capital assets, net	1,907		2,342		4,249
Operating lease right-of-use assets	—		1,695		1,695
Goodwill	—		2,191		2,191
Non-current assets	—		109		109
Total assets classified as held for sale	$	1,907	$	7,045	$	8,952
Accounts payable and accrued liabilities	$	—	$	(639)	$	(639)
Operating lease liability, current	—		(441)		(441)
Total current liabilities classified as held-for-sale	—		(1,080)		(1,080)
Operating lease liability, non-current	—		(787)		(787)
Total liabilities classified as held-for-sale	$	—	$	(1,867)	$	(1,867)

(1) During the nine months ended September 30, 2022, the Company was unsuccessful in finding a satisfactory buyer for certain of its Michigan locations. As a result, the assets at these specific locations no longer meet the criteria for being classified as held-for-sale (refer to Note 7 for further discussion).

XML

INTANGIBLE ASSETS AND GOODWILL (Tables)

9 Months Ended

Sep. 30, 2022

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule of Intangible Assets

The following table details the intangible asset balances by major asset classes:

Intangibles	September 30, 2022		December 31, 2021
Finite-lived intangible assets:
Management contracts	$	1,808	$	1,511
Customer relationships	1,000		1,000
Total finite-lived intangible assets	2,808		2,511
Accumulated amortization on finite-lived intangible assets:
Management contracts	(931)		(493)
Customer relationships	(850)		—
Total accumulated amortization on finite-lived intangible assets	(1,781)		(493)
Finite-lived intangible assets, net	1,027		2,018
Indefinite-lived intangible assets
Cannabis licenses	134,780		117,677
Total intangibles, net	$	135,807	$	119,695

Schedule of Finite-Lived Intangible Assets, Future Amortization Expense

Expected annual amortization expense for existing intangible assets subject to amortization as of September 30, 2022 is as follows for each of the next five fiscal years:

Amortization of Intangibles	2022		2023		2024		2025		2026
Amortization expense	$	297	$	584	$	146	$	—	$	—

Schedule of Goodwill

The following table details the changes in the carrying amount of goodwill:

Goodwill	Total
December 31, 2021	$	43,310
Adjustment to purchase price allocation	(16,500)
Other Adjustments(1)	3,682
September 30, 2022	$	30,492

(1) Represents adjustments related to the remeasurement of certain deferred tax assets and related adjustments within the measurement period.

XML

INVESTMENTS (Tables)

9 Months Ended

Sep. 30, 2022

Investments [Abstract]

Schedule of Investments

The carrying values of the Company’s investments in the Unaudited Condensed Consolidated Statements of Financial Position as of September 30, 2022 and December 31, 2021 are as follows:

Investments	September 30, 2022		December 31, 2021
Investments held at FV-NI	$	34,328	$	35,226
Total long-term investments	$	34,328	$	35,226

Schedule of Investment Income (Loss)

Income (loss) from investments, net in the Unaudited Condensed Consolidated Statements of Operations during the three and nine months ended September 30, 2022 and 2021 is as follows:

Investment income (loss)	Three Months Ended September 30,				Nine Months Ended September 30,
	2022		2021		2022		2021
Short-term investments	$	1	$	—	$	4	$	—
Investments held at FV-NI	16		489		150		(777)
Income (loss) from investments, net	$	17	$	489	$	154	$	(777)

XML

NOTES RECEIVABLE (Tables)

9 Months Ended

Sep. 30, 2022

Receivables [Abstract]

Schedule of Notes Receivable

Notes receivable as of September 30, 2022 and December 31, 2021 consisted of the following:

	September 30, 2022		December 31, 2021
Promissory notes receivable	$	34,257	$	27,260
Line of credit receivable	6,831		12,609
Interest receivable	3,524		2,834
Allowance for notes and interest receivables	(14,769)		(8,036)
Total notes receivable	$	29,843	$	34,667
Less: Notes receivable, current	2,500		7,104
Notes receivable, non-current	$	27,343	$	27,563

XML

CAPITAL ASSETS, net (Tables)

9 Months Ended

Sep. 30, 2022

Property, Plant and Equipment [Abstract]

Schedule of Capital Assets, net

Net property, plant and equipment consisted of:

	September 30, 2022		December 31, 2021
Land	$	3,828	$	3,777
Building	57,935		43,921
Right-of-use asset, finance leases	10,731		5,077
Furniture, fixtures and equipment	31,587		31,325
Leasehold improvements	37,399		51,646
Construction in progress	17,409		7,644
Capital assets, gross	$	158,889	$	143,390
Less: accumulated depreciation	(23,527)		(16,593)
Capital assets, net	$	135,362	$	126,797

XML

LEASES (Tables)

9 Months Ended

Sep. 30, 2022

Leases [Abstract]

Schedule of Lease Cost

Balance Sheet Information	Classification	September 30, 2022		December 31, 2021
Right-of-use assets
Operating	Operating lease right-of-use assets	$	22,730	$	24,598
Finance	Capital assets, net	9,986		4,522
Total right-of-use assets		$	32,716	$	29,120
Lease liabilities
Current
Operating	Operating lease liability, current	$	2,298	$	2,145
Financing	Debt, current	5,635		—
Non-current
Operating	Operating lease liability, non-current	22,324		24,255
Financing	Debt, non-current	5,290		5,245
Total lease liabilities		$	35,547	$	31,645

		Three Months Ended September 30,				Nine Months Ended September 30,
Statement of Operations Information	Classification	2022		2021		2022		2021
Short-term lease expense	General and administrative	$	(28)	$	(40)	$	190	$	17
Operating lease expense	General and administrative	1,221		1,038		3,613		3,175
Finance lease expense:
Amortization of right of use asset	Depreciation and amortization	63		63		190		190
Interest expense on lease liabilities	Interest expense	314		190		855		561
Sublease income	Other income (loss), net	—		—		—		(3)
Net operating and finance lease cost		$	1,598	$	1,291	$	4,658	$	3,923

		Nine Months Ended September 30,
Statement of Cash Flows Information	Classification	2022		2021
Cash paid for operating leases	Net cash used in operating activities	$	3,390	$	3,747
Cash paid for finance leases - interest	Net cash used in operating activities	$	843	$	508

Schedule of Operating Lease, Liability, Maturity

The following represents the Company’s future minimum payments required under existing leases with initial terms of one year or more as of September 30, 2022:

Maturity of lease liabilities	Operating Leases		Finance Leases
2022	$	1,147	$	5,858
2023	4,349		722
2024	4,310		743
2025	4,347		766
2026	4,428		789
Thereafter	20,285		12,487
Total lease payments	$	38,866	$	21,365
Less: interest	14,244		10,440
Present value of lease liabilities	$	24,622	$	10,925
Weighted average remaining lease term (years)	8		2
Weighted average discount rate	10%		12%

Schedule of Finance Lease, Liability, Maturity

The following represents the Company’s future minimum payments required under existing leases with initial terms of one year or more as of September 30, 2022:

Maturity of lease liabilities	Operating Leases		Finance Leases
2022	$	1,147	$	5,858
2023	4,349		722
2024	4,310		743
2025	4,347		766
2026	4,428		789
Thereafter	20,285		12,487
Total lease payments	$	38,866	$	21,365
Less: interest	14,244		10,440
Present value of lease liabilities	$	24,622	$	10,925
Weighted average remaining lease term (years)	8		2
Weighted average discount rate	10%		12%

XML

INVENTORY (Tables)

9 Months Ended

Sep. 30, 2022

Inventory Disclosure [Abstract]

Schedule of Inventory

The Company’s inventory balance consists of the following:

	September 30, 2022		December 31, 2021
Retail inventory	$	4,116	$	3,331
Wholesale inventory	37,143		28,643
Cultivation inventory	6,492		6,367
Supplies & other	3,141		3,463
Total	$	50,892	$	41,804

XML

DEBT (Tables)

9 Months Ended

Sep. 30, 2022

Debt Disclosure [Abstract]

Schedule of Debt

The Company’s debt balances consist of the following:

Debt balances	September 30, 2022		December 31, 2021
Financing liability (failed sale-leaseback)	$	15,253	$	15,253
Finance lease liabilities	10,925		5,245
7.50% Loan due April 2026	31,156		30,763
6.10% Secured debenture due September 2030	46,388		46,050
Note due December 2024	3,958		4,750
9.75% Credit facilities due January 2026	94,412		68,673
Total debt	$	202,092	$	170,734
Less: current portion of debt	7,218		1,583
Total long-term debt	$	194,874	$	169,151

Scheduled Maturities of Debt

Scheduled maturities of debt, excluding amortization of discount and issuance costs, are as follows:

2022	$	6,426
2023	1,583
2024	1,584
2025	—
2026	133,011
Thereafter	70,532
Total payments (excluding amortization of discount and issuance costs)	$	213,136

XML

SHAREHOLDERS’ EQUITY AND NON-CONTROLLING INTERESTS (Tables)

9 Months Ended

Sep. 30, 2022

Equity [Abstract]

Schedule of Stock by Class

The table below details the change in Pubco shares outstanding by class for the three and nine months ended September 30, 2022:

Shareholders’ Equity	Fixed Shares	Floating Shares	Fixed Shares Held in Treasury	Floating Shares Held in Treasury	Fixed Multiple Shares	Total Shares Outstanding
December 31, 2021	74,665	32,962	(589)	(253)	118	106,903
Issuances	3,897	969	—	—	—	4,866
NCI conversions	265	113	—	—	—	378
September 30, 2022	78,827	34,044	(589)	(253)	118	112,147

Schedule of Warrants

A summary of the warrants activity outstanding is as follows:

Warrants	Fixed Shares	Floating Shares
December 31, 2021	5,817	2,524
Expired	—	—
September 30, 2022	5,817	2,524

Schedule of Summarized Financial Information

Summarized financial information of HSCP is presented below. USCo2 does not have discrete financial information separate from HSCP.

HSCP net asset reconciliation	September 30, 2022			December 31, 2021
Current assets	$	93,253		$	113,011
Non-current assets	385,138			375,807
Current liabilities	(18,429)			(29,256)
Non-current liabilities	(220,299)			(195,791)
Other NCI balances	(723)			(718)
Accumulated equity-settled expenses	(239,592)			(226,596)
Net assets	$	(652)		$	36,457
HSCP/USCo2 ownership % of HSCP	16.36		%	17.24		%
Net assets allocated to USCo2/HSCP	$	(107)		$	6,285
Net assets attributable to other NCIs	723			718
Total NCI	$	616		$	7,003

	Three Months Ended September 30,						Nine Months Ended September 30,
HSCP Summarized Statement of Operations	2022			2021			2022			2021
Net loss allocable to HSCP/USCo2	$	(16,549)		$	(10,052)		$	(27,589)		$	(18,882)
HSCP/USCo2 weighted average ownership % of HSCP	16.84		%	17.57		%	16.96		%	17.80		%
Net loss allocated to HSCP/USCo2	$	(2,787)		$	(1,766)		$	(4,679)		$	(3,361)
Net loss allocated to other NCIs	3			5			4			14
Net loss attributable to NCIs	$	(2,784)		$	(1,761)		$	(4,675)		$	(3,347)

Schedule of Conversions of Stock

A reconciliation of the beginning and ending amounts of convertible units is as follows:

Convertible Units	September 30, 2022	December 31, 2021
Beginning balance	23,076	24,142
NCI units converted to Pubco	(378)	(1,066)
Ending balance	22,698	23,076

XML

EQUITY-BASED COMPENSATION EXPENSE (Tables)

9 Months Ended

Sep. 30, 2022

Share-Based Payment Arrangement [Abstract]

Schedule of Restricted Stock and Restricted Stock Unit, Activity

Restricted Share Units (“RSUs”)

	Fixed Shares			Floating Shares
Restricted Share Units (Fair value information expressed in whole dollars)	RSUs	Weighted Average Grant Date Fair Value		RSUs	Weighted Average Grant Date Fair Value
Unvested, January 1, 2022	3,188	$	7.30	1,262	$	7.39
Granted	7,717	$	0.67	95	$	1.19
Forfeited	(533)	$	2.07	(83)	$	2.54
Vested	(3,811)	$	4.08	(764)	$	7.90
Unvested, September 30, 2022	6,561	$	1.80	510	$	6.27
Vested and unreleased(1)	225	$	5.80	24	$	15.15
Outstanding, September 30, 2022	6,786	$	1.93	534	$	6.67

(1) RSUs that are vested and unreleased represent RSUs that are pending delivery.

Schedule of Option Activity

Stock options

	Fixed Shares			Floating Shares
Stock Options (Exercise price expressed in whole dollars)	Options	Weighted Average Exercise Price		Options	Weighted Average Exercise Price
Options outstanding, January 1, 2022	1,529	$	11.07	2,414	$	3.06
Granted	5,849	$	0.59	—	$	—
Forfeited	(41)	$	5.66	(91)	$	2.57
Expired	—	$	—	(20)	$	2.55
Options outstanding, September 30, 2022	7,337	$	2.75	2,303	$	3.09
Options exercisable, September 30, 2022	1,229	$	12.85	1,925	$	3.14

XML

EARNINGS PER SHARE (Tables)

9 Months Ended

Sep. 30, 2022

Earnings Per Share [Abstract]

Schedule of Earnings Per Share, Basic and Diluted

Basic and diluted loss per share is as follows:

	Three Months Ended September 30,				Nine Months Ended September 30,
	2022		2021		2022		2021
Net loss attributable to common shareholders of the Company	$	(22,214)	$	(12,296)	$	(44,837)	$	(22,657)
Weighted average shares outstanding - basic	111,200		106,332		108,795		104,524
Effect of dilutive securities	—		—		—		—
Weighted average shares - diluted	111,200		106,332		108,795		104,524
Net loss per share attributable to common shareholders of the Company - basic	$	(0.20)	$	(0.12)	$	(0.41)	$	(0.22)
Net loss per share attributable to common shareholders of the Company - diluted	$	(0.20)	$	(0.12)	$	(0.41)	$	(0.22)

XML

NATURE OF OPERATIONS (Details) $ in Thousands	Sep. 23, 2020 USD ($) shares	Jun. 27, 2019	Sep. 30, 2022
Class of Stock [Line Items]
Share conversion (percentage)		0.5818
6.10% Secured debenture due September 2030
Class of Stock [Line Items]
Interest rate (percent)			6.10%
6.10% Secured debenture due September 2030 | Universal Hemp
Class of Stock [Line Items]
Interest rate (percent)			6.10%
Universal Hemp | Canopy Growth | Canopy Growth | Debenture | Universal Hemp
Class of Stock [Line Items]
Debenture amount, amount advanced | $	$ 50,000
Fixed Shares
Class of Stock [Line Items]
Percent of share - canopy reorganization	0.7
Floating Shares
Class of Stock [Line Items]
Percent of share - canopy reorganization	0.3
PVS, Fixed Shares
Class of Stock [Line Items]
Canopy reorganization, shares exchanged (in shares)	28
PVS, Floating Shares
Class of Stock [Line Items]
Canopy reorganization, shares exchanged (in shares)	12
Fixed Multiple Share
Class of Stock [Line Items]
Percent of share - canopy reorganization	0.7
Floating Multiple Share
Class of Stock [Line Items]
Percent of share - canopy reorganization	0.3

XML

SIGNIFICANT ACCOUNTING POLICIES (Details) - USD ($) shares in Thousands, $ in Thousands	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
Accounting Policies [Abstract]
Cash and cash equivalents	$ 26,476	$ 27,868	$ 43,180
Restricted cash	95	$ 1,098	1,098
Allowance for doubtful accounts	63		445
Unrecognized tax benefits	$ 6,161		$ 7,695
Antidilutive shares (in shares)	47,999	42,621

XML

ACQUISITIONS, DIVESTITURES AND ASSETS HELD FOR SALE (Schedule of Purchase Price Allocation) (Details) - USD ($) $ in Thousands		12 Months Ended
	Jul. 02, 2018	Dec. 31, 2021	Sep. 30, 2022	Oct. 01, 2021
Purchase Price Allocation
Goodwill		$ 43,310	$ 30,492
CWG
Purchase Price Allocation
Cash and cash equivalents		828
Inventory		1,200
Other current assets		347
Capital assets, net		3,312
Operating lease right-of-use asset		1,584
Goodwill		1,482
Other non-current assets		40
Accounts payable and accrued liabilities		(464)
Taxes payable		(68)
Operating lease liability, current		(193)
Other current liabilities		3
Operating lease liability, non-current		(1,391)
Fair value of net assets acquired		10,880
Consideration paid:
Settlement of pre-existing relationship		10,880
Total consideration		10,880
CWG | Intangible assets, net - cannabis licenses
Purchase Price Allocation
Intangible assets, net		3,200
CWG | Intangible assets, net - customer relationships
Purchase Price Allocation
Intangible assets, net		1,000
Greenleaf
Purchase Price Allocation
Cash and cash equivalents		1,209
Inventory		2,692
Other current assets		1,520
Capital assets, net		22,923
Operating lease right-of-use asset		2,819
Goodwill		1,819
Intangible assets, net				$ 2,953
Other non-current assets		189
Accounts payable and accrued liabilities		(1,829)
Taxes payable		(33)
Operating lease liability, current		(315)
Other current liabilities		(294)
Operating lease liability, non-current		(2,504)
Fair value of net assets acquired		44,996
Consideration paid:
Settlement of pre-existing relationship		44,996
Total consideration	$ 8,245	44,996
Greenleaf | Intangible assets, net - cannabis licenses
Purchase Price Allocation
Intangible assets, net		16,800
Greenleaf | Intangible assets, net - customer relationships
Purchase Price Allocation
Intangible assets, net		0
Total
Purchase Price Allocation
Cash and cash equivalents		2,037
Inventory		3,892
Other current assets		1,867
Capital assets, net		26,235
Operating lease right-of-use asset		4,403
Goodwill		3,301
Other non-current assets		229
Accounts payable and accrued liabilities		(2,293)
Taxes payable		(101)
Operating lease liability, current		(508)
Other current liabilities		(291)
Operating lease liability, non-current		(3,895)
Fair value of net assets acquired		55,876
Consideration paid:
Settlement of pre-existing relationship		55,876
Total consideration		55,876
Total | Intangible assets, net - cannabis licenses
Purchase Price Allocation
Intangible assets, net		20,000
Total | Intangible assets, net - customer relationships
Purchase Price Allocation
Intangible assets, net		$ 1,000

XML

ACQUISITIONS, DIVESTITURES AND ASSETS HELD FOR SALE (Narrative) (Details) $ / shares in Units, shares in Millions					1 Months Ended		3 Months Ended		9 Months Ended		12 Months Ended
	Oct. 01, 2021 USD ($)	Apr. 30, 2021 USD ($)	Mar. 19, 2021 USD ($)	Jul. 02, 2018 USD ($) $ / shares shares	Jul. 31, 2022 USD ($) dispensary	Sep. 30, 2021 USD ($) dispensary	Sep. 30, 2022 USD ($)	Sep. 30, 2021 USD ($)	Sep. 30, 2022 USD ($)	Sep. 30, 2021 USD ($)	Dec. 31, 2021 USD ($)	Apr. 30, 2022 USD ($)	Mar. 31, 2022 USD ($)	Apr. 27, 2021 USD ($)	Feb. 28, 2021 USD ($)
Business Acquisition [Line Items]
De-recognized deferred tax liability									$ 889,000	$ 8,125,000
Write down (recovery) of assets held-for-sale							$ 0	$ 0	874,000	(8,616,000)
Oregon
Business Acquisition [Line Items]
Number of dispensaries to be sold | dispensary					4
Acreage Florida, Inc.
Business Acquisition [Line Items]
De-recognized deferred tax liability										6,044,000
Discontinued Operations, Disposed of by Sale | Medford Cultivation and Processing Facility
Business Acquisition [Line Items]
Promissory notes												$ 2,000,000			$ 3,000,000
Disposal group, not discontinued operation, gain on disposal									290,000
De-recognized deferred tax liability									375,000
Discontinued Operations, Disposed of by Sale | Acreage Florida, Inc.
Business Acquisition [Line Items]
Promissory notes						$ 60,000,000		60,000,000		60,000,000
Gain on sale										11,682,000
Held-for-sale | Medford Cultivation and Processing Facility
Business Acquisition [Line Items]
Promissory notes													$ 2,000,000
Held-for-sale | Oregon
Business Acquisition [Line Items]
Promissory notes					$ 6,200,000	$ 6,500,000		6,500,000		6,500,000
Disposal group, not discontinued operation, gain on disposal									$ 3,189,000
Number of dispensaries to be sold | dispensary						4
Cash consideration					100,000	$ 250,000
Remaining balance to acquire businesses					$ 5,850,000
Promissory note term					36 months
Promissory note stated interest rate (percent)					12.00%
Annual principal payments					$ 1,000,000
Disposed of by Sale, Additional Cash | Medford Cultivation and Processing Facility
Business Acquisition [Line Items]
Promissory notes															750,000
Disposed of by Sale, Additional Cash | Acreage Florida, Inc.
Business Acquisition [Line Items]
Promissory notes						21,500,000		21,500,000		21,500,000
Disposed of by Sale, Promissory Note | Medford Cultivation and Processing Facility
Business Acquisition [Line Items]
Promissory notes															$ 1,250,000
Disposed of by Sale, Promissory Note | Acreage Florida, Inc.
Business Acquisition [Line Items]
Promissory notes						31,500,000		31,500,000		31,500,000
Remaining balance to acquire businesses											$ 31,500,000			$ 31,500,000
Disposed of by Sale, Promissory Note | Viridescent Realty Trust, Inc | Notes Receivable
Business Acquisition [Line Items]
Disposal group, not discontinued operation, gain on disposal										(2,000,000)
Remaining balance to acquire businesses						28,000,000		28,000,000		28,000,000
Gain (Loss) on Sale of Financing Receivable										2,000,000
Disposed of by Sale, Common Stock | Acreage Florida, Inc.
Business Acquisition [Line Items]
Promissory notes						$ 7,000,000		$ 7,000,000		$ 7,000,000
Lock up period										1 year
Greenleaf
Business Acquisition [Line Items]
Total purchase price	$ 44,996,000
Greenleaf
Business Acquisition [Line Items]
Percentage of voting interests acquired (percent)	100.00%
Total consideration				$ 8,245,000							44,996,000
Sellers notes issued	$ 42,043,000			$ 6,096,000
Number of shares issued (in shares) | shares				1.2
Share price (USD per share) | $ / shares				$ 7.73
Line of credit issued				$ 31,200,000
Payments to acquire notes receivable	3,300,000
Intangible assets, net	$ 2,953,000
Settlement of pre-existing relationship											44,996,000
Greenleaf | Promissory Note
Business Acquisition [Line Items]
Promissory notes issued				$ 12,500,000
CWG
Business Acquisition [Line Items]
Percentage of voting interests acquired (percent)		100.00%
Total consideration											10,880,000
Settlement of pre-existing relationship											$ 10,880,000
CWG | Line of Credit
Business Acquisition [Line Items]
Total consideration		$ 9,321,000
Settlement of pre-existing relationship		$ 1,559,000
NCC Real Estate, LLC
Business Acquisition [Line Items]
Total consideration			$ 850,000
Fair value of previously held interest			$ 286,000

XML

ACQUISITIONS, DIVESTITURES AND ASSETS HELD FOR SALE (Assets Held for Sale) (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Total current assets classified as held-for-sale	$ 0	$ 8,952
Total current liabilities classified as held-for-sale	$ 0	(1,867)
Held-for-sale
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Cash		223
Inventory		445
Notes receivable, current		31
Other current assets		9
Total current assets classified as held-for-sale		708
Capital assets, net		4,249
Operating lease right-of-use assets		1,695
Goodwill		2,191
Non-current assets		109
Total assets classified as held for sale		8,952
Accounts payable and accrued liabilities		(639)
Operating lease liability, current		(441)
Total current liabilities classified as held-for-sale		(1,080)
Operating lease liability, non-current		(787)
Total liabilities classified as held-for-sale		(1,867)
Held-for-sale | Michigan
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Cash		0
Inventory		0
Notes receivable, current		0
Other current assets		0
Total current assets classified as held-for-sale		0
Capital assets, net		1,907
Operating lease right-of-use assets		0
Goodwill		0
Non-current assets		0
Total assets classified as held for sale		1,907
Accounts payable and accrued liabilities		0
Operating lease liability, current		0
Total current liabilities classified as held-for-sale		0
Operating lease liability, non-current		0
Total liabilities classified as held-for-sale		0
Held-for-sale | Oregon
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Cash		223
Inventory		445
Notes receivable, current		31
Other current assets		9
Total current assets classified as held-for-sale		708
Capital assets, net		2,342
Operating lease right-of-use assets		1,695
Goodwill		2,191
Non-current assets		109
Total assets classified as held for sale		7,045
Accounts payable and accrued liabilities		(639)
Operating lease liability, current		(441)
Total current liabilities classified as held-for-sale		(1,080)
Operating lease liability, non-current		(787)
Total liabilities classified as held-for-sale		$ (1,867)

XML

INTANGIBLE ASSETS AND GOODWILL (Schedule of Intangible Assets) (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Finite-Lived Intangible Assets [Line Items]
Total finite-lived intangible assets	$ 2,808	$ 2,511
Total accumulated amortization on finite-lived intangible assets	(1,781)	(493)
Finite-lived intangible assets, net	1,027	2,018
Indefinite-lived intangible assets	134,780	117,677
Total intangibles, net	135,807	119,695
Management contracts
Finite-Lived Intangible Assets [Line Items]
Total finite-lived intangible assets	1,808	1,511
Total accumulated amortization on finite-lived intangible assets	(931)	(493)
Customer relationships
Finite-Lived Intangible Assets [Line Items]
Total finite-lived intangible assets	1,000	1,000
Total accumulated amortization on finite-lived intangible assets	$ (850)	$ 0

XML

INTANGIBLE ASSETS AND GOODWILL (Intangible Asset Narrative) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Acquired Indefinite-lived Intangible Assets [Line Items]
Goodwill re-allocated			$ 16,500
Impairment of intangible assets, finite-lived				$ 818
Reversal of deferred tax liabilities				207
Deferred tax (income) expense			(889)	(8,125)
Amortization of intangible assets	$ 296	$ 3,117	1,288	7,588
Greenleaf
Acquired Indefinite-lived Intangible Assets [Line Items]
Goodwill re-allocated	16,800		16,800
Intangible assets, adjustments	$ 16,800		$ 16,800
Acreage Florida, Inc.
Acquired Indefinite-lived Intangible Assets [Line Items]
Deferred tax (income) expense				$ (6,044)
Minimum
Acquired Indefinite-lived Intangible Assets [Line Items]
Useful life			3 months 18 days
Maximum
Acquired Indefinite-lived Intangible Assets [Line Items]
Useful life			1 year 6 months
Customer-Related Intangible Assets
Acquired Indefinite-lived Intangible Assets [Line Items]
Useful life			3 months 18 days
Management contracts
Acquired Indefinite-lived Intangible Assets [Line Items]
Useful life			1 year 6 months

XML

INTANGIBLE ASSETS AND GOODWILL (Future Amortization Table) (Details) $ in Thousands	Sep. 30, 2022 USD ($)
Goodwill and Intangible Assets Disclosure [Abstract]
2022	$ 297
2023	584
2024	146
2025	0
2026	$ 0

XML

INTANGIBLE ASSETS AND GOODWILL (Goodwill) (Details) $ in Thousands	9 Months Ended
	Sep. 30, 2022 USD ($)
Goodwill [Roll Forward]
Beginning balance	$ 43,310
Goodwill re-allocated	(16,500)
Other Adjustments	3,682
Ending balance	$ 30,492

XML

INVESTMENTS (Schedule Investment Holdings) (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Investments [Abstract]
Investments held at FV-NI	$ 34,328	$ 35,226
Total long-term investments	$ 34,328	$ 35,226

XML

INVESTMENTS (Schedule of Investment Income) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Net Investment Income [Line Items]
Income (loss) from investments, net	$ 17	$ 489	$ 154	$ (777)
Short-term investments
Net Investment Income [Line Items]
Income (loss) from investments, net	1	0	4	0
Investments held at FV-NI
Net Investment Income [Line Items]
Income (loss) from investments, net	$ 16	$ 489	$ 150	$ (777)

XML

INVESTMENTS (Narrative) (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	Sep. 28, 2020	Sep. 23, 2020	Sep. 30, 2022
Subsidiary or Equity Method Investee [Line Items]
Proceeds from secured debenture		$ 50,000
Amount invested	$ 34,019
6.10% Secured debenture due September 2030
Subsidiary or Equity Method Investee [Line Items]
Interest rate (percent)		6.10%	6.10%
Universal Hemp | Investment Partnership
Subsidiary or Equity Method Investee [Line Items]
Financial interest in the Investment partnership	100.00%
Universal Hemp | Investment Partnership | Investment Partnership
Subsidiary or Equity Method Investee [Line Items]
Financial interest in the Investment partnership	100.00%
Universal Hemp | Class B Units | Investment Partnership
Subsidiary or Equity Method Investee [Line Items]
Number of shares acquired (in shares)	34,019
Par value (USD per share)	$ 1
Universal Hemp | Class B Units | Investment Partnership | Investment Partnership
Subsidiary or Equity Method Investee [Line Items]
Financial interest in the Investment partnership	100.00%

XML

NOTES RECEIVABLE (Schedule of Notes Receivable) (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Accounts, Notes, Loans and Financing Receivable [Line Items]
Interest receivable	$ 3,524	$ 2,834
Allowance for notes and interest receivables	(14,769)	(8,036)
Total notes receivable	29,843	34,667
Less: Notes receivable, current	2,500	7,104
Notes receivable, non-current	27,343	27,563
Promissory notes receivable
Accounts, Notes, Loans and Financing Receivable [Line Items]
Principal outstanding	34,257	27,260
Line of credit receivable
Accounts, Notes, Loans and Financing Receivable [Line Items]
Principal outstanding	$ 6,831	$ 12,609

XML

NOTES RECEIVABLE (Narrative) (Details) $ in Thousands			1 Months Ended					3 Months Ended		9 Months Ended		12 Months Ended
	Feb. 10, 2022 USD ($)	Apr. 27, 2021 USD ($) promissor_Note	Jul. 31, 2022 USD ($) dispensary	Apr. 30, 2022 USD ($)	Sep. 30, 2021 USD ($) dispensary	Jun. 30, 2021 USD ($) segment	May 31, 2021 promissor_Note	Sep. 30, 2022 USD ($)	Sep. 30, 2021 USD ($)	Sep. 30, 2022 USD ($)	Sep. 30, 2021 USD ($) payment	Dec. 31, 2021 USD ($)	Aug. 31, 2022 USD ($)	Apr. 30, 2021
Accounts, Notes, Loans and Financing Receivable [Line Items]
Interest income from loans receivable								$ 474	$ 1,067	$ 1,256	$ 4,125
Allowance for credit loss								14,769		14,769		$ 8,036
Loss on notes receivable								7,219	0	7,219	1,726
Collection of notes receivable	$ 5,279
Collection of notes receivable										7,106	13,225
Number of promissory notes sold | promissor_Note							2
CWG
Accounts, Notes, Loans and Financing Receivable [Line Items]
Percentage of voting interests acquired (percent)														100.00%
Oregon
Accounts, Notes, Loans and Financing Receivable [Line Items]
Number of dispensaries to be sold | dispensary			4
Held-for-sale | Oregon
Accounts, Notes, Loans and Financing Receivable [Line Items]
Promissory note term			36 months
Secured promissory note			$ 5,850
Promissory note stated interest rate (percent)			12.00%
Number of dispensaries to be sold | dispensary					4
Disposal group, not discontinued operation, gain on disposal										(3,189)
Disposed of by Sale, Promissory Note | Acreage Florida, Inc.
Accounts, Notes, Loans and Financing Receivable [Line Items]
Secured promissory note		$ 31,500										31,500
Number of secured promissory notes | promissor_Note		3
Principal
Accounts, Notes, Loans and Financing Receivable [Line Items]
Allowance for credit loss								12,292		12,292		6,046
Accrued Interest
Accounts, Notes, Loans and Financing Receivable [Line Items]
Allowance for credit loss								$ 2,477		$ 2,477		1,990
Notes Receivable | Disposed of by Sale, Promissory Note | Acreage North Dakota, LLC
Accounts, Notes, Loans and Financing Receivable [Line Items]
Collection of notes receivable												$ 3,500
Notes Receivable | Disposed of by Sale, Promissory Note | Viridescent Realty Trust, Inc
Accounts, Notes, Loans and Financing Receivable [Line Items]
Secured promissory note					$ 28,000				28,000		28,000
Collection of notes receivable						$ 26,000
Number of promissory notes sold | segment						2
Disposal group, not discontinued operation, gain on disposal											2,000
Interest Bearing Notes Receivable | Oregon
Accounts, Notes, Loans and Financing Receivable [Line Items]
Promissory note term				12 months
Secured promissory note				$ 1,250									$ 500
Promissory note stated interest rate (percent)				12.50%									12.50%
Non-interest Bearing Notes Receivable | Oregon
Accounts, Notes, Loans and Financing Receivable [Line Items]
Non - interest secured promissory note													$ 750
PATC
Accounts, Notes, Loans and Financing Receivable [Line Items]
Management fee expense											$ 2,500
Number of payments | payment											7
Maximum obligation					$ 7,150				$ 7,150		$ 7,150

XML

CAPITAL ASSETS, net (Details) - USD ($)	1 Months Ended	3 Months Ended		9 Months Ended
	Aug. 31, 2021	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
Property, Plant and Equipment [Line Items]
Right-of-use asset, finance leases		$ 10,731,000		$ 10,731,000		$ 5,077,000
Capital assets, gross		158,889,000		158,889,000		143,390,000
Less: accumulated depreciation		(23,527,000)		(23,527,000)		(16,593,000)
Capital assets, net		135,362,000		135,362,000		126,797,000
Depreciation		751,000	$ 928,000	4,731,000	$ 2,083,000
Depreciation capitalized to inventory		1,963,000	876,000	5,679,000	$ 2,567,000
Tornado Formation from Hurricane Ida
Property, Plant and Equipment [Line Items]
Loss from natural disaster, gross	$ 9,130,000
Loss from natural disaster, insurance proceeds	$ 7,000,000
Loss from natural disaster, net of insurance proceeds			$ 2,130,000
Assets related to Michigan Operations
Property, Plant and Equipment [Line Items]
Fair value of assets held for sale		0		0
Impairment				1,907,000
Land
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross		3,828,000		3,828,000		3,777,000
Building
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross		57,935,000		57,935,000		43,921,000
Furniture, fixtures and equipment
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross		31,587,000		31,587,000		31,325,000
Leasehold improvements
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross		37,399,000		37,399,000		51,646,000
Construction in progress
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross		$ 17,409,000		$ 17,409,000		$ 7,644,000

XML

LEASES (Balance Sheet Information) (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Right-of-use assets
Operating	$ 22,730	$ 24,598
Finance	9,986	4,522
Total right-of-use assets	32,716	29,120
Lease liabilities
Operating lease liability, current	2,298	2,145
Finance lease liability, current	5,635	0
Operating lease liability, non-current	22,324	24,255
Finance lease liability, noncurrent	5,290	5,245
Total lease liabilities	$ 35,547	$ 31,645
Finance lease, right-of-use asset, statement of financial position	Capital assets, net	Capital assets, net
Finance lease, liability, current, statement of financial position, extensible list	Debt, current	Debt, current
Finance lease, liability, non-current, statement of financial position, extensible list	Debt, non-current	Debt, non-current

XML

LEASES (Income Statement Information) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Leases [Abstract]
Short-term lease expense	$ (28)	$ (40)	$ 190	$ 17
Operating lease expense	1,221	1,038	3,613	3,175
Amortization of right of use asset	63	63	190	190
Interest expense on lease liabilities	314	190	855	561
Sublease income	0	0	0	(3)
Net operating and finance lease cost	$ 1,598	$ 1,291	$ 4,658	$ 3,923

XML

LEASES (Cash Flow Statement Information) (Details) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Leases [Abstract]
Cash paid for operating leases	$ 3,390	$ 3,747
Cash paid for finance leases - interest	$ 843	$ 508

XML

LEASES (Lease Maturities) (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Operating Leases
2022	$ 1,147
2023	4,349
2024	4,310
2025	4,347
2026	4,428
Thereafter	20,285
Total lease payments	38,866
Less: interest	14,244
Present value of lease liabilities	$ 24,622
Weighted average remaining lease term (years)	8 years
Weighted average discount rate	10.00%
Finance Leases
2022	$ 5,858
2023	722
2024	743
2025	766
2026	789
Thereafter	12,487
Total lease payments	21,365
Less: interest	10,440
Present value of lease liabilities	$ 10,925	$ 5,245
Weighted average remaining lease term (years)	2 years
Weighted average discount rate	12.00%

XML

LEASES (Narrative) (Details)	Sep. 30, 2022 lease
Leases [Abstract]
Number of leases not yet commenced	0

XML

INVENTORY (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Inventory Disclosure [Abstract]
Retail inventory	$ 4,116	$ 3,331
Wholesale inventory	37,143	28,643
Cultivation inventory	6,492	6,367
Supplies & other	3,141	3,463
Total	$ 50,892	$ 41,804

XML

INVENTORY (Narrative) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Inventory Disclosure [Abstract]
Inventory write-down	$ 6,286		$ 6,286
Loss on impairment	$ 506	$ 2,339	$ 2,973	$ 3,157

XML

DEBT (Schedule of Debt) (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021	Dec. 16, 2021	Sep. 28, 2020
Debt Instrument [Line Items]
Financing liability (failed sale-leaseback)	$ 15,253	$ 15,253
Finance lease liabilities	10,925	5,245
Total debt	202,092	170,734
Less: current portion of debt	7,218	1,583
Total long-term debt	$ 194,874	169,151
7.50% Loan due April 2026
Debt Instrument [Line Items]
Interest rate (percent)	7.50%			7.50%
Loans	$ 31,156	30,763
6.10% Secured debenture due September 2030
Debt Instrument [Line Items]
Interest rate (percent)	6.10%
Loans	$ 46,388	46,050
Note due December 2024
Debt Instrument [Line Items]
Loans	$ 3,958	4,750
9.75% Credit facilities due January 2026
Debt Instrument [Line Items]
Interest rate (percent)	9.75%		9.75%
Loans	$ 94,412	$ 68,673

XML

DEBT (Maturities) (Details) $ in Thousands	Sep. 30, 2022 USD ($)
Debt Disclosure [Abstract]
2022	$ 6,426
2023	1,583
2024	1,584
2025	0
2026	133,011
Thereafter	70,532
Total payments (excluding amortization of discount and issuance costs)	$ 213,136

XML

DEBT (Narrative) (Details) $ / shares in Units, shares in Thousands				1 Months Ended		3 Months Ended		9 Months Ended
	Dec. 16, 2021 USD ($) leverage_ratio	Sep. 28, 2020 USD ($) $ / shares shares	Sep. 23, 2020 USD ($)	Apr. 30, 2022 USD ($)	Nov. 30, 2020 USD ($) payment	Sep. 30, 2022 USD ($)	Sep. 30, 2021 USD ($)	Sep. 30, 2022 USD ($)	Sep. 30, 2021 USD ($)	Dec. 31, 2021 USD ($)
Debt Instrument [Line Items]
Interest expense						$ 5,688,000	$ 3,620,000	$ 15,989,000	$ 14,072,000
Amortization of debt issuance costs						381,000	298,000	1,132,000	821,000
Debt discount amortization						297,000	$ 493,000	849,000	2,914,000
Discounts						5,062,000		5,062,000		$ 6,194,000
Debt issuance costs						5,982,000		5,982,000		6,320,000
Interest payable						$ 1,167,000		1,167,000		$ 1,432,000
Amount invested		$ 34,019,000
Repayment of short-term debt		$ 18,000,000
Amendment fee	$ 413,000
Number of debt payments | payment					10
Proceeds from issuance of debt								$ 25,000,000	$ 6,301,000
CanWell Settlement
Debt Instrument [Line Items]
Accrued loss contingency loss					$ 7,750,000
Universal Hemp | Investment Partnership
Debt Instrument [Line Items]
Financial interest in the Investment partnership		100.00%
11065220 Canada Inc | Canopy Growth | Canopy Growth
Debt Instrument [Line Items]
Face amount			$ 100,000,000
Investment Partnership | Universal Hemp | Investment Partnership
Debt Instrument [Line Items]
Financial interest in the Investment partnership		100.00%
Universal Hemp | Universal Hemp
Debt Instrument [Line Items]
Amount invested		$ 34,019,000
Class B Units | Investment Partnership | Universal Hemp
Debt Instrument [Line Items]
Number of shares acquired (in shares) | shares		34,019
Par value (USD per share) | $ / shares		$ 1
Class B Units | Investment Partnership | Universal Hemp | Investment Partnership
Debt Instrument [Line Items]
Financial interest in the Investment partnership		100.00%
Class A Units | Investment Partnership | Universal Hemp
Debt Instrument [Line Items]
Amount invested		$ 1,019,000
Debenture | 11065220 Canada Inc | Canopy Growth | Canopy Growth
Debt Instrument [Line Items]
Interest rate (percent)			6.10%
Debenture amount, amount advanced			$ 50,000,000
Debenture amount, amount to be advanced			$ 50,000,000
Debt term			10 years
Debenture | Universal Hemp | Canopy Growth | Canopy Growth | Universal Hemp
Debt Instrument [Line Items]
Debenture amount, amount advanced			$ 50,000,000
Debt issuance costs			$ 4,025,000
6.10% Secured debenture due September 2030
Debt Instrument [Line Items]
Interest rate (percent)			6.10%			6.10%		6.10%
Securities Purchase Agreement | Convertible Debt
Debt Instrument [Line Items]
Repayment of short-term debt		$ 11,000,000
7.50% Loan due April 2026
Debt Instrument [Line Items]
Interest rate (percent)		7.50%				7.50%		7.50%
Debenture amount, amount advanced		$ 33,000,000
Debt issuance costs		$ 959,000
Debt term		3 years
9.75% Credit facilities due January 2026
Debt Instrument [Line Items]
Discounts	4,000,000
Debt issuance costs	$ 1,500,000
Interest rate (percent)	9.75%					9.75%		9.75%
Face amount	$ 150,000,000
Proceeds from issuance of debt	$ 75,000,000
Collateral assignment agreements percent	1.00%
Unused line fee, percentage	3.00%
Number of leverage ratios | leverage_ratio	2
Fee amount	$ 500,000
9.75% Credit Facilities Due January 2026, Initial Draw
Debt Instrument [Line Items]
Face amount	75,000,000
9.75% Credit Facilities Due January 2026, Delayed Draw
Debt Instrument [Line Items]
Face amount	$ 25,000,000
Proceeds from delayed draw facility				$ 25,000,000
Delayed draw, term for issuance	12 months
9.75% Credit Facilities Due January 2026, Committed Accordion Facility
Debt Instrument [Line Items]
Face amount	$ 50,000,000
6.10% Secured debenture due September 2030
Debt Instrument [Line Items]
Interest rate (percent)						6.10%		6.10%
6.10% Secured debenture due September 2030 | Universal Hemp
Debt Instrument [Line Items]
Interest rate (percent)						6.10%		6.10%

XML

SHAREHOLDERS’ EQUITY AND NON-CONTROLLING INTERESTS (Schedule of Stock by Class) (Details) shares in Thousands	9 Months Ended
	Sep. 30, 2022 shares
Class Of Stock [Roll Forward]
Common stock, outstanding, beginning (in shares)	106,903
Treasury stock, period start (in shares)	(842)
Common stock, outstanding, ending (in shares)	112,147
Treasury stock, period end (in shares)	(842)
Fixed Shares | Pubco
Class Of Stock [Roll Forward]
Common stock, outstanding, beginning (in shares)	74,665
Issuances (in shares)	3,897
NCI conversions (shares)	265
Common stock, outstanding, ending (in shares)	78,827
Floating Shares | Pubco
Class Of Stock [Roll Forward]
Common stock, outstanding, beginning (in shares)	32,962
Issuances (in shares)	969
NCI conversions (shares)	113
Common stock, outstanding, ending (in shares)	34,044
Fixed Shares Held in Treasury | Pubco
Class Of Stock [Roll Forward]
Treasury stock, period start (in shares)	(589)
Issuances (in shares)	0
NCI conversions (shares)	0
Treasury stock, period end (in shares)	(589)
Floating Shares Held in Treasury | Pubco
Class Of Stock [Roll Forward]
Treasury stock, period start (in shares)	(253)
Issuances (in shares)	0
NCI conversions (shares)	0
Treasury stock, period end (in shares)	(253)
Fixed Multiple Shares | Pubco
Class Of Stock [Roll Forward]
Common stock, outstanding, beginning (in shares)	118
Issuances (in shares)	0
NCI conversions (shares)	0
Common stock, outstanding, ending (in shares)	118
Total Shares Outstanding | Pubco
Class Of Stock [Roll Forward]
Common stock, outstanding, beginning (in shares)	106,903
Issuances (in shares)	4,866
NCI conversions (shares)	378
Common stock, outstanding, ending (in shares)	112,147

XML

SHAREHOLDERS’ EQUITY AND NON-CONTROLLING INTERESTS (Warrants) (Details) shares in Thousands	9 Months Ended
	Sep. 30, 2022 shares
Fixed Shares
Class Of Warrant Or Right [Roll Forward]
Beginning balance (in shares)	5,817
Expired (in shares)	0
Ending balance (in shares)	5,817
Floating Shares
Class Of Warrant Or Right [Roll Forward]
Beginning balance (in shares)	2,524
Expired (in shares)	0
Ending balance (in shares)	2,524

XML

SHAREHOLDERS’ EQUITY AND NON-CONTROLLING INTERESTS (Warrants Narrative) (Details)	9 Months Ended
	Sep. 30, 2022 USD ($) $ / shares
Class of Warrant or Right [Line Items]
Warrants term	4 years
Warrant contractual weighted average life remaining (in years)	2 years 4 months 24 days
Aggregate intrinsic value | $	$ 0
Fixed Shares | Minimum
Class of Warrant or Right [Line Items]
Exercise price (USD per share)	$ 3.15
Fixed Shares | Maximum
Class of Warrant or Right [Line Items]
Exercise price (USD per share)	4.00
Floating Shares | Minimum
Class of Warrant or Right [Line Items]
Exercise price (USD per share)	3.01
Floating Shares | Maximum
Class of Warrant or Right [Line Items]
Exercise price (USD per share)	$ 4.00

XML

SHAREHOLDERS’ EQUITY AND NON-CONTROLLING INTERESTS (NCI Narrative) (Details) $ in Thousands	3 Months Ended						9 Months Ended
	Sep. 30, 2022 USD ($)	Jun. 30, 2022 USD ($)	Mar. 31, 2022 USD ($)	Sep. 30, 2021 USD ($)	Jun. 30, 2021 USD ($)	Mar. 31, 2021 USD ($)	Sep. 30, 2022 USD ($)	Sep. 30, 2021 USD ($)
Class of Stock [Line Items]
USCo2 conversion, fixed share	0.7						0.7
USCo2 conversion, floating share	0.3						0.3
USCo2 Ownership of HSCP	0.22%						0.22%
HSCP ownership by LLC members	16.14%						16.14%
HSCP owned by Pubco	83.64%						83.64%
NCI adjustments for changes in ownership	$ 0	$ 0	$ 0	$ 0	$ 0	$ 0
Non-controlling Interests
Class of Stock [Line Items]
NCI adjustments for changes in ownership	$ (697)	$ 4,524	$ (5)	$ (76)	$ 1,463	$ (601)	$ 55	$ 862

XML

SHAREHOLDERS’ EQUITY AND NON-CONTROLLING INTERESTS (Noncontrolling Interest Balance Sheet Allocation) (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Subsidiary-specific information [Line Items]
Current assets	$ 93,272	$ 112,979
Non-current assets	389,625	378,572
Current liabilities	(76,505)	(66,793)
Non-current liabilities	(248,198)	(220,488)
Total NCI	616	7,003
HSCP LLC
Subsidiary-specific information [Line Items]
Current assets	93,253	113,011
Non-current assets	385,138	375,807
Current liabilities	(18,429)	(29,256)
Non-current liabilities	(220,299)	(195,791)
Other NCI balances	(723)	(718)
Accumulated equity-settled expenses	(239,592)	(226,596)
Net assets	(652)	36,457
Net assets allocated to USCo2/HSCP	(107)	6,285
Net assets attributable to other NCIs	$ 723	$ 718
HSCP LLC | HSCP/USCo2
Subsidiary-specific information [Line Items]
HSCP/USCo2 ownership % of HSCP	16.36%	17.24%

XML

SHAREHOLDERS’ EQUITY AND NON-CONTROLLING INTERESTS (Noncontrolling Interest, P&L Allocation) (Details) - USD ($) $ in Thousands	3 Months Ended						9 Months Ended
	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2021	Sep. 30, 2022	Sep. 30, 2021
Subsidiary-specific information [Line Items]
Net loss allocable to HSCP/USCo2	$ (24,998)	$ (10,603)	$ (13,911)	$ (14,057)	$ (3,306)	$ (8,642)	$ (49,512)	$ (26,004)
Net loss attributable to NCIs	(2,784)			(1,761)			(4,675)	(3,347)
HSCP LLC
Subsidiary-specific information [Line Items]
Net loss allocable to HSCP/USCo2	$ (16,549)			$ (10,052)			$ (27,589)	$ (18,882)
HSCP/USCo2 weighted average ownership % of HSCP	16.84%			17.57%			16.96%	17.80%
Net loss allocated to HSCP/USCo2	$ (2,787)			$ (1,766)			$ (4,679)	$ (3,361)
Net loss allocated to other NCIs	$ 3			$ 5			$ 4	$ 14

XML

SHAREHOLDERS’ EQUITY AND NON-CONTROLLING INTERESTS (Schedule of Conversions by Stock) (Details) - shares shares in Thousands	9 Months Ended	12 Months Ended
	Sep. 30, 2022	Dec. 31, 2021
Convertible Units Outstanding [Roll Forward]
Beginning balance	23,076	24,142
NCI units converted to Pubco	(378)	(1,066)
Ending balance		23,076
NCI Convertible Units
Convertible Units Outstanding [Roll Forward]
Ending balance	22,698

XML

EQUITY-BASED COMPENSATION EXPENSE (Expense by Plan) (Details) - Equity-based compensation - Plan shares in Thousands	9 Months Ended
	Sep. 30, 2022 shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Percentage of outstanding stock	15.00%
Shares available for grant (in shares)	3,199

XML

EQUITY-BASED COMPENSATION EXPENSE (RSU) (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands		3 Months Ended		9 Months Ended
	Sep. 23, 2020	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Restricted Stock Units (RSUs)
Weighted Average Grant Date Fair Value
Granted (USD per share)	$ 6.41
Requisite service period				3 years
Equity-based compensation expense		$ 2,256	$ 3,092	$ 7,645	$ 14,044
Fair value		1,427	$ 718	$ 4,760	$ 15,045
Weighted average remaining contractual term				2 years
Aggregate intrinsic value, outstanding		3,856		$ 3,856
Unrecognized compensation expense		$ 13,005		$ 13,005
Unrecognized compensation expense, period				1 year
Restricted Stock Units, Fixed
RSUs
Beginning Balance (shares)				3,188
Granted (shares)				7,717
Forfeited (shares)				(533)
Vested (shares)				(3,811)
Ending Balance (shares)		6,561		6,561
Vested and unreleased (shares)		225		225
Outstanding (shares)		6,786		6,786
Weighted Average Grant Date Fair Value
Beginning Balance (USD per share)				$ 7.30
Granted (USD per share)				0.67
Forfeited (USD per share)				2.07
Vested (USD per share)				4.08
Ending Balance (USD per share)		$ 1.80		1.80
Vested and unreleased (USD per share)		5.80		5.80
Outstanding (USD per share)		$ 1.93		$ 1.93
Restricted Stock Units, Floating
RSUs
Beginning Balance (shares)				1,262
Granted (shares)				95
Forfeited (shares)				(83)
Vested (shares)				(764)
Ending Balance (shares)		510		510
Vested and unreleased (shares)		24		24
Outstanding (shares)		534		534
Weighted Average Grant Date Fair Value
Beginning Balance (USD per share)				$ 7.39
Granted (USD per share)				1.19
Forfeited (USD per share)				2.54
Vested (USD per share)				7.90
Ending Balance (USD per share)		$ 6.27		6.27
Vested and unreleased (USD per share)		15.15		15.15
Outstanding (USD per share)		$ 6.67		$ 6.67

XML

EQUITY-BASED COMPENSATION EXPENSE (Options) (Details) - USD ($)	1 Months Ended	3 Months Ended		9 Months Ended
	May 31, 2022	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Weighted Average Exercise Price
Weighted average remaining contractual term				5 years
Weighted average remaining contractual term, exercisable				6 years
Cost not yet recognized		$ 2,182,000		$ 2,182,000
Fixed Shares
Options
Beginning balance (shares)				1,529,000
Granted (shares)				5,849,000
Forfeited (shares)				(41,000)
Expired (shares)				0
Ending balance (shares)		7,337,000		7,337,000
Exercisable (shares)		1,229,000		1,229,000
Weighted Average Exercise Price
Beginning balance (USD per share)				$ 11.07
Granted (USD per share)				0.59
Forfeited (USD per share)				5.66
Expired (USD per share)				0
Ending balance (USD per share)		$ 2.75		2.75
Exercisable (USD per share)		$ 12.85		$ 12.85
Aggregate intrinsic value for options outstanding		$ 0		$ 0
Floating Shares
Options
Beginning balance (shares)				2,414,000
Granted (shares)				0
Forfeited (shares)				(91,000)
Expired (shares)				(20,000)
Ending balance (shares)		2,303,000		2,303,000
Exercisable (shares)		1,925,000		1,925,000
Weighted Average Exercise Price
Beginning balance (USD per share)				$ 3.06
Granted (USD per share)				0
Forfeited (USD per share)				2.57
Expired (USD per share)				2.55
Ending balance (USD per share)		$ 3.09		3.09
Exercisable (USD per share)		$ 3.14		$ 3.14
Options
Weighted Average Exercise Price
Vesting period				3 years
Equity-based compensation expense		$ 300,000	$ 1,076,000	$ 725,000	$ 3,147,000
Unrecognized compensation expense, period				2 years
Options | Minimum
Weighted Average Exercise Price
Expiration period				5 years
Weighted average remaining contractual term				4 years
Options | Maximum
Weighted Average Exercise Price
Expiration period				10 years
Weighted average remaining contractual term				4 years
Other Fixed Shares
Weighted Average Exercise Price
Shares issued (in shares)	301
Other Floating Shares
Weighted Average Exercise Price
Shares issued (in shares)	127
Other Shares
Weighted Average Exercise Price
Equity-based compensation expense	$ 600,000

XML

COMMITMENTS AND CONTINGENCIES (Commitments and Prior Plan of Arrangement with Canopy Growth) (Details) $ in Thousands	Sep. 30, 2022 USD ($)	Jun. 19, 2019 company
Commitments and Contingencies Disclosure [Abstract]
Maximum obligation under lines of credit receivable | $	$ 15,150
Number of companies involved In agreement | company		2

XML

COMMITMENTS AND CONTINGENCIES (Second Amendment to the Arrangement Agreement) (Details) $ / shares in Units, $ in Thousands	Sep. 23, 2020 USD ($) $ / shares shares
Business Acquisition [Line Items]
Cash payment | $	$ 37,500
Fixed shares percent - canopy reorganization | $ / shares	$ 0.3048
Exerciseable period - canopy reorganization	30 days
Expiration period - canopy reorganization	10 years
Canopy Growth
Business Acquisition [Line Items]
Maximum number of shares allowed for issuance under agreement (in shares)	32,700,000
Restricted Stock Units (RSUs)
Business Acquisition [Line Items]
Weighted average grant date fair value (USD per share) | $ / shares	$ 6.41
Fixed Shares
Business Acquisition [Line Items]
Percent of share - canopy reorganization	0.7
Floating Shares
Business Acquisition [Line Items]
Percent of share - canopy reorganization	0.3
PVS, Fixed Shares
Business Acquisition [Line Items]
Canopy reorganization, shares exchanged (in shares)	28
PVS, Floating Shares
Business Acquisition [Line Items]
Canopy reorganization, shares exchanged (in shares)	12
Fixed Multiple Share
Business Acquisition [Line Items]
Percent of share - canopy reorganization	0.7
Floating Multiple Share
Business Acquisition [Line Items]
Percent of share - canopy reorganization	0.3

XML

COMMITMENTS AND CONTINGENCIES (Debenture) (Details) - Canopy Growth - Canopy Growth - 11065220 Canada Inc	Sep. 23, 2020 USD ($)
Business Acquisition [Line Items]
Face amount	$ 100,000,000
Debenture
Business Acquisition [Line Items]
Debenture amount, amount advanced	50,000,000
Debenture amount, amount to be advanced	$ 50,000,000
EBITDA ratio measurement period	90 days
Interest coverage ratio	2.0
Interest rate (percent)	6.10%
Debt term	10 years
Period non-core divestitures are completed	18 months

XML

COMMITMENTS AND CONTINGENCIES (Advisor fee) (Details) - USD ($) $ in Thousands	1 Months Ended	9 Months Ended
	Nov. 07, 2022	Sep. 30, 2022
Loss Contingencies [Line Items]
Advisor fee		$ 7,000
Subsequent Event
Loss Contingencies [Line Items]
Advisor fee	$ 3,000
Intial Payment Of Advisor	500
Payment to advisor in share value	$ 2,000

XML

COMMITMENTS AND CONTINGENCIES (Surety Bonds) (Details) $ in Thousands	9 Months Ended
	Sep. 30, 2022 USD ($)
Commitments and Contingencies Disclosure [Abstract]
Indemnification obligation, surety bonds	$ 5,000

XML

COMMITMENTS AND CONTINGENCIES (Canwell Settlement) (Details) - CanWell Settlement - USD ($) $ in Thousands	1 Months Ended	20 Months Ended
	Nov. 30, 2020	Jun. 30, 2022
Loss Contingencies [Line Items]
Accrued loss contingency loss	$ 7,750
Repayments of promissory note		$ 3,792

XML

COMMITMENTS AND CONTINGENCIES (New York Outstanding Litigation and Lease Dispute) (Details)	Nov. 02, 2018 defendant
New York Outstanding Litigation
Loss Contingencies [Line Items]
Number of defendants	16

XML

RELATED PARTY TRANSACTIONS (Details) $ / shares in Units, shares in Thousands				1 Months Ended			3 Months Ended	9 Months Ended
	Dec. 16, 2021 USD ($)	Sep. 28, 2020 USD ($) $ / shares shares	Sep. 23, 2020 USD ($)	Apr. 30, 2022 USD ($)	Jun. 30, 2021 segment	May 31, 2021 USD ($) promissor_Note	Sep. 30, 2022 USD ($)	Sep. 30, 2022 USD ($)
Related Party Transaction [Line Items]
Number of promissory notes sold | promissor_Note						2
Amount invested		$ 34,019,000
Repayment of short-term debt		$ 18,000,000
Universal Hemp | Investment Partnership
Related Party Transaction [Line Items]
Financial interest in the Investment partnership		100.00%
6.10% Secured debenture due September 2030
Related Party Transaction [Line Items]
Interest rate (percent)			6.10%				6.10%	6.10%
Interest expense, related party							$ 624,000	$ 1,851,000
7.50% Loan due April 2026
Related Party Transaction [Line Items]
Interest rate (percent)		7.50%					7.50%	7.50%
Debenture amount, amount advanced		$ 33,000,000
Debt issuance costs		959,000
9.75% Credit facilities due January 2026
Related Party Transaction [Line Items]
Interest rate (percent)	9.75%						9.75%	9.75%
Face amount	$ 150,000,000
Unused line fee, percentage	3.00%
9.75% Credit Facilities Due January 2026, Initial Draw
Related Party Transaction [Line Items]
Face amount	$ 75,000,000
9.75% Credit Facilities Due January 2026, Delayed Draw
Related Party Transaction [Line Items]
Face amount	25,000,000
Proceeds from delayed draw facility				$ 25,000,000
9.75% Credit Facilities Due January 2026, Committed Accordion Facility
Related Party Transaction [Line Items]
Face amount	50,000,000
Notes Receivable | Disposed of by Sale, Promissory Note | Viridescent Realty Trust, Inc
Related Party Transaction [Line Items]
Number of promissory notes sold | segment					2
Proceeds from sale of finance receivables						$ 28,000
Notes Receivable | Disposed of by Sale, Additional Cash | Viridescent Realty Trust, Inc
Related Party Transaction [Line Items]
Proceeds from sale of finance receivables						$ 26,000
Third-Party Syndicated Affiliates | 9.75% Credit facilities due January 2026
Related Party Transaction [Line Items]
Debt instrument, committed amount	70,000,000
Viridescent Realty Trust, Inc | 9.75% Credit facilities due January 2026
Related Party Transaction [Line Items]
Debt instrument, committed amount	30,000,000
Interest expense, related party							$ 824,000	$ 2,215,000
Viridescent Realty Trust, Inc | 9.75% Credit Facilities Due January 2026, Initial Draw
Related Party Transaction [Line Items]
Debt instrument, committed amount	$ 100,000,000
Universal Hemp | Universal Hemp
Related Party Transaction [Line Items]
Amount invested		$ 34,019,000
High Street or its wholly owned subsidiaries | Michigan Consulting Agreement
Related Party Transaction [Line Items]
Consulting fees or rents paid								$ 0
Class B Units | MB Melody LP | Universal Hemp | Investment Partnership
Related Party Transaction [Line Items]
Number of shares acquired (in shares) | shares		34,019
Par value (USD per share) | $ / shares		$ 1
Debenture | Universal Hemp | Canopy Growth | Canopy Growth | Universal Hemp
Related Party Transaction [Line Items]
Debenture amount, amount advanced			$ 50,000,000
Debt issuance costs			$ 4,025,000
Convertible Debt | Securities Purchase Agreement
Related Party Transaction [Line Items]
Repayment of short-term debt		$ 11,000,000

XML

REPORTABLE SEGMENTS (Details)	9 Months Ended
	Sep. 30, 2022 segment
Segment Reporting [Abstract]
Number of reportable segments	1

XML

EARNINGS PER SHARE (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended			9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021		Sep. 30, 2022	Sep. 30, 2021
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Net loss attributable to common shareholders of the Company	$ (22,214)	$ (12,296)		$ (44,837)	$ (22,657)
Weighted average shares outstanding - basic (in share)	111,200	106,332	[1]	108,795	104,524	[1]
Effect of dilutive securities (in shares)	$ 0	$ 0		$ 0	$ 0
Weighted average shares - diluted (in share)	111,200	106,332	[1]	108,795	104,524	[1]
Net loss per share attributable to common shareholders of the Company - basic (USD per share)	$ (0.20)	$ (0.12)	[1]	$ (0.41)	$ (0.22)	[1]
Net loss per share attributable to common shareholders of the Company - diluted (USD per share)	$ (0.20)	$ (0.12)	[1]	$ (0.41)	$ (0.22)	[1]
Antidilutive shares (in shares)				47,999	42,621
Restricted Stock Units, Fixed
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive shares (in shares)	6,786			6,786
Restricted Stock Units, Floating
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive shares (in shares)	534			534
Fixed Shares
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive shares (in shares)	7,337			7,337
Floating Shares
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive shares (in shares)	2,303			2,303
Fixed Warrants
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive shares (in shares)	5,817	7,131		5,817	7,131
Floating Warrants
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive shares (in shares)	2,524	3,087		2,524	3,087
Restricted Stock Units, Fixed
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive shares (in shares)		3,621			3,621
Restricted Stock Units, Floating
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive shares (in shares)		1,757			1,757
Fixed Shares
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive shares (in shares)		1,530			1,530
Floating Shares
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive shares (in shares)		2,419			2,419
NCI Convertible Units
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive shares (in shares)	22,698	23,076		22,698	23,076

[1] Presentation of September 30, 2021 figures have been revised.

XML

SUBSEQUENT EVENTS (Details) - Subsequent Event $ in Thousands	Oct. 25, 2022 Rate	Oct. 24, 2022 USD ($)
Acreage Holdings | Canopy Growth and Canopy USA, LLC
Subsequent Event [Line Items]
Consideration of common share (in shares) | Rate	45.00%
Certain directors and current and former officers holdings (percent)	0.073
Amended Credit Facility
Subsequent Event [Line Items]
Credit facility amount		$ 150,000
Amount available for immediate draw		$ 25,000
Fee percentage		1.00%
Amendment fee amount		$ 1,250
Amended Credit Facility | Acreage Holdings | Canopy Growth and Canopy USA, LLC
Subsequent Event [Line Items]
Consideration of common share (in shares) | Rate	30.48%
Percentage of voting interests acquired (percent)	70.00%
Amended Credit Facility | Prime
Subsequent Event [Line Items]
Interest rate (percent)		5.75%
Prime floor (percent)		5.50%

XML

Label	Element	Value
High Street Capital Partners, LLC (“HSCP”) [Member] | Current Holders [Member] | Tax Receivable Agreement [Member] | Canopy Growth Corporation [Member] | Subsequent Event [Member]
Tax Receivable Agreement, Equity Interests Issued And Issuable	acrg_TaxReceivableAgreementEquityInterestsIssuedAndIssuable	$ 15,300,000
High Street Capital Partners, LLC (“HSCP”) [Member] | Directors, Officers And Consultants [Member] | Canopy Growth Corporation [Member] | Subsequent Event [Member]
Tax Receivable Agreement, Equity Interests Issued And Issuable	acrg_TaxReceivableAgreementEquityInterestsIssuedAndIssuable	19,500,000
Canopy Growth and Canopy USA, LLC [Member] | Tax Receivable Agreement, Eligible Participants [Member] | Canopy Growth Corporation [Member] | Subsequent Event [Member]
Tax Receivable Agreement, Final Consideration Issuable, Equity Interests	acrg_TaxReceivableAgreementFinalConsiderationIssuableEquityInterests	19,500,000
Canopy Growth and Canopy USA, LLC [Member] | Tax Receivable Agreement, Eligible Participants [Member] | Tax Receivable Agreement [Member] | Canopy Growth Corporation [Member] | Subsequent Event [Member]
Tax Receivable Agreement, Equity Interests Issued And Issuable	acrg_TaxReceivableAgreementEquityInterestsIssuedAndIssuable	15,300,000
Canopy Growth and Canopy USA, LLC [Member] | Current And Former Unit Holders [Member] | Canopy Growth Corporation [Member] | Subsequent Event [Member]
Tax Receivable Agreement, Equity Interests Issued And Issuable	acrg_TaxReceivableAgreementEquityInterestsIssuedAndIssuable	$ 30,500,000